Announcements

26 March 2024
Journal of Personalized Medicine | Highly Cited Special Issues about Respiratory Disease in 20222023


We are pleased to invite you to read the highly cited Special Issues in 2022–2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) about respiratory disease. We hope that this announcement will provide useful information for this field.

The Special Issues list is as follows:

Asthma: From Phenotypes to Personalized Medicine
Edited by Prof. Dr. Petros Bakakos
Views: 31000+ | Cited by 85+

Personalized Therapy of Asthma
Edited by Dr. Luisa Brussino
Views: 17000+ | Cited by 30+

 

Challenges in COVID-19 and Related Complications
Edited by Prof. Dr. Amelia Filippelli and Dr. Valeria Conti
Views: 15000+ | Cited by 25+

Clinical Presentation, Treatment and Vaccination in COVID-19
Edited by Prof. Dr. Dorota Zarębska-Michaluk and Prof. Dr. Robert Flisiak
Views: 10000+ | Cited by 20+

You are welcome to view all the Special Issues and submit relevant papers to the Journal of Personalized Medicine. If you have any questions, you can contact the JPM Editorial Office.

Journal of Personalized Medicine Editorial Office

23 March 2024
Journal of Personalized Medicine | Most Cited Papers in 2022–2023 in the Section “Epidemiology”


We are pleased to invite you to read the most cited papers in 2022­­–2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Epidemiology”. The list of papers is as follows:

1. “Oral Health among Elderly, Impact on Life Quality, Access of Elderly Patients to Oral Health Services and Methods to Improve Oral Health: A Narrative Review”
by Michael Janto, Raluca Iurcov, Cristian Marius Daina, Daniela Carmen Neculoiu, Alina Cristiana Venter, Dana Badau, Adrian Cotovanu, Marcel Negrau, Corina Lacramioara Suteu, Monica Sabau et al.
J. Pers. Med. 2022, 12(3), 372; https://doi.org/10.3390/jpm12030372
Available online: https://www.mdpi.com/2075-4426/12/3/372

2. “Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature”
by Andrea Perrottelli, Noemi Sansone, Giulia Maria Giordano, Edoardo Caporusso, Luigi Giuliani, Antonio Melillo, Pasquale Pezzella, Paola Bucci, Armida Mucci and Silvana Galderisi
J. Pers. Med. 2022, 12(12), 2070; https://doi.org/10.3390/jpm12122070
Available online: https://www.mdpi.com/2075-4426/12/12/2070

3. “MicroRNAs—A Promising Tool for Asthma Diagnosis and Severity Assessment: A Systematic Review”
by Mohammed Aref Kyyaly, Elena Vladimirovna Vorobeva, Dilini M. Kothalawala, Wei Chern Gavin Fong, Peijun He, Collin L. Sones, Mohammad Al-Zahrani, Tilman Sanchez-Elsner, Syed Hasan Arshad and Ramesh J. Kurukulaaratchy
J. Pers. Med. 2022, 12(4), 543; https://doi.org/10.3390/jpm12040543
Available online: https://www.mdpi.com/2075-4426/12/4/543

4. “Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis”
by Bernadette Corica, Giulio Francesco Romiti, Stefania Basili and Marco Proietti
J. Pers. Med. 2022, 12(4), 547; https://doi.org/10.3390/jpm12040547
Available online: https://www.mdpi.com/2075-4426/12/4/547

5. “Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome”
by Carles Perpiñan, Laia Bertran, Ximena Terra, Carmen Aguilar, Jessica Binetti, Miguel Lopez-Dupla, Anna Rull, Laia Reverté, Elena Yeregui, Frederic Gómez-Bertomeu et al.
J. Pers. Med. 2022, 12(3), 391; https://doi.org/10.3390/jpm12030391
Available online: https://www.mdpi.com/2075-4426/12/3/391

6. “Neutralization Assessments Reveal High Cardiothoracic Ratio and Old Age as Independent Predictors of Low Neutralizing Antibody Titers in Hemodialysis Patients Receiving a Single Dose of COVID-19 Vaccine”
by Chun-Yu Chen, Kuan-Ting Liu, Shin-Ru Shih, Jung-Jr Ye, Yih-Ting Chen, Heng-Chih Pan, Heng-Jung Hsu, Chiao-Yin Sun, Chin-Chan Lee, Chun-Ying Wu et al.
J. Pers. Med. 2022, 12(1), 68; https://doi.org/10.3390/jpm12010068
Available online: https://www.mdpi.com/2075-4426/12/1/68

7. “Impact of Smoking Status on Lung Cancer Characteristics and Mortality Rates between Screened and Non-Screened Lung Cancer Cohorts: Real-World Knowledge Translation and Education”
by Fu-Zong Wu, Yun-Ju Wu, Chi-Shen Chen and Shu-Ching Yang
J. Pers. Med. 2022, 12(1), 26; https://doi.org/10.3390/jpm12010026
Available online: https://www.mdpi.com/2075-4426/12/1/26

8. “Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis”
by Ippazio Cosimo Antonazzo, Carla Fornari, Sandy Maumus-Robert, Eleonora Cei, Olga Paoletti, Pietro Ferrara, Sara Conti, Paolo Angelo Cortesi, Lorenzo Giovanni Mantovani, Rosa Gini et al.
J. Pers. Med. 2022, 12(2), 178; https://doi.org/10.3390/jpm12020178
Available online: https://www.mdpi.com/2075-4426/12/2/178

9. “COVID-19 Vaccines during Pregnancy and Breastfeeding: A Systematic Review”
by Blanca Novillo and Alicia Martínez-Varea
J. Pers. Med. 2023, 13(1), 40; https://doi.org/10.3390/jpm13010040
Available online: https://www.mdpi.com/2075-4426/13/1/40

10. “Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term Perspective”
by Hyo Geun Choi, Ho Suk Kang, Hyun Lim, Joo-Hee Kim, Ji Hee Kim, Seong-Jin Cho, Eun Sook Nam, Kyueng-Whan Min, Ha Young Park, Nan Young Kim et al.
J. Pers. Med. 2022, 12(7), 1144; https://doi.org/10.3390/jpm12071144
Available online: https://www.mdpi.com/2075-4426/12/7/1144

4 March 2024
MDPI Insights: The CEO's Letter #9 - Romania, Research Integrity, Viruses

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts


Reka Kovacs (Deputy Office Manager, MDPI), Stefan Tochev (CEO, MDPI), and Sandra Ana Spatariu (Office Manager, MDPI) at the MDPI office in Cluj, Romania.

MDPI’s Impact on Romania

In February, I visited our office in Cluj, Romania. I worked closely with our senior office managers and various teams, including the departments of training, marketing and conferences, as well as our journal relationship specialists, reviewing our service to the local scholarly community. During the visit, I also met with representatives from Babes-Bolyai University and the Technical University of Cluj-Napoca. Our multifunctional Romanian office plays an important role in supporting our collaborations with the local market as well as helping to meet MDPI’s overall business needs.


Feedback and strategy meeting with a group of MDPI’s Journal Relationship Specialists at the MDPI office in Cluj, Romania.

With 22,436 articles, Romania ranks as a top 20 contributing country to MDPI’s total number of papers published as at 28 February 2024. This highlights the importance of our collaboration with Romanian-affiliated authors and the growing opportunity to support their publishing needs. MDPI is one of the few academic publishers with a significant presence in Romania, boasting over 360 colleagues across our offices in Bucharest and Cluj. We are also proud to hire colleagues from local institutions to launch their careers within publishing.

Romania ranks as a top 20 contributing country.

The Numbers: 2019–2023

MDPI has seen a healthy increase in submissions from Romanian authors over the past three years, from 8,439 in 2021 to 11,866 by end of 2023, with most submissions going to journals such as Sustainability, Medicina, Diagnostics, IJMS, Applied Sciences, and JCM. From 2019 to 2023, MDPI published articles from 32,145 authors affiliated with Romanian institutions. Over those years, we have worked with Romanian Guest Editors on nearly 3,000 occasions to support their Special Issue and Topical collections.

With more than 300 Editorial Board Members from Romania, 34 appear on the board of Mathematics, 27 on Materials, 19 on Polymers, 18 on Coatings, and 16 on Molecules, while three serve as Section Editors-in-Chief (SEiC) on our journals Coatings (3.4 IF, 4.6 Citescore), Magnetochemistry (2.7 IF, 3.5 Citescore), and Chemosensors (4.2 IF, 3.9 Citescore).

Institutional Open Access Programs

Our commitment to working with institutions is evident in Romania, where we have established eight Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Bucharest, the University of Medicine and Pharmacy Cluj-Napoca, and most recently the National Institute for Laser, Plasma and Radiation Physics.

Our growth and presence in Romania are a true testament.

We also have IOAP agreements with Babes-Bolyai University and the Technical University of Cluj-Napoca, where I had the opportunity to meet senior stakeholders during my visit. Below are a few photos capturing our meeting with Prof. Radu Silaghi-Dumitrescu (Head of Faculty of Chemistry, Babes-Bolyai University) at the MDPI office in Cluj, Romania, along with a photo from our meeting with Vice Deans Nicoleta Cobarzan, Nicoleta Ilies, and Hoda Gavril, from the faculty of Civil Engineering at the Technical University of Cluj, Romania.


Our growth and presence in Romania are a true testament to the service we provide to the scholarly community and the relationships we foster in that region. We look forward to continuing to support Romanian scholars and institutions by providing a valuable and trusted experience with MDPI, the leader in open access publishing.

Impactful Research

MDPI Joins the STM Integrity Hub

MDPI has long been a supporter and partner of STM, with our involvement ranging from sponsoring and attending events to helping organize event programs. By joining the STM Integrity Hub, we aim to further our commitment to STM initiatives aimed at safeguarding the integrity of science.

“We are pleased to welcome MDPI as the 35th organisation participating in the Hub. This expansion is critical, as every new member enhances our capacity to prevent fraudulent submissions from entering the academic record.”

Joris van Rossum, Director of Research Integrity, STM

MDPI operates in full alignment with STM Integrity Hub's values of shared data and experiences. We strongly believe in collaboration and open exchange for the purposes of creating a holistic approach to support research integrity at MDPI itself and across the entire academic publishing industry. The Integrity Hub is an excellent example of how publishers can come together to jointly address industry-wide challenges related to research integrity, such as manuscripts that breach research integrity standards and paper-mills.

I look forward to our Research Integrity and Publication Ethics Team (RIPE) team immersing themselves in this initiative, exchanging information, best practices, and tools for the benefit of the entire scholarly ecosystem. We believe that ethical publishing standards should be implemented across the board, and we aim to be rigorous in our approach, addressing research integrity issues and improving the impact of published research.

Inside MDPI

MDPI Expands Research Integrity and Publication Ethics Team (RIPE)

In addition to external collaborations and joint initiatives aimed at further strengthening our commitment to research integrity, we are also enhancing our internal efforts. This includes improving our processes and guidelines and expanding our teams and departments to ensure quality assurance throughout our publishing process.

We are pleased to announce the expansion of our Research Integrity and Publication Ethics Team (RIPE) at MDPI. The RIPE team has recently welcomed new colleagues, each bringing unique skills and a personal commitment to prioritize ethical considerations in all our work.

The demand for research integrity and high ethical standards in academic publishing is steadily rising across our industry. Our expanded RIPE team will work to enhance and align our practices with industry best practices, ensuring excellence in research integrity and publication ethics.


Stefan Tochev (CEO, MDPI) introduces Dr. Tim Tait-Jamieson (Research Integrity Lead, MDPI) for his presentation on MDPI’s Retraction and Approval Process to a group of Journal Relationship Specialists at the MDPI office in Cluj, Romania: “The demand for research integrity and publication ethics is steadily rising across our industry.”

Introducing our Research Integrity and Publication Ethics Team

Led by Dr. Tim Tait-Jamieson (Research Integrity Lead), the RIPE team comprises Dr. Ivana Resanovic (Research Integrity Manager), Dr. Lavinia Rogojina (Research Integrity Manager), Ms. Diana Apodaritei (Research Integrity Specialist), Dr. Zoltan Mihaly (Research Integrity Specialist), Mr. Aleksandar Đukić (Research Integrity Specialist), Ms. Ana Stankovic (Research Integrity Specialist), and Ms. Anna Pena (Publication Ethics Assistant).

Please click here to access everything that you need to know about MDPI’s Research and Publication Ethics.

With this span of complementary roles, the RIPE team collaborates directly with journal editorial teams and works closely with various departments, including our Scientific Office Board and our Journal Relationship Specialists. The team’s primary objectives are to help prevent issues regarding research integrity and publication ethics during peer review, uphold MDPI’s ethics policies, adhere to industry standards, and resolve publication ethics and research integrity issues and complaints.

Quality Updates to Special Issues Oversight

At MDPI, we are committed to reviewing policies pertaining to the quality of research. In this blog post, Shaheena Patel (Communications Associate, MDPI), outlines two recent updates to MDPI journal processes. These updates pertain to Special Issue (SI) quality guidelines, in line with criteria provided by COPE and DOAJ. Alongside the SI updates, details regarding the new minor corrections policy introduced in 2024 are provided in the blog.

The two updates we implemented include greater oversight and the verification of Guest Editor credentials. These guidelines require that Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) take responsibility for overseeing SIs.

PS. Thank you, James Butcher, for featuring this up in your 67th issue of the Journalogy newsletter.

Read more:

Coming Together for Science

Viruses 2024 – A World of Viruses

I am pleased to share the success of our MDPI conference Viruses 2024 – A World of Viruses, held 14-16 February, in Barcelona. With 240 registrations, this event brought together top scientists, researchers, and industry experts from 40 countries to share their findings on the latest developments in viral pathogenesis and immune responses.

Attendees gathered for the 5th edition of the Viruses’ conference, where we hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes, along with 14 invited speakers, 47 selected speakers, and nine flash poster presenters, to discuss the most significant issues in virology today.

Recap on the #Viruses2024 Conference

Take a look at the key moments from MDPI’s Viruses event and please join us in commemorating a gathering for global knowledge and cooperation. A heartfelt thank-you to all attendees; their passion and engagement played a crucial role in making this event an engaging success!

Below are calls to action from the keynote speakers encouraging collaboration and communication:

“There’s never been a better time than now to really take the power that we have both in terms of basic research and also in biotech and pharma to develop antiviral agents.” - Dr. Charles M. Rice, The Rockefeller University, New York, USA

“The collaboration between labs is absolutely essential. Improving initial detection and improving communication is a must for all of us working in science.” - Prof. Dr. Luis Enjuanes, National Center of Biotechnology (CNB-CSIC), Madrid, Spain

Our thanks go to our sponsors and partnering societies, our Viruses journal and editorial team, our Barcelona colleagues, and the social media, conference and other MDPI teams for making this event a memorable occasion. View the event gallery here.

Upcoming In-Person Event

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities
Location: Barcelona, Spain

Esteemed speakers at MMCS 2024 include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.

Find more upcoming MDPI events here.


Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Researcher to Reader (R2R) Conference

From 20–21 February 2024, I had the pleasure of attending the Researcher to Reader (R2R) conference in London, which MDPI has proudly sponsored over the years. The conference programme offered a variety of session formats, including workshops, panel discussions, debates, interviews, presentations, and lightning talks, with opportunities to discuss relevant topics.

We take pride in supporting the scientific community, bringing researchers across the world together to network, exchange ideas and share the latest in science and publishing. In 2023, MDPI invested close to 2 million CHF in sponsoring over 2,000 scientific and publishing-related conferences worldwide.

R2R Peer Review Innovations Workshop

I found the R2R conference to be engaging, with the workshops being particularly enjoyable. My colleague Giulia Stefenelli (Chair of Scientific Office Board) and I participated in the “Peer Review Innovations” workshop, which spanned four sessions over the two days. These sessions explored the future of peer review and how we can improve the peer review process for everyone involved. Notably, the large majority of attendees expressed their opinion that peer review, as currently practiced, requires significant improvement. Together, we collaborated on potential immediate and long-term improvements and innovative processes, aiming to create an ecosystem beneficial to all stakeholders by strengthening submission systems with the aim of reducing threats and making authors more responsible for their work. We also discussed the opportunity for academic institutions to better scrutinize the quality of the work produced and submitted to journals.

Our group comprised publishers, software providers, librarians, and more, bringing diverse perspectives to the discussions. These interactions were relevant to MDPI’s ongoing conversations, providing insights to our efforts. The session also made me appreciate that MDPI is doing well, as the group discussions included the subject of various quality checks that we have already embedded in our processes, ensuring that we keep abreast of industry standards.

The need for an optimized system to incentivize the activities of editors and reviewers was also a focus of discussion, as well as the support that reviewers need from publishers via the provision of strong reports through fixed forms, questionnaires and training.

At MDPI, we are currently auditing our reviewer program to improve reviewer recognition, guidelines, and methods for identifying suitable reviewers, while maintaining our commitment to quality and timeliness.

Congratulations to Mark Carden, Conference Director, and the R2R team for organizing a productive and successful event. PS: The break times were greatly appreciated as well!

Stefan Tochev
Chief Executive Officer
MDPI AG

29 February 2024
Journal of Personalized Medicine | Most Viewed Special Issues in 2022–2023 in the Section “Clinical Medicine, Cell, and Organism Physiology”


We are pleased to invite you to read the most viewed Special Issues from 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Clinical Medicine, Cell, and Organism Physiology”. We hope this announcement will provide useful information for this field.

The Special Issue list is as follows:

The Current State of Psychiatry: Personalized Medicine and Treatment
Edited by Dr. Daichi Sone and Dr. Yoshihiro Noda
Views: 17000+ | Cited by 25+

Personalized Medicine in Acute Care Surgery: Postoperative Complications and Prognosis
Edited by Dr. Roberto Bini
Views: 17000+ | Cited by 10+

Establishment and Characterization of Novel Patient-Derived Cancer Cell Line
Edited by Dr. Yuki Yoshimatsu and Dr. Tadashi Kondo
Views: 15000+ | Cited by 25+

Care Personalization in Parkinson Disease
Edited by Dr. Tiago A. Mestre
Views: 14000+ | Cited by 10+

Advancements in Minimally Invasive Urological Surgery and Endourology
Edited by Dr. Dorit E. Zilberman
Views: 12000+ | Cited by 10+

Applied Invasive Coronary Physiology for Tailored Treatment of Coronary Artery Disease
Edited by Dr. Gábor Tamás Szabó and Dr. Zsolt Kőszegi
Views: 7800+ | Cited by 10+

You are welcome to view all the Special Issues and submit relevant papers to the Journal of Personalized Medicine. If you have any questions, you can contact the Editorial Office at [email protected].

Journal of Personalized Medicine Editorial Office

23 February 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022 in the Section “Pharmacogenetics”


We are pleased to invite you to read the most viewed papers in 2022 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Pharmacogenetics”. The list of papers is as follows:

1. “Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care”
by Elpiniki Rentzeperi, Stavroula Pegiou, Theocharis Koufakis, Maria Grammatiki and Kalliopi Kotsa
J. Pers. Med. 2022, 12(3), 454; https://doi.org/10.3390/jpm12030454
Available online: https://www.mdpi.com/2075-4426/12/3/454

2. “Advances in Preclinical In Vitro Models for the Translation of Precision Medicine for Cystic Fibrosis”
by Iris A. L. Silva, Onofrio Laselva and Miquéias Lopes-Pacheco
J. Pers. Med. 2022, 12(8), 1321; https://doi.org/10.3390/jpm12081321
Available online: https://www.mdpi.com/2075-4426/12/8/1321

3. “Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes”
by Artemis Kyriakidou, Angeliki V. Kyriazou, Theocharis Koufakis, Yiannis Vasilopoulos, Maria Grammatiki, Xanthippi Tsekmekidou, Iakovos Avramidis, Stefanos Baltagiannis, Dimitrios G. Goulis, Pantelis Zebekakis et al.
J. Pers. Med. 2022, 12(3), 424; https://doi.org/10.3390/jpm12030424
Available online: https://www.mdpi.com/2075-4426/12/3/424 

4. “The Rise of Population Genomic Screening: Characteristics of Current Programs and the Need for Evidence Regarding Optimal Implementation”
by Kimberly S. Foss, Julianne M. O’Daniel, Jonathan S. Berg, Sabrina N. Powell, Rosemary Jean Cadigan, Kristine J. Kuczynski, Laura V. Milko, Katherine W. Saylor, Megan Roberts, Karen Weck et al.
J. Pers. Med. 2022, 12(5), 692; https://doi.org/10.3390/jpm12050692
Available online: https://www.mdpi.com/2075-4426/12/5/692

5. “CFTR and Gastrointestinal Cancers: An Update”
by Rahul Bhattacharya, Zachary Blankenheim, Patricia M. Scott and Robert T. Cormier
J. Pers. Med. 2022, 12(6), 868; https://doi.org/10.3390/jpm12060868
Available online: https://www.mdpi.com/2075-4426/12/6/868

6. “Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study”
by Antonio Del Casale, Leda Marina Pomes, Luca Bonanni, Federica Fiaschè, Clarissa Zocchi, Alessio Padovano, Ottavia De Luca, Gloria Angeletti, Roberto Brugnoli, Paolo Girardi et al.
J. Pers. Med. 2022, 12(2), 316; https://doi.org/10.3390/jpm12020316
Available online: https://www.mdpi.com/2075-4426/12/2/316

7. “Evidence for Cardiorenal Protection with SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Patients with Diabetic Kidney Disease”
by Panagiotis I. Georgianos, Vasilios Vaios, Stefanos Roumeliotis, Konstantinos Leivaditis, Theodoros Eleftheriadis and Vassilios Liakopoulos
J. Pers. Med. 2022, 12(2), 223; https://doi.org/10.3390/jpm12020223
Available online: https://www.mdpi.com/2075-4426/12/2/223

8. “Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)”
by Josiah D. Allen, Lusi Zhang, Alyssa N. K. Johnson, Pamala A. Jacobson, Catherine A. McCarty, Amy L. Pittenger and Jeffrey R. Bishop
J. Pers. Med. 2022, 12(9), 1398; https://doi.org/10.3390/jpm12091398
Available online: https://www.mdpi.com/2075-4426/12/9/1398 

9. “Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis”
by Julie Mésinèle, Manon Ruffin, Loïc Guillot, Pierre-Yves Boëlle, Harriet Corvol and on behalf of the French CF Modifier Gene Study Investigators
J. Pers. Med. 2022, 12(2), 252; https://doi.org/10.3390/jpm12020252
Available online: https://www.mdpi.com/2075-4426/12/2/252

10. “Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy”
by Anna C. Virgili Manrique, Juliana Salazar, María Jesús Arranz, Silvia Bagué, Ruth Orellana, Antonio López-Pousa, Paula Cerdà, Isidre Gracia, Katarina Majercakova, Ana Peiró et al.
J. Pers. Med. 2022, 12(4), 618; https://doi.org/10.3390/jpm12040618
Available online: https://www.mdpi.com/2075-4426/12/4/618

23 February 2024
Meet Us at the 144th Annual Meeting of the Pharmaceutical Society of Japan, 28–31 March 2024, Yokohama, Japan


Conference: The 144th Annual Meeting of the Pharmaceutical Society of Japan
Date: 28–31 March 2024
Location: Yokohama, Japan

MDPI will be attending the 144th Annual Meeting of the Pharmaceutical Society of Japan at Booth #79, and we welcome researchers from different backgrounds to visit and share their latest ideas with us.

The theme of the 144th Annual General Meeting is: “Creation of a Pharmaceutical Culture that Co-prosperity with “Genes” and “Environment”: Toward the Integration of Sustainable “Digital Therapy”.

With the introduction of vaccines, the sale of therapeutic drugs, and the establishment of treatment systems, the fight against COVID-19 has become a coexistent situation. We hope that this annual general meeting will be an opportunity for many researchers, medical professionals, and educators involved in pharmaceutical research to gather, present the latest research results, and discuss how pharmaceutical education should be. We hope that it will be an opportunity to create sustainable innovations for the future.

The following MDPI journals will be represented:

  • Biomedicines;
  • JPM;
  • Molecules;
  • Pharmaceuticals;
  • Pharmaceuticals.

If you are planning on attending this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://confit.atlas.jp/guide/event/pharm144/top.

6 February 2024
Meet Us at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024), 27–30 April 2024, Barcelona, Spain


MDPI will attend the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) as an exhibitor. This conference will be held in Barcelona, Spain, from 27 to 30 April 2024.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.eccmid.org/.

2 February 2024
Acknowledgment of the Reviewers of JPM in 2023

In recognizing the exceptional efforts of our reviewers in 2023, we express our sincere gratitude for upholding the high standards of JPM. Their commitment ensured the rigorous peer review that is integral to quality academic publishing.

In 2023, JPM received 4960 review reports, from 4226 reviewers. This past year, we worked with reviewers from 92 countries and regions, reflecting the diversity in our collaboration with research communities. Their dedication shapes scholarly discourse and advances global research. The editorial team expresses gratitude for the vital role played by each reviewer in the JPM family throughout 2023, and we look forward to their continued support in 2024.

The following are the reviewers who have consented to show their names:

Abbirami Elangovan Koichi Taira
Abdelrahman Elsayid Komsun Suwannarurk
Abdolreza Jamilian Komuraiah Myakala
Abdou Zoure Konstantin Yarygin
Abdulqadir Nashwan Konstantinos Arvanitakis
Abdussalam Elhanashi Konstantinos Sidiropoulos
Abhijit Nair Konstantinos Tigkiropoulos
Abhishek Jha Konstantinos Tsaknakis
Abid Hussain Korhan Kilic
Abiola Adepoju Kota Kodama
Abouzar Najafi Kousalya Prabahar
Abraham Pouliakis Koustav Sarkar
Abraham Wall-Medrano Kresimir Basic
Abuzer Coskun Kristin Nieman
Ach Taieb Krisztina Martha
Adam Halinski Krzysztof Dowgierd
Adel Girgis Krzysztof Nowosielski
Adina Marza Kshama Gupta
Adina Thomaidis KuanJung Chen
Adity Pore Kulandaisamy Arulsamy
Adli Ali Kundlik Gadhave
Adrian Costache Kunihiko Umekita
Adriana Alexandru Lakshmi Menon
Adriana Grigoraș Lalu Muhammad Irham
Adriana Objelean Lan Zhao
Agata Pietrzak Lana Ei Osta
Agnieszka Drozdzik Laszlo Zavori
Agnieszka Jeleń Lateef Ahmad
Agnieszka Owczarczyk-Saczonek Laura Gilbertson
Agostino Guida Laura Hays
agostino roasio Laura Pittari
Ahmed Abdelnaser Mohamed Laura Zlibinaite
Ahmed Abu-Awwad Laurence Hamard
Ahmed Afify Laurentiu Simion
Ahmed Al-Abd Leandro Da Silva
Ahmed Bakillah Lee Nguyen
Ahmed Doghish Lenycia de Cassya Lopes Neri
Ahmed Elmasry Leonardo Euripedes de Andrade Silva
Ahmed Elshahat Leonardo Tariciotti
Ahmed Hamdan Leonardo Vivarelli
Ahmed Imran Leonid Bystrykh
Aida Petca Lesley Storey
Aiken Dao Lidia Perenc
Ajinkya Pawar Lidija Savić
Ajith Polopnowita Lilya Dzhemileva
Akihiko Katayama Lin Yang
Alberto Alperi Lincoln Faria da Silva
Alberto Martino Linda Frintrop
Aldo Bove Linda Hazlett
Alejandra García-Gasca Linda Peters
Aleksander Zwierz Ling Luo
Aleksandr Poliakov Liudmyla V. Garmanchuk
Aleksandras Vilionskis Livia Bobu
Alena Lochmannova livia nastri
Alessandra Sinopoli Ljiljana Jeličić
Alessandra Verzelloni Sef Lorenzo Caruso
Alessandro Alaimo Lorenzo Menicanti
Alessandro Mariani Lubomir Skladany
Alexander Korthaus Luca Di Gianfrancesco
Alexander Zemchenkov Luca Lazzari
Alexandra Filippopoulou Luca Potestio
Alexandrina Muntean Lucía Ortiz-Comino
Alexey Lipengolts Lucia Stanciakova
Alexey Piskunov Lucian Evdochim
Alfredo Téllez Valencia Lucio Mango
Ali Memarian Ludovica Anna Cimini
Alice Chiara Manetti Luigi Irace
Alin Nedelcu Luigi La Via
Alina Dima Luis Apaza Ticona
Alina González-Quevedo Luis Espejo-Antúnez
Alina Popa Luis Jacinto-Alemán
Alina Zorina Stuparu Stroe Luis López-Fernández
Alin-Constantin Pînzariu Luis Soares Luis
Alireza Baratloo Luka Clarke
Alireza Tafazoli Luka Matak
Allen Titus Lukas Holzer
Alperen Degirmenci Lukas Müller-Wirtz
Álvaro Dowling Lukasz Nawacki
Álvaro López-Díaz Łukasz Pulik
Alvaro Macias Łukasz Rzepiński
Alvaro Manuel Rodriguez-Rodriguez Lung-Chi Lee
Álvaro Plaza Reyes Lusi Zhang
Amany Abdel-Rahman Lut Tamam
Amaranta De Miguel-Rubio Luz Moran
Amin Nakhostin-Ansari Lyudmila Bel'skaya
Amit Chougule M. Belén Alonso Ortiz
Ammad Ahmad Farooqi M. Esperanza Cerdán
Ana I. Faustino-Rocha Maciej Skotak
Ana Leticia Fornari Caprara Maciej Zieliński
Ana Martins Madankumar Ghatge
Ana Teresa Gabriel Made Suandika
Ana Tomas Magdalena Chirilă
Anand Joshi Magdalena Emilia Grzybowska
Anand Paramasivam Magdalena Kurnik-Łucka
Anastasia Karlsen Magdalena Stasiak
Anastasios Potiris Magdalena Wujak
Anastasiya Kazantseva Mahesh Nepal
Ancuta Mihai Mahmoud Abdallah
Anders Örbom Makoto Nakamura
Andor Molnár Malene Pedersen
Andre Luiz Costa Małgorzata Klimek
Andrea Cassoni Małgorzata Matysek
Andrea Furka Małgorzata Sobiecka
Andrea Perrelli Mana Mukherjee
Andreas Brodehl manohar kodavati
Andreas Savelsbergh Manoj Temnjre
Andreas Schmutzler Mansoor Fateh
Andrei Colita Mansoor-Ali Vaali-Mohammed
Andrei Marian Feier Manuel Coheña-Jimenez
Andrej Belančić Manuel Florian Struck
Andrey Glotov Manuel López-Baamonde
Andrzej Brudnicki Manuel Muro
Andrzej Konieczny Manuel Rebollo Salas
Aneta Klotzka Maochun Wang
Aneta Wieczorek Marcello Della Corte
Ángel Luis García-Otín Marchel Vetrile
Angel Vértiz-Hernández Márcio Formiga
Angela De Palma Marco Dolci
Angela Madalina Lazar Marco Manzetti
Angelo Naselli Marco Zedda
Anish Ray Marcos Brioschi
Ankit Tanwar Marcus Horstmann
Ankona Banerjee Marcus Mareel
Ankush Jamthikar Marek Paul
Anna Charuta Mária Belovičová
Anna Drabczyk Maria Blanco-Diaz
Anna Kasielska-Trojan Maria Cristina Cangussú
Anna Koumarianou Maria Guembe
Anna Pieczyńska Maria Kalafati
Anna Staniszewska Maria Lasalvia
Anna Szumilewicz Maria Loureiro
Anna Zalewska Maria Malvina Tsamouri
Annalisa Pace Maria P Ntalouka
Anson Kai Chun Chau Maria Papasavva
Anthony Valverde Maria Paulino
Antigoni Sakellaropoulou Maria Radanova
Anton Kiselev María Rúa-Alonso
Anton Tkachenko Maria Simonenko
Antonella De Luca Maria Szubert
Antonino Di Pino Maria Zavala-Cerna
Antonio Borzelli Marialuisa Zedde
Antonio Pontoriero Marian Simka
Antonio Santagostini Marilena Mangiardi
Antonio Vinci Marin Lozić
Anwar Sayed Marin Ogorevc
Apostolos Agrafiotis Marina Chukalina
Apostolos Zaravinos Marina Quartu
Arianna Di Stadio Marino Paroli
Arif Sabta Aji Mario Šokac
Aris Kaltsas Mário Sousa
Arlette Setiawan Marios Spanakis
armencea gabriel Mariusz Niemczyk
Aron Tendler Mariusz Siemiński
Arrigo Cicero Mariza Vorster
arshiya Sultana Marjan Mirsalehi
Arun Pandian J Marko Baralić
Asaad Babker Marko Bašković
Ashton Theakstone Marko Tarle
Ashwani Sharma Marouan Zoghbi
Asmaa Khafaga Marta Rogalska
Atar Singh Kushwah Marta Woldanska-Okonska
Athanasia Proklou Martha Sierra-Vargas
Athanasios Kiourtis Martin Meier
Atheer Zgair Martin Richter
Athikhun Suwannakhan Martina Kleber
Atsushi Kawahara Mary Kosmidis
Attila Frigy Masahiro Tajika
Atukuri Dorababu Masaki Ueno
Aydin Eresen Masoud Keikha
Ayman Elsamanoudy Massimo D'Archivio
Azam Shirinabadi Farahani Matias Ferrán Escobedo
Azamossadat Hosseini Matteo Bradicich
Ba Thong Nguyen Matteo Mario Carlà
Bálint Tamaskovics Matteo Ripa
Baotong Zhang Matthias Unterhuber
Barbara Mognetti Mau-Ern Poh
Barbara Ruaro Maurizio Marchesini
Barbara Verro Mayur Doke
Baris Eser Mayur Virarkar
Bartłomiej Henryk Noszczyk Md Ariful Haque
Beatrice Gallo Md Daud Mohd Khairi
Beatrice Heim Md Sofiqul Islam
Beenish Chaudhry Mehdi Moghanibashi
Benjamin Rolles Mehran Ghasemzadeh
Beom Sun Chung Mehrnaz Shoushtarian
Berenika Szczęśniak-Sięga Meir Barak
Bernard Speculand Melissa Burmeister
Beth Thielen Melvin Ambele
Bilal Haj Najeeb Mercedes Bermúdez
Bin Du Mercedes gimeno
Blanca Bazán-Perkins Mercedes Mitjavila Casanovas
Blažen Marijić Michael Garnet Irwin
Bogdan Amuzescu Michael Joachim
Bogdan Iliescu Michael Kovalev
Boris Kozlov Michail Papafaklis
Boris Malyugin Michał Łobacz
Boris Tadic Michela D'Ascanio
Branimir Anić Michele Coviello
Bruno Fionda Michele Finotti
Cai-Ping Zhang Mieszko Wieckiewicz
Camelia Cojocariu Miguel Á. Castro Villamor
Camelia Gurban Miguel Gonzalez-Gay
Camil Mirestean Miguel Mendoza-Catalán
Camillo Fulchignoni Mihaela Ionica
Caner Günaydın Mihaela Luca
Carina Balcoş Mihai Dumitru
Carla Pisani Mihai Georgescu
Carlos Delgado-Miguel Mikhail Dubinin
Carlos Escobar Mikhail Kostik
Carlos Fernandez-Patron Mikołaj Maga
Carlos Martín Ardila Milan D. Perovic
Carlos Oliveira Milan R. Nikolić
Carlos Ortiz-Mendoza Min Deng
Carmelina Zirafa Ming Yang
Carmen Álvarez-Nieto Mingfei Sheng
Carmen Pavelescu Mingming Zhao
Carol Nash Mircea Lițescu
Cassiano Gonçalves-de-Albuquerque Mircea Vasile Milaciu
Catalin Bulai Miriam Sanchez-SanSegundo
Catarina Tomás Mithun Rudrapal
Caterina Piazza MK Nieuwenhuis
Chaemoon Lim Mohamed Abuzaid
Chaitanya Gadepalli Mohamed Ali
Chaiyaboot Ariyachet Mohamed Lounis
Chakradhara Rao S Uppugunduri Mohamed Mokhtar Nagy
Chandrabose Selvaraj Mohammad Alwahsh
Chandrakanta Mahanty Mohammad Athar
Chao Shen Mohammad Barary
Chao Yin Kuo Mohammad Basha
Chao-Hui Yang Mohammad Khalil
Charles D. Ponte Mohammad Khan
Che Hsueh Yang Mohammad Qneibi
Chen-Cheng Yang Mohammed Abuzaid
Cheng Yang Mohammed Ezzat
Chengquan Ma Mohammed Sayed
Chethan Kn Mohammed Shuaib
Chih-Kun Hsiao Mohd Kausar
Chris DeVera mohsen Norouzinia
Christian Colcuc mohsin shah
Christian Schubert Moises Leon Juarez
Christian Selinger Mojtaba Moradi
Christian Smolle Mona Alshahawey
Christina Anna Stratopoulou Mona Batish
Christoph Faschinger Mona Sadat Larijani
Christopher Lievens Mona Tan
Christos Orovas Monica Mendoza-Rodriguez
Christos Rizos Monica Rusticeanu
Cicero Benjamim Monika Łopuszańska-Dawid
Cihad Dundar Monika Prakash
Cinzia Rotondo Monika Ruszala
Ciprian Ilea Monika Zawadka-Kunikowska
Ciprian Tanasescu Mounir M. Salem Bekhit
Cipriana Stefanescu Mubarak Mustapha
Clara Hjalmarsson Muhammad Kibriya
Claudia Tregnago Muhammad Sarfaraz Iqbal
Claudio Sorino Muhammad Ubaid Hafeez
Claudiu Morgovan Muhammet Sayan
Claudiu Popescu Murat Akand
Clemens Schopper Murat Tuğcu
Corrado Ciatti Mustafa Kursat Sahin
Corrado Zengarini Nabil Hasona
Cosimo Galletti Nadeem Ullah
Cristian Baicus Nader Bakheet
Cristian Mornos Namdev Togre
Cristiana Sieiro Santos Nan Miao
Cristina Vassalle Nancy Monroy-Jaramillo
Cristina Zbârcea Naomichi Okamoto
Cynthia Munoz Naresh Kumar Ravichandran
Dagmara Szmajda-Krygier Naresh Poondla
Damiano Patrono Narongchai Autsavapromporn
Dana Lawrence Naseer Ahmed
Daniel Costache Nasui Bogdana Adriana
Daniel Dalla Torre Natalia Piekuś-Słomka
Daniel Lindegger Natalia Shnayder
Daniel Meier Navid Abedpoor
Daniel Piskorz Navin Kumar Ojha
Daniele Corbo Nawaz Muhammad
Daniele Sola Nazanin Ebrahimiadib
Danieli Andrade Neal Davies
Danijela Cvetković Neelanjan Vishnu
Daria Piacentino Nejc Kozar
David Areshidze Nejc Umek
David Bar-Or Nenad Bukvic
Davide Agnoletti Nessr Abu Rached
Davide Brotto Nestor Cabrera-Munoz
Davide Giuseppe Ribaldone Nicola Alberto Valente
Davor Plavec Nicola Mondanelli
Debashis Dutta Nicolae Gica
Deepali Mathur Nicolas Nunez
Demin Cai Nicolò Brandi
Denis Dupoiron Nikola Štoković
Dhan Shrestha Nikolaos Sideris
Dhanya Ravindran Nikolaos Stavropoulos
Diego de Ortueta Nikolina Mihaylova
Diletta Ami Nina Novozhilova
Dimitrios A. Liakopoulos Nisarat Phithakwatchara
Dimitrios Rikos Nishant Kumar
Dimitris Tatsis Niya Mileva
Dinko Vitezic Noemi Salmeri
Dino Sgarabotto Noha Hammad
Dipak Kumar Sahoo Noor Jahan
Divya Gupta Norhafiza Mat Lazim
Divya Radhakrishnan Norizzati Amsah
Divya Sahu Norma Ab Rahman
Diwakar Guragain Norzawani Jaffar
Dmitri Panfilov Nouran salah
Dmitrii Maltsev Oana Sirbu
Dobromira Shopova Octavian Neagoe
Doina Todea Olga Balafa
Dolors Rodriguez-Pardo Olgica Mihaljevic
Domen Vozel Oliver Riesenbeck
Domenico Lio Oliver Sander
Domenico Plantone Olivier Rukundo
Dominic Amuzu Omar Hamdy
Dominic Augustine Omneya Attallah
Dominik Pruski Oriol Cantó Navés
Domiziano Tarantino osama Gheith
Donghwa Kim Ouafa Sijilmassi
Donghwan Park P. Radhakrishnanand
Dorin Novacescu Paloma Malagón
Doris F. Oberle Paolo Santini
Douglas Lightstone Paria Motahari
Do-Youn Lee Partha Narayan Dey
Dr Jaya Shanker Tedla Patrick Weydt
Drago Jelovac Pattharawin Pattharanitima
Dragos Predescu Paul Amieux
Dragos Serban Paul Bălănescu
Dzintra Kazoka Paulina Adamska
Edit Xhajanka Paulo Santos
Edith Gjevjon Paulo Schwingel
Eduardo Vieira Neto Pawel Grabala
Edward Bliss Paweł Wałek
Edwin Chang Paweł Wańkowicz
Edyta Urbanska Pedro Dorado
Eftihia Polyzogopoulou Pedro Guillen
Egidijus Šimoliūnas Pedro Serralheiro
Einas Yousef Peggy Sekula
Eirini Christodoulou Pejman Rohani
Ekaterina Garbaruk Pengyu Zong
Ekaterina Georgieva Per Olof Lundgren
Eleftherios Gkioulekas Pere Planellas
Elena Dantes Peter Adatara
Elena Dinte Peter Kanizsai
Elena Grakova Peter Keogh
Elena Nemtsova Philipp Kriechling
Elena R Lebedeva Pierre Tennstedt
Elena V. Shakhtshneider Pietro Mesirca
Elena Valeeva Pilar Paredes
Eleni Timotheadou pinar cevik
Eleni-Myrto Trifylli Pınar Cihan
Elenko Popov Piotr Gabryel
Eleuterio A. Sánchez Romero Plamen Todorov
Elham Hosseini Poay Sian Sabrina Lee
Elisa Belluzzi Ponti Donatella
Elisa Russo Pornchai Sathirapanya
Elizabeth Lee Pramodkumar Gupta
Elizeu Carvalho Pranothi Mulinti
Elvira Orduna-Hospital Prapaporn Suprasert
Elżbieta Grześk Prasath Manogaran
Eman Mehanna Qian Chen
Eman Toraih Qinying Yu
Emanuele Bernardinelli qixin wang
Emilia Severin Rada Kazakova
Emiliano Tesoro-Cruz Rada Miskovic
Emina Sudar-Milovanovic Radosław Balwierz
Enita Nakas Radoslaw Kiedrowicz
Enrique Cervantes-Pérez Radu Chicea
Enrique Gea-Izquierdo Radu Crisan-Dabija
Enwu Liu Radu Racovita
Erand Llanaj Rafaela Gutiérrez Cáceres
Erdogan Bulut Raffaele Frazzi
Eric Huet Raffaele Pellegrino
Erica Neri Raghunadharao Digumarti
Esma Inan Yuksel Raid Al-Ani
Essam Ahmed Mohammed Rajmohan Dharmaraj
Estefania Nuñez Rakshit Shah
Estela Sanguesa Raluca Roman
Eugen Ionescu Ramcés Falfán-Valencia
Eugene Loos Ramesh G.P
Evgeniya Kaigorodova Rami Al-Rohil
Evi Fleischhacker Ramit Maoz Segal
Ewa Toporowska-Kowalska Ramona Meanti
Fabiano Vilhena Ramu Inala
Fábio Lanferdini Rana Youness
Fabrizio Ceresa Rares Mircea Birlutiu
Fahad Kidwai Raul Díaz
Farah Hamandi Ravindra Samarth
Farhan Siddique Ravindra Thakkar
Faris Khan Ray-Chang Wu
Fatemeh Khatami Razieh Rabani
Fatih Hatipoglu Razvan Ionescu
Fausto Maffini Rebecca Eshraghi
Fedele Lembo Reka Varnai
Federica Scarfì Remington L. Nevin
Federico Mazza Reza Zolfaghari Emameh
FELIPE CHAVES Ricardo Dias
Fenglei Li Ricardo González-Ramírez
Feras Darwish Darwish El-Hajji Ricardo Ribeiro
Ferdinando Antonio Gulino Richard N. Merchant
Fernanda Gentil Rini Arianti
Fernanda Mesquita Rita Kiss
Fernando Guerra-Infante Robert Adamu Shey
Fernando Muñoz-Hernández Robert Gerwin
Fernando Sanchez Lasheras Roberta Monzani
Filippo Confalonieri Roberto Cemin
Filippo Manelli Roberto de la Plaza Llamas
Filippo Mariano Roberto Lazzarini
Filomena Puntillo Roberto Scicali
Flaviu Moldovan Robin Cooper
Florian Ebel Robinson Sabino-Silva
Florin Achim Rodolfo Abarca-Vargas
Forogh Soltaninejad Rodolfo Reda
Frada Burstein Rodolfo Valtuille
Francesco Bianco Rodrigo Torres
Francesco Bosco Rogério Manuel Ferreira
Francesco Claps Rosa Di Liddo
Francesco Doglietto Rosa María Giráldez-Pérez
Francesco D'Oria Rosa María Oliart-Ros
Francesco Meani Roshan Katekar
Francesco Menzella Roshanak Ghods
Francesk Mulita Roxana Liana Lucaciu
Francisco Malano Ruben Sanchez-Gomez
Franco Alchiede Simonato Runzhuo Ma
Fuat Demirkíran Ruta Vaiciuniene
Gabriel Magrin Rute Pereira
Gabriela Mellado-Sanchez Rute Santos
Gabriele Melegari Ruxandra Diana Sinescu
Gabriele Reinartz Ryszard Antkowiak
Gabriele Sorce S. Ramkumar
Gaddi Blumrosen Sabina Antonela Antoniu
Gennadi Saiko Sachin Chaugule
George E. MacKinnon III Sadashige Uemura
George Imataka Safaa Elkholi
Georgiana Nemeti Sajal Sen
Georgiana-Emmanuela Gilca-Blanariu salvatore crimi
Georgios Katsaras Samar Tharwat
Georgios Panos Samo Fokter
Gerald Lushington Sanam Dolati
Gerardo Cazzato Sandeep Kumar Mishra
Gerardo Santos-Lopez Sandro Glumac
Gerson Aparecido Foratori-Junior Sandro Jose Ribeiro Bonatto
Ghulam Mustafa Sanjit Mukherjee
Giacomo Papotto Santhosh Kumar Pasupuleti
Giacomo Zaccherini Santi Mandal
Gian Pio Sorice Santiago Perez-Lloret
Giancarlo Micheletto Sarabjeet Sudan
Gianluca Manni Sarah Shueb
Gilles Lesieur Sarawut Lapmanee
Gina Mendez-Callejas Sasho Stoleski
Giordano D'Urso Sasi Viktor
Giorgio Prouse Satish Sagar
Giorgos Dritsakis Satoru Munakata
Giovanna Salata Saumya Shah MD
Giovanni De Angelis saurabh chaturvedi
Giovanni Guglielmo Laracca Saverio Muscoli
Giovanni Pennisi Sayed Abdelwahab
Giovanni Viroli Sayed Goda
Giulia Pellecchia Sebastian Tranca
Giulia Santo Sedigheh Sadat Naimi
Giuliano Tocci Sehar Iqbal
Giulio Mengozzi Selim Ayhan
Giuseppe Basile Semer Maksoud
Giuseppe Lisco Senija Eminović
Giuseppe Seghieri Sergey Igumnov
Giuseppe Stefani Sergey Lytaev
Gjin Ndrepepa Sezer Okay
Gladiol Zenunaj Shadma Wahab
Gonçalo Garcia Shahjada Selim
Goohyeon Hong Shaina Schwartz
Gopinath M. Sundaram Sheila Veronese
Goran Augustin Sherihan AbdelHamid
Goran Kvaščev Shibo Yu
Gotam Das Shiek Ahmed
Gözde Şengül Ayçiçek Shifu Aggarwal
Grazyna Puto Shi-hua Xiang
Grigorios Dimas Shinya Suzuki
Grzegorz Bartosz shivani Bansal
Guillaume Drevin Shobana Navaneethabalakrishnan
Guillermina Ferro-Flores Shruthi Mohan
Guillermo Til-Perez Shuo-Chen Chien
Gulali Aktas Sigmar Schnutenhaus
Gülay Taşcı Siladitya Khan
Gülden Gülden Silvia Pianigiani
Gule Cinar Sima Romina-Marina
Gündüz Yümün Simon Allen
Güneş Şenol Simona Coniac
Gunnar Wichmann Simone Cilio
Gurpreet Chhabra Siva Prasad Panda
Guy Friedrich Sivabaskari Pasupathy
Habib Karim Siwei Zhang
Hadia Almahli Sladjan Pavlovic
Hailong Hu Slavica Kvolik
Hamid Morovati So Young Yoo
Hamidreza Khaleghzadeh Socorro Retana-Marquez
Hana Rauchová Sofia Bhatia
hani Chanbour Sofia Perazzo
Hany H. Arab Soha Albeitawi
Hao Du Solomon Viswas Raja
Harikesh Dubey Song Wang
Harikumar Rajaguru Sonia Regina Pasian
Harpreet Kaur Sorana-Maria Bucur
Harshraj Leuva Sorin Radu Fleaca
Haruhiko Sugimura Sorina Mihaela Solomon
Hasnaa Jalou Soutik Ghosal
Hatem El-Shanti Srdjan Kesic
He Sun Srdjan Masic
He Zhang Srijit Das
Heba Abdelal Stankovska Gordana
Heba Sahyon Stefan Brocke
Heber Arbildo Vega Stefan Naydenov
Hege F. Berg Stefan Pusch
Helen Cohen Stefan Russmann
Henk Maria Koning Stefania Troise
Henrique Pauna Stefano Fornasaro
Henry Atkinson Stefano Priola
Hermínia Dias Stefano Saran
Hervé Reychler Stephen Gerfer
Hideo Kato Stephen T Sonis
Hideo Wada Sudhir Kshirsagar
Himanshu Khajuria Sudipta Panja
Hiren Mewada Sugandh Kumar
Hiro Sato Sujith Pereira
Hiroaki Neki Sulea Daniela
Hiroshi Inui Sumeet Nayak
Hiroshi Matsushita Sunil Rai
Hisayoshi Kawahara Surajit Basak
Hon Cheong So Suyanto Suyanto
Honglei Ren Svetlana Guryanova
Hongyang Ma Syed Ali Raza Naqvi
Hoon Park Syed Furqan Qadri
hosam habib Syed Mohd Faisal
Hossam Donya Tadashi Kawai
Hossam El-Sherbiny Taha Koray Sahin
Hsiang-Ning Luk Takahiro Nemoto
Hsin-Hua Lee Takao Hamamoto
Huacheng Zhang Tamer Hamdy
Hubert Hackl Tanja M. Luković
Hugo Martiniano Tarek Mohamed
Hui Liu Tariq Ali
Huiling Hong Tariq Malik
Hülya Şimşek Társis Vieira
Husam Qanash Tasneem Arsiwala
Hüsamettin Vatansev Tatiana Arefieva
hussein hamade Tatiana Berezina
Huyentran Tran Tatiana Kalinina
Iakovos Armenis Tatsuji Mizukami
Ibrahim Bello Taweegrit Siripongboonsitti
Ie-bin Lian Telma Almeida
Ignazio Marino Teng Zhou
Iman Tavassoly Thach Nguyen
Imran Ali Khan ThankGod Onyiche
Ina Sevic Thayne Kowalski
Inaki Elio Theodoros Tokas
Inbar Levkovich Thijs Van Der Zijden
Inés Llamas-Ramos Thomas Ducret
Ioana Pavaleanu Thomas Lindner
Ioannis Kanakis Thomas Mayer
Ioannis Kougioumtzis Tijana Išić Denčić
Ioannis Lyros Tim Hulsen
Ionuț Jeican Tim Reynolds
Irena Galić Tim Wende
Irena Wojsyk – Banaszak Timothy Hardcastle
Irene Baroni Tina Didari
Irene Lorrai Tito Brambullo
Irene Madrigal Tomáš Čajka
Irfan Idris Tomas Fait
Iride Francesca Ceresa Tomasz Banas
Irina Kologrivova Tomasz Frączyk
Irina Pronina Tommaso Greco
Irshad Ahmad Tommaso Lombardi
Isabel Escobio Prieto Tommaso Torresin
Isabelle Piazza Tongtong Lu
Isac Medeiros Toni Lassila
Isha Singh Tran Nguyen
Ismini Lasithiotaki Tsukasa Okiyoneda
Iuliana Magdalena Starcea Tuba Taslamacioglu Duman
Iuliu Gabriel Cocuz Tudor Olariu
Ivan Bratchenko Tudor Pop
Ivan Pavić Tunc Eren
Ivana Banic Ujjawal Sharma
Ivana Fratrić Ulises de la Cruz-Mosso
Ivo Bozovic Ulrich Frey
Ivo Soares Ulrich Ronellenfitsch
Jacob Genizi Uri Farkash
Jacopo Di Gregorio Usein M Dzhemilev
Jacopo Lisoni Usman Illahi
Jaime Mella-Raipán Utibe-Abasi Udoh
Jakub Bargiel Valentino Natoli
Jakub Kufel Valeria Dionisi
James Russell Valerio Ricci
Jamir Pitton Rissardo Vasile Valeriu Lupu
Jan Azarov Vasile-Bogdan Halatiu
Jan Damoiseaux Vasileios P. Papadopoulos
Jan de Laat Vasiliki Karava
Jan Lowery Venkata Nagaraj Kakaraparthi
Janko Samardzic Venkata Rajesh Yella
Jasper van Assche Vera Larina
Javier Martinez-Useros Vicente León-Muñoz
Jeanne Wilson-Rawls Victor Díaz-Flores García
Jennifer Pursley Víctor Hernández-Beltrán
Jenny Vilchis-Gil Victoria McKenna
Jeong Heo Victoria Sanchez-Martin
Jeong Min Han Vidya Rattan
Jeremy Lavine Vijaya Anand Arumugam
Jessica Zuñiga-Hernandez Vincenzo Zanon
Jessie Poquérusse Vinícius Simão
Jesus Oliva Pascual-vaca Vinod Kumar
Jianhai Chen Vivian Paraskevi Douglas
Jie Liu Vjekoslav Peitl
Jie Qian Vladimir Bilim
Jing Zhang Vladimir Chobot
Jiraporn Leanpolchareanchai Vladimir Poroch
Jitbanjong Tangpong Vladimira Boyadzhieva
Jitendra Kumar Sinha Vlasios Karageorgos
Jochen D Schipke Volkan Karataşlı
Jochen Winter Walter Flapper
John Bernat Warawut Chaiwong
John W. Berkenbosch Waseem Jerjes
Johnny Ionut Efanov Wasim Ahmad
Johnson Retnaraj Samuel Selvan Christyraj Wassim Abou-Kheir
Jonathan Pan Wei Feng
Jorge González-Gutiérrez Wei Ni
José A. Carrión Wei Shi
José Antonio Picó-Monllor Weita Chen
José Jaime Martínez-Magaña Weiting Wang
José López Castro Wen-Chih Liu
José Prieto Wenjun Zhu
Josefa Gonzalez-Santos Werner Cordier
Joseph Hornak Wilhelm Mistiaen
Joshua Tobias William Hammond
Jovanka Gencel-Augusto Wirawan Adikusuma
Joydeep Chakraborty Wladimir Beck
József Furák Wojciech Konarski
Juan Maza-Solano Wojciech Paslawski
Judita Kinkorová Wojciech Szlasa
Judith Catella Woo-Jong Kim
Juergen Grauvogel Xiaobo Wu
Juergen Taxis Xiaojing Huang
Julian Freen-van Heeren Xiaokang Wu
Julian Künzel Xin Tong
Julio Plaza-Diza Xinglin Yang
Julius Höhne Xinli Li
Juliusz Huber Xiruo Li
Junaidi Khotib Xun Tao
junchao Guo Yanira Vasquez
Jung Eun Kim Yaniv Steinfeld
Junhel Dalanon Yanning Zuo
Jure Urbančič Yanpeng Li
K. Sreedhara Pai Yansong Qi
Ka Huen YIP Yanying Huo
Kacper Nijakowski Yavuz Samanci
Kah Teik Chew Yedukondala Rao Veeranki
Kaloyan Georgiev Yen Tan
Kamalakannan Radhakrishnan Ying Qing
Kamil Gill Yoichi Watanabe
Kamil Nelke Yong-Moon Lee
Kanon Jatuworapruk Yongqiang Wang
Kaori Ueda Youakim Saliba
Karel Kostev Yuan Fang
Karen Kyuregyan Yue Hui Lau
Karolina Filipska-Blejder Yuichi Adachi
Karolina Pieniawska-Śmiech Yuichi Yoshii
Karthiga M Yuko Ono
Katarina Savic Vujovic Yung-Taek Ouh
Katarzyna Kwiecień-Jaguś Yuriy Vasil'ev
Katarzyna Ogrodzka-Ciechanowicz Yury Zhernov
Katarzyna Zorena Yuta Hikichi
Kate Kloot Yuval Krieger
Katharina M. Rentsch Zainub Jooma
Katharina Roeher Zeljko Vlaisavljevic
Katsuhiro Ito Zesergio Melo
Katsushi Okuyama Zhanchao Li
Kazim Arga Zhaoqing Cong
Kazuyuki Matsushita Zhiyuan Xu
Keitaro Kanie Zhonglei Wang
Kelsey Cook zhongshan cheng
Ken Takahashi Zoran Gluvic
Kenji Nakamura Zoran Todorovic
Kenji Yamagata Zorana Dobrijević
Kentaro Kawabe Zsolt Kőszegi
Kevin Bain Zsolt Piróth
Kevin Fricka Zulfan Zazuli
Kevin T. Batty Zulvikar Ulhaq
Khaled Saad Zuzana Hudáková
Kirk Stephenson Zvonko Rumboldt
Kodai Kitagawa Artem Ovchinnikov

31 January 2024
MDPI Insights: The CEO's Letter #8 - Altmetric and Flat Fee Agreement

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI and Digital Science Meeting

At MDPI, we are committed to providing our authors with the essential tools to publish, promote, and track their research. In line with this commitment, we have established a longstanding collaboration with Digital Science, a company specializing in research data and analytical insights for the research community. Our collaboration integrates their Altmetric tool, offering us and our authors the ability to track a variety of sources that monitor and report attention surrounding publications.

As part of our collaboration, we recently hosted Cathy Holland, Director of Global Publisher Business Development, and Helen Cooke, Managing Director of Publisher Sales, from Digital Science, at our MDPI headquarters in Basel, Switzerland.


Left to right: Facundo Santomé (Senior Marketing Manager, MDPI), Constanze Shelhorn (Indexing Manager, MDPI), Cathy Holland (Director of Global Publisher Business Development, Digital Science), Helen Cooke (Managing Director of Publisher Sales, Digital Science), and Stefan Tochev (CEO, MDPI) in front of MDPI headquarters in Basel, Switzerland.

During our meeting, we discussed MDPI’s publishing philosophy and explored further avenues for collaboration. We look forward to continuing our partnership with Digital Science, aiming to improve our services yet further and meet the needs of our authors more closely than ever.

What is Altmetric?

You will notice that MDPI articles feature an Altmetric score, a colourful doughnut capturing the score in the upper right corner of the article page. This score represents ‘alternative metrics,’ as distinct from traditional metrics such as Impact Factor, CiteScore, and Scimago Journal Rank.

Altmetrics complement traditional citation-based metrics by capturing online discussions related to a specific research topic. By analyzing both sets of data, we can obtain a comprehensive understanding of the attention a particular research output receives and the sources in which it is mentioned.

“Almetric provides visual insights into where research is being discussed”

Sources Tracked by Altmetric


Altmetric badge showing the Altmetric score and colour-coded mention sources.

Altmetric monitors various sources, categorizing them into segments such as policy documents, peer reviews, Wikipedia, news and blogs, and social media, among other sources. Each category is identifiable by a specific colour.

The Altmetric badge provides visual insights into where the research is being discussed. A more colourful badge indicates broader mentions across multiple platforms. Such tracking enables us to gauge the extent of an article’s online dissemination, noting that increased visibility may correlate with higher citation rates.

Read more:

Impactful Research

Ten High-Altmetric Articles Published by MDPI

As at 30 January 2024, Altmetric has tracked 670,500 MDPI research outputs from MDPI, resulting in over 4.3 million mentions. This includes over 71,894 mentions in policy and patents and 294,714 mentions in news and blogs, with some achieving an Altmetric score as high as 28,754.

So, what is a good Altmetric score? There are various ways to put this score into context. You can find out more about the score in context and how to evaluate your work by this means.

Here are ten MDPI papers ranking in the top 5% of all research outputs scored by Altmetric.

“Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort”

J. Pers. Med. 2017, 7(2), 3; https://doi.org/10.3390/jpm7020003

Altmetric page: https://mdpi.altmetric.com/details/20477344

Altmetric shows that this article appeared in 253 news stories from 209 outlets including Forbes, BBC, and Fox News.

“Daylight Saving Time and Acute Myocardial Infarction: A Meta-Analysis”

J. Clin. Med. 2019, 8(3), 404; https://doi.org/10.3390/jcm8030404

Altmetric page: https://mdpi.altmetric.com/details/57654628

Altmetric shows that this article appeared in 295 news stories from 207 outlets including Forbes, The Atlantic, and New York Times.

“The Preliminary Analysis of Cave Lion Cubs Panthera spelaea (Goldfuss, 1810) from the Permafrost of Siberia”

Quaternary 2021, 4(3), 24; https://doi.org/10.3390/quat4030024

Altmetric page: https://mdpi.altmetric.com/details/111086701

Altmetric shows that this article appeared in 182 news stories from 134 outlets including CBC News, CNN, and National Geographic.

“Not the Cat’s Meow? The Impact of Posing with Cats on Female Perceptions of Male Dateability”

Animals 2020, 10(6), 1007; https://doi.org/10.3390/ani10061007

Altmetric page: https://mdpi.altmetric.com/details/83796184

Altmetric shows that this article appeared in 124 news stories from 98 outlets including VICE, CNN and The Guardian.

“Behaviour and Welfare Impacts of Releasing Elephants from Overnight Tethers: A Zimbabwean Case Study”

Animals 2022, 12(15), 1933; https://doi.org/10.3390/ani12151933

Altmetric page: https://mdpi.altmetric.com/details/133463915

Altmetric shows that this article appeared in 192 news stories from 186 outlets.

How do I use altmetrics?

Altmetric Explorer provides a detailed step-by-step guide and instruction video for first-time users of the tool. The guide includes useful diagrams that make it easy to get started.

Sharing Research Online

For research to be tracked across different sources, Altmetric needs a research output with a persistent identifier: a DOI, ISBN, PubMed ID, handle ID, etc. When sharing research, it is important to include a link to the original research output.

“An Update on Eukaryotic Viruses Revived from Ancient Permafrost”

Viruses 2023, 15(2), 564; https://doi.org/10.3390/v15020564

Altmetric page: https://mdpi.altmetric.com/details/142929875

Altmetric shows that this article appeared in 250 news stories from 180 outlets including CTV, Fox News, and CNN.

“The Global Problem of Insufficient Sleep and Its Serious Public Health Implications”

Healthcare 2019, 7(1), 1; https://doi.org/10.3390/healthcare7010001

Altmetric page: https://mdpi.altmetric.com/details/53406248

Altmetric shows that this article appeared in 252 news stories from 168 outlets including BBC, Harvard Business Review, and Forbes.

“A Detailed Review Study on Potential Effects of Microplastics and Additives of Concern on Human Health”

Int. J. Environ. Res. Public Health 2020, 17(4), 1212; https://doi.org/10.3390/ijerph17041212

Altmetric page: https://mdpi.altmetric.com/details/86529137

Altmetric shows that this article appeared in 197 news stories from 150 outlets including BBC, The Tribune, and World Economic Forum.

“An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach to Public Health”

Int. J. Environ. Res. Public Health 2018, 15(3), 431; https://doi.org/10.3390/ijerph15030431

Altmetric page: https://mdpi.altmetric.com/details/34714141

Altmetric shows that this article appeared in 232 news stories from 149 outlets including Forbes, New York Times, and Harvard Business Review.

“Garden Scraps: Agonistic Interactions between Hedgehogs and Sympatric Mammals in Urban Gardens”

Animals 2023, 13(4), 590; https://doi.org/10.3390/ani13040590

Altmetric page: https://mdpi.altmetric.com/details/142934305

Altmetric shows that this article appeared in 172 news stories from 168 outlets including BBC.

Inside MDPI

MDPI Annual Meeting Celebrations in China

On Thursday 25 January, over 1,300 MDPI colleagues from our two offices in Beijing gathered to kick off MDPI’s traditional ‘Annual Meetings.’ These celebrations take place in MDPI’s offices across China, including Dalian, Tianjin, Wuhan, and Nanjing.

The evenings include performances, informative talks and presentations, awards, and entertainment, providing an ideal platform to recognize our colleagues, celebrate their achievements, and set our sights on the future.

“It is essential that we stay connected and share best practices”

I sent a video congratulating everyone on their work and sharing our vision of building MDPI into the most trusted OA publisher, highlighting the roles each of us has to play in achieving that goal.

Unfortunately I could not join in person, but you may recall my recent trip, when I visited our offices in Beijing and Wuhan, which I look forward to visiting again this year.

Although our headquarters are in Basel, Switzerland, and we are expanding throughout Europe and North America, the majority of MDPI’s workforce is in China and throughout the Asia-Pacific region, including offices in Singapore, Thailand, Japan, and newly opened office in South Korea. It is essential that as a global organization, we stay connected and share best practices in order to grow collectively and continue providing the exceptional service to our authors.

The Annual Meeting is a moment to reflect and enjoy the year’s hard work and dedication.

I extend our best wishes to all for the Chinese New Year (Xīnnián kuàilè)!

Coming Together for Science

MDPI and TU Delft Adopt Flat Fee Model in Extended Partnership

We are excited to announce a renewed three-year partnership with Delft University of Technology (TU Delft) in the Netherlands. This collaboration introduces a fixed lump-sum fee, covering publishing costs from 2024 to 2026.

“This initiative reflects our dedication to transparent and inclusive publishing”

TU Delft-affiliated authors will enjoy cost-free publishing in any MDPI journal during this period, aligning with our commitment to removing barriers for open access publishing. The agreement supports Plan S compliance and facilitates a seamless publishing process for TU Delft corresponding authors. This initiative reflects our dedication to transparent and inclusive publishing, providing stability and predictability both for authors and for institutions.

For further details on our Institutional Open Access Program (IOAP), please contact us.

Benefits to MDPI’s IOAP

At MDPI we have a long tradition of partnerships, including our Institutional Open Access Program (IOAP). IOAP supports institutions through simplification, access, transparency, APC discounts, and institutional repository deposits. The program simplifies administrative processes, offers central payment, and allows easy opting in and out. Participants gain free access to Susy, MDPI’s online submission system, with extensive article metadata and exportable data. APC discounts and Book Processing Charge discounts are available for affiliated authors. Automated deposits to institutional repositories and streamlined matching of papers to IOAP participants enhance the overall experience.

For further information, see our IOAP FAQ.

Closing Thoughts

Reflections on the 2024 APE Conference

MDPI was proud to co-sponsor the Academic Publishing in Europe (APE) 2024 Conference that took place in Berlin, Germany, from 9–10 January 2024.

The conference theme, ‘Keep the Conversation Going!’, explored the evolving landscape of scholarly communication. APE is one of the key conferences I make a point to attend each year. January offers a valuable opportunity to engage with new contacts, reconnect with familiar faces, and participate in impactful discussions and presentations among professionals, scholars, and practitioners in the field.

“It's fascinating to see how other publishers are leveraging AI”

Highlights

Some of the standout panels for me include: the role of the UN Sustainable Development Goals (SDGs) within the publishing industry. It was encouraging to hear the current status quo, though I was eager also to learn about the exciting projects planned for 2024 and beyond. These will allow us to track progress in subsequent years. At MDPI, we remain committed to promoting Open–Access (OA) content on SDGs through scientific articles and books. Furthermore, we extend our commitment to sustainability by financially supporting researchers through initiatives such as the World Sustainability Award and the Emerging Sustainability Leader Award, as well as waiving the APC for feature papers on each SDG.

In recent years, discussions on AI have become increasingly prominent at such conferences. It’s fascinating to see how other publishers are leveraging AI to meet the evolving needs of their audiences while at the same time using it to safeguard the scientific process. Other engaging panels that I enjoyed included updates on transformation beyond transformative agreements, the principles of lean change, incentive structures related to research integrity, and the panel on reviewer incentives.

“We can share best practices and lessons learned”

Incorporating MDPI’s Insights into Conferences

I must confess that I sometimes feel overlooked when MDPI is not invited to participate in crucial industry discussions. As the leading open access publisher and the third-largest publisher overall, we possess extensive experience in many of these areas and can offer valuable contributions to these discussions. We can share best practices, lessons learned, and our thinking about future trajectories. For instance, in panels discussing reviewer incentives, at MDPI we offer a discount voucher to reviewers for future submissions, reflecting our commitment to fostering a robust peer review process. In 2022 alone, MDPI collected over 1.4 million peer review reports, informing the decision-making processes of our editors. Given our expertise in these areas, it would be natural to include MDPI in such discussions. I therefore extend an invitation to future conference organizers to consider MDPI for speaking engagements and collaborative opportunities.

Stefan Tochev
Chief Executive Officer
MDPI AG

24 January 2024
Journal of Personalized Medicine | Most Viewed Papers in 2023


1. “Effects of Red and Infrared Laser Therapy in Patients with Tinnitus: A Double-Blind, Clinical, Randomized Controlled Study Combining Light with Ultrasound, Drugs and Vacuum Therapy”
by Vitor Hugo Panhóca, Antônio Eduardo de Aquino Junior, Viviane Brocca de Souza, Simone Aparecida Ferreira, Lais Tatiane Ferreira, Karina Jullienne de Oliveira Souza, Patricia Eriko Tamae, Marcelo Saito Nogueira and Vanderlei Salvador Bagnato
J. Pers. Med. 2023, 13(4), 581; https://doi.org/10.3390/jpm13040581
Available online: https://www.mdpi.com/2075-4426/13/4/581

2. “Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series”
by Leonard B. Weinstock, Renee M. Nelson and Svetlana Blitshteyn
J. Pers. Med. 2023, 13(11), 1562; https://doi.org/10.3390/jpm13111562
Available online: https://www.mdpi.com/2075-4426/13/11/1562

3. “Management of Hyponatremia in Heart Failure: Practical Considerations”
by Victoriţa Şorodoc, Andreea Asaftei, Gabriela Puha, Alexandr Ceasovschih, Cătălina Lionte, Oana Sîrbu, Cristina Bologa, Raluca Ecaterina Haliga, Mihai Constantin, Adorata Elena Coman et al.
J. Pers. Med. 2023, 13(1), 140; https://doi.org/10.3390/jpm13010140
Available online: https://www.mdpi.com/2075-4426/13/1/140

4. “Vasopressin in Sepsis and Other Shock States: State of the Art”
by Raquel García-Álvarez and Rafael Arboleda-Salazar
J. Pers. Med. 2023, 13(11), 1548; https://doi.org/10.3390/jpm13111548
Available online: https://www.mdpi.com/2075-4426/13/11/1548

5. “Ratings of the Effectiveness of 13 Therapeutic Diets for Autism Spectrum Disorder: Results of a National Survey”
by Julie S. Matthews and James B. Adams
J. Pers. Med. 2023, 13(10), 1448; https://doi.org/10.3390/jpm13101448
Available online: https://www.mdpi.com/2075-4426/13/10/1448

6. “Fenugreek and Its Effects on Muscle Performance: A Systematic Review”
by Waleed I. Albaker
J. Pers. Med. 2023, 13(3), 427; https://doi.org/10.3390/jpm13030427
Available online: https://www.mdpi.com/2075-4426/13/3/427

7. “A Review of the Role of Artificial Intelligence in Healthcare”
by Ahmed Al Kuwaiti, Khalid Nazer, Abdullah Al-Reedy, Shaher Al-Shehri, Afnan Al-Muhanna, Arun Vijay Subbarayalu, Dhoha Al Muhanna and Fahad A. Al-Muhanna
J. Pers. Med. 2023, 13(6), 951; https://doi.org/10.3390/jpm13060951
Available online: https://www.mdpi.com/2075-4426/13/6/951

8. “White Matter Hyperintensities in Young Patients from a Neurological Outpatient Clinic: Prevalence, Risk Factors, and Correlation with Enlarged Perivascular Spaces”
by Qiaoqiao Zou, Mingliang Wang, Danni Zhang, Xiaoer Wei and Wenbin Li
J. Pers. Med. 2023, 13(3), 525; https://doi.org/10.3390/jpm13030525
Available online: https://www.mdpi.com/2075-4426/13/3/525

9. “The Correlation between Metformin Use and Incident Dementia in Patients with New-Onset Diabetes Mellitus: A Population-Based Study”
by Kuang-Hua Huang, Ya-Fang Tsai, Chiachi Bonnie Lee, Shuo-Yan Gau, Tung-Han Tsai, Ning-Jen Chung and Chien-Ying Lee
J. Pers. Med. 2023, 13(5), 738; https://doi.org/10.3390/jpm13050738
Available online: https://www.mdpi.com/2075-4426/13/5/738

10. “L-Carnitine and Chronic Kidney Disease: A Comprehensive Review on Nutrition and Health Perspectives”
by Bharti Sharma and Dinesh Kumar Yadav
J. Pers. Med. 2023, 13(2), 298; https://doi.org/10.3390/jpm13020298
Available online: https://www.mdpi.com/2075-4426/13/2/298

11. “The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder”
by Neluwa-Liyanage R. Indika, Richard E. Frye, Daniel A. Rossignol, Susan C. Owens, Udara D. Senarathne, Andreas M. Grabrucker, Rasika Perera, Marielle P. K. J. Engelen and Nicolaas E. P. Deutz
J. Pers. Med. 2023, 13(2), 252; https://doi.org/10.3390/jpm13020252
Available online: https://www.mdpi.com/2075-4426/13/2/252

12. “COVID-19 and New-Onset Psychosis: A Comprehensive Review”
by Lorenzo Moccia, Georgios D. Kotzalidis, Giovanni Bartolucci, Sara Ruggiero, Laura Monti, Marco Biscosi, Beatrice Terenzi, Ottavia M. Ferrara, Marianna Mazza, Marco Di Nicola et al.
J. Pers. Med. 2023, 13(1), 104; https://doi.org/10.3390/jpm13010104
Available online: https://www.mdpi.com/2075-4426/13/1/104 

13. “The Relationship between Gastroesophageal Reflux Disease and Chronic Kidney Disease”
by Xiaoliang Wang, Zachary Wright, Eva D. Patton-Tackett and Gengqing Song
J. Pers. Med. 2023, 13(5), 827; https://doi.org/10.3390/jpm13050827
Available online: https://www.mdpi.com/2075-4426/13/5/827

14. “Lung Dysfunction and Chronic Kidney Disease: A Complex Network of Multiple Interactions”
by Guido Gembillo, Sebastiano Calimeri, Valeria Tranchida, Salvatore Silipigni, Davide Vella, Domenico Ferrara, Claudia Spinella, Domenico Santoro and Luca Visconti
J. Pers. Med. 2023, 13(2), 286; https://doi.org/10.3390/jpm13020286
Available online: https://www.mdpi.com/2075-4426/13/2/286

15. “ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia”
by Amir Hamzah Abdul Latiff, Salina Husain, Baharudin Abdullah, Palaniappan Suppiah, Vincent Tan, Tang Ing Ping, Kent Woo, Yoke-Yeow Yap, Claus Bachert, Holger J. Schunemann et al.
J. Pers. Med. 2023, 13(5), 835; https://doi.org/10.3390/jpm13050835
Available online: https://www.mdpi.com/2075-4426/13/5/835

16. “A Narrative Review on REM Sleep Deprivation: A Promising Non-Pharmaceutical Alternative for Treating Endogenous Depression”
by Cătălina Angela Crișan, Zaki Milhem, Roland Stretea, Ioan-Marian Țața, Răzvan Mircea Cherecheș and Ioana Valentina Micluția
J. Pers. Med. 2023, 13(2), 306; https://doi.org/10.3390/jpm13020306
Available online: https://www.mdpi.com/2075-4426/13/2/306 

17. “Patient Self-Inflicted Lung Injury—A Narrative Review of Pathophysiology, Early Recognition, and Management Options”
by Peter Sklienka, Michal Frelich and Filip Burša
J. Pers. Med. 2023, 13(4), 593; https://doi.org/10.3390/jpm13040593
Available online: https://www.mdpi.com/2075-4426/13/4/593

18. “Causes of Polyserositis: A Systematic Review”
by Laura Elena Stoichitoiu, Georgeta Daniela Ionescu, Ingrid Neatu and Cristian Baicus
J. Pers. Med. 2023, 13(5), 834; https://doi.org/10.3390/jpm13050834
Available online: https://www.mdpi.com/2075-4426/13/5/834

19. “Tramadol May Increase Risk of Hip Fracture in Older Adults with Post-Traumatic Osteoarthritis”
by Ting-Yu Wu, Wen-Tien Wu, Ru-Ping Lee, Ing-Ho Chen, Tzai-Chiu Yu, Jen-Hung Wang and Kuang-Ting Yeh
J. Pers. Med. 2023, 13(4), 580; https://doi.org/10.3390/jpm13040580
Available online: https://www.mdpi.com/2075-4426/13/4/580

20. “Mast Cell Activation Syndrome Update—A Dermatological Perspective”
by Dana Mihaela Mihele, Paul Andrei Nistor, Gabriela Bruma, Cristina Iulia Mitran, Madalina Irina Mitran, Carmen Elena Condrat, Mihaela Tovaru, Mircea Tampa and Simona Roxana Georgescu
J. Pers. Med. 2023, 13(7), 1116; https://doi.org/10.3390/jpm13071116
Available online: https://www.mdpi.com/2075-4426/13/7/1116

19 January 2024
Journal of Personalized Medicine | Most Cited Papers in 2023


1. “Predicting the Onset of Diabetes with Machine Learning Methods”
by Chun-Yang Chou, Ding-Yang Hsu and Chun-Hung Chou
J. Pers. Med. 2023, 13(3), 406; https://doi.org/10.3390/jpm13030406
Available online: https://www.mdpi.com/2075-4426/13/3/406

2. “A Review of the Role of Artificial Intelligence in Healthcare”
by Ahmed Al Kuwaiti, Khalid Nazer, Abdullah Al-Reedy, Shaher Al-Shehri, Afnan Al-Muhanna, Arun Vijay Subbarayalu, Dhoha Al Muhanna and Fahad A. Al-Muhanna
J. Pers. Med. 2023, 13(6), 951; https://doi.org/10.3390/jpm13060951
Available online: https://www.mdpi.com/2075-4426/13/6/951

3. “The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism Spectrum Disorder”
by Neluwa-Liyanage R. Indika, Richard E. Frye, Daniel A. Rossignol, Susan C. Owens, Udara D. Senarathne, Andreas M. Grabrucker, Rasika Perera, Marielle P. K. J. Engelen and Nicolaas E. P. Deutz
J. Pers. Med. 2023, 13(2), 252; https://doi.org/10.3390/jpm13020252
Available online: https://www.mdpi.com/2075-4426/13/2/252

4. “Three-Dimensional Accuracy and Stability of Personalized Implants in Orthognathic Surgery: A Systematic Review and a Meta-Analysis”
by Alexandru Diaconu, Michael Boelstoft Holte, Gabriele Berg-Beckhoff and Else Marie Pinholt
J. Pers. Med. 2023, 13(1), 125; https://doi.org/10.3390/jpm13010125
Available online: https://www.mdpi.com/2075-4426/13/1/125

5. “Efficacy and Safety of Distal Radial Access for Transcatheter Arterial Chemoembolization (TACE) of the Liver”
by Roberto Minici, Raffaele Serra, Marco Giurdanella, Marisa Talarico, Maria Anna Siciliano, Gianpaolo Carrafiello and Domenico Laganà
J. Pers. Med. 2023, 13(4), 640; https://doi.org/10.3390/jpm13040640
Available online: https://www.mdpi.com/2075-4426/13/4/640

6. “Is Ozone a Valid Adjuvant Therapy for Periodontitis and Peri-Implantitis? A Systematic Review”
by Francesco D’Ambrosio, Mario Caggiano, Alfonso Acerra, Massimo Pisano and Francesco Giordano
J. Pers. Med. 2023, 13(4), 646; https://doi.org/10.3390/jpm13040646
Available online: https://www.mdpi.com/2075-4426/13/4/646

7. “Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence”
by Rosa Méndez Hernández and Fernando Ramasco Rueda
J. Pers. Med. 2023, 13(2), 333; https://doi.org/10.3390/jpm13020333
Available online: https://www.mdpi.com/2075-4426/13/2/333

8. “Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches”
by Valeria Conti, Graziamaria Corbi, Francesco Sabbatino, Domenico De Pascale, Carmine Sellitto, Berenice Stefanelli, Nicola Bertini, Matteo De Simone, Luigi Liguori, Ilenia Di Paola et al.
J. Pers. Med. 2023, 13(2), 334; https://doi.org/10.3390/jpm13020334
Available online: https://www.mdpi.com/2075-4426/13/2/334

9. “Multi-Modal Stacking Ensemble for the Diagnosis of Cardiovascular Diseases”
by Taeyoung Yoon and Daesung Kang
J. Pers. Med. 2023, 13(2), 373; https://doi.org/10.3390/jpm13020373
Available online: https://www.mdpi.com/2075-4426/13/2/373

10. “COVID-19 and New-Onset Psychosis: A Comprehensive Review”
by Lorenzo Moccia, Georgios D. Kotzalidis, Giovanni Bartolucci, Sara Ruggiero, Laura Monti, Marco Biscosi, Beatrice Terenzi, Ottavia M. Ferrara, Marianna Mazza, Marco Di Nicola et al.
J. Pers. Med. 2023, 13(1), 104; https://doi.org/10.3390/jpm13010104
Available online: https://www.mdpi.com/2075-4426/13/1/104

11. “Ethical Implications of Chatbot Utilization in Nephrology”
by Oscar A. Garcia Valencia, Supawadee Suppadungsuk, Charat Thongprayoon, Jing Miao, Supawit Tangpanithandee, Iasmina M. Craici and Wisit Cheungpasitporn
J. Pers. Med. 2023, 13(9), 1363; https://doi.org/10.3390/jpm13091363
Available online: https://www.mdpi.com/2075-4426/13/9/1363

12. “A Summary on Tuberculosis Vaccine Development—Where to Go?”
by Fan Jiang, Tiehui Sun, Peng Cheng, Jie Wang and Wenping Gong
J. Pers. Med. 2023, 13(3), 408; https://doi.org/10.3390/jpm13030408
Available online: https://www.mdpi.com/2075-4426/13/3/408

13. “A Multi-Task Convolutional Neural Network for Semantic Segmentation and Event Detection in Laparoscopic Surgery”
by Giorgia Marullo, Leonardo Tanzi, Luca Ulrich, Francesco Porpiglia and Enrico Vezzetti
J. Pers. Med. 2023, 13(3), 413; https://doi.org/10.3390/jpm13030413
Available online: https://www.mdpi.com/2075-4426/13/3/413

14. “Use of Telemedicine Healthcare Systems in Children and Adolescents with Chronic Disease or in Transition Stages of Life: Consensus Document of the Italian Society of Telemedicine (SIT), of the Italian Society of Preventive and Social Pediatrics (SIPPS), of the Italian Society of Pediatric Primary Care (SICuPP), of the Italian Federation of Pediatric Doctors (FIMP) and of the Syndicate of Family Pediatrician Doctors (SIMPeF)”
by Susanna Esposito, Cristiano Rosafio, Francesco Antodaro, Alberto Argentiero, Marta Bassi, Paolo Becherucci, Fabio Bonsanto, Andrea Cagliero, Giulia Cannata, Fabio Capello et al.
J. Pers. Med. 2023, 13(2), 235; https://doi.org/10.3390/jpm13020235
Available online: https://www.mdpi.com/2075-4426/13/2/235

15. “Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation”
by Umit M. Sahiner, Mattia Giovannini, Maria M. Escribese, Giovanni Paoletti, Enrico Heffler, Montserrat Alvaro Lozano, Domingo Barber, Giorgio Walter Canonica and Oliver Pfaar
J. Pers. Med. 2023, 13(5), 845; https://doi.org/10.3390/jpm13050845
Available online: https://www.mdpi.com/2075-4426/13/5/845

16. “Immunoinformatic-Based Multi-Epitope Vaccine Design for Co-Infection of Mycobacterium tuberculosis and SARS-CoV-2”
by Cong Peng, Fengjie Tang, Jie Wang, Peng Cheng, Liang Wang and Wenping Gong
J. Pers. Med. 2023, 13(1), 116; https://doi.org/10.3390/jpm13010116
Available online: https://www.mdpi.com/2075-4426/13/1/116

17. “The Association between Alexithymia and Social Media Addiction: Exploring the Role of Dysmorphic Symptoms, Symptoms Interference, and Self-Esteem, Controlling for Age and Gender”
by Alessio Gori and Eleonora Topino
J. Pers. Med. 2023, 13(1), 152; https://doi.org/10.3390/jpm13010152
Available online: https://www.mdpi.com/2075-4426/13/1/152

18. “The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration”
by Anna Pisani, Fabiola Paciello, Valeria Del Vecchio, Rita Malesci, Eugenio De Corso, Elena Cantone and Anna Rita Fetoni
J. Pers. Med. 2023, 13(4), 652; https://doi.org/10.3390/jpm13040652
Available online: https://www.mdpi.com/2075-4426/13/4/652

19. “The Role of Cold Atmospheric Plasma in Wound Healing Processes in Critically Ill Patients”
by Tatiana Bolgeo, Antonio Maconi, Menada Gardalini, Denise Gatti, Roberta Di Matteo, Marco Lapidari, Yaroslava Longhitano, Gabriele Savioli, Andrea Piccioni and Christian Zanza
J. Pers. Med. 2023, 13(5), 736; https://doi.org/10.3390/jpm13050736
Available online: https://www.mdpi.com/2075-4426/13/5/736

20. “Epidemiology and Risk Factors of UTIs in Children—A Single-Center Observation”
by Maria Daniel, Hanna Szymanik-Grzelak, Janusz Sierdziński, Edyta Podsiadły, Magdalena Kowalewska-Młot and Małgorzata Pańczyk-Tomaszewska
J. Pers. Med. 2023, 13(1), 138; https://doi.org/10.3390/jpm13010138
Available online: https://www.mdpi.com/2075-4426/13/1/138

10 January 2024
Meet Us at the 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research, 18–20 April 2024, Yokohama, Japan

MDPI will attend the 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research as an exhibitor. This conference will be held in Yokohama, Japan, from 18 to 20 April 2024.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://site2.convention.co.jp/jssr2024/index_en.html.

2 January 2024
MDPI Insights: The CEO's Letter #7 - Nobel Laureates Entrust MDPI with Their Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Nobel Prize Laureates Entrust MDPI with Their Research

The Nobel Prize stands as a hallmark of distinction, honouring ground-breaking research across disciplines. Annually, the Nobel Prizes are awarded in six categories: Physics, Chemistry, Medicine or Physiology, Literature, Peace, and Economic Sciences.

Through the years, renowned scholars have entrusted MDPI with their work. As at December 2023, 26 Nobel laureates have contributed to more than 75 articles across 25 MDPI journals, including: Antibiotics, Applied Sciences, Biology, Biomedicines, Cancers, Catalysts, Cells, Crystals, Entropy, Games, IJMS, Life, Materials, Micromachines, Molecules, Pharmaceuticals, PharmaceuticsPhotonics, Quantum Beam Science, Remote Sensing, Sensors, Solids, Universe, Vaccines, and Viruses.

The best of the best trust us with their work.

Nobel Prize Laureates Who Have Published with MDPI

We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath.

The privilege of hosting such contributors resonates deeply with our editorial teams. For instance, in this interview, the Editor-in-Chief (EiC) of Universe speaks on the significance of publishing a paper by Nobel laureate Gerard ’t Hooft within the journal.

2023 Nobel Prize Winners Published by MDPI

Nobel Prize Winners, 2023: Katalin Karikó, Drew Weissman, Anne L’Huillier (Ill. Niklas Elmehed © Nobel Prize Outreach)

Three laureates from the 2023 Nobel Prize cohort have trusted MDPI as their publishing platform. Notably, in a 2022 Pharmaceutics paper, molecular biologist Katalin Karikó and her team presented a methodology for evaluating mRNA capping efficiency, pivotal for therapeutic applications. Pharmaceutics had previously dedicated a Special Issue to “mRNA Therapeutics: A Themed Issue in Honor of Professor Katalin Karikó”, spotlighting ten articles from August 2021 to February 2022.

In the journal Vaccines, Professor Drew Weissman, collaborating with scholars from Pennsylvania University and George Mason University, contributed an influential review titled “Nanomaterial Delivery Systems for mRNA Vaccines”. His collaborative efforts spanned five papers across MDPI journals between 2021 and 2023.

Furthermore, Anne L'Huillier of Lund University, only the fifth female recipient of the Physics Prize, co-authored an article in Applied Sciences focusing on "Advanced EUV and X-Ray Optics". Similarly, Pierre Agostini, an Emeritus Professor from Ohio State University, co-authored an article featured in the special issue "Attosecond Science and Technology: Principles and Applications".

We extend heartfelt congratulations to all Nobel Prize laureates and express sincere gratitude for their confidence in MDPI as a platform for their scholarly contributions.

Read more:

Impactful Research

MDPI Journals Newly Indexed in 2023

The aim of indexing is to enhance the quality and credibility of published research, ensuring that researchers access the most credible resources available. While the principle behind citation indexing is straightforward, it remains one of the most dependable methods for tracking an idea's evolution across various scientific disciplines.

Throughout the year, MDPI works to expand the reach of our publications across premier multidisciplinary databases like Web of Science, Scopus, EBSCO, and ProQuest. This initiative is spearheaded by MDPI's Indexing team, under the leadership of Dr. Constanze Schelhorn.

In 2023, MDPI achieved 54 new acceptances in Scopus, 29 in Web of Science, 52 in EBSCO, and 83 in DOAJ: Directory of Open Access Journals.

The team prioritizes ensuring that our journals feature in numerous specialized databases, including PMC, PubMed, MEDLINE, Inspec, CAS, and FSTA, among others. Currently, MDPI collaborates with over 65 renowned international databases, consistently enhancing our database affiliations annually.

MDPI’s journals are indexed in all major global databases.

Furthermore, we collaborate with universities and government organizations to list our journals in country-specific ranking lists and relevant institutional repositories. This ensures compliance with requirements often set by funders or institutions for authors to publish in specific journals.

Web of Science Adds 24 MDPI Journals to Emerging Sources Citation Index (ESCI)

Clarivate recently analysed MDPI’s new journals, resulting in 24 journals, mainly established in 2020, being added to the ESCI in November and December 2023. Additionally, five journals passed this assessment earlier in the year. For a complete list of our journals in Web of Science, refer here. Journals in the ESCI meet 24 quality criteria, ensuring editorial rigor. They may be considered for inclusion in broader indices like the Science Citation Index Expanded (SCIE), the Social Sciences Citation Index (SSCI), or the Arts and Humanities Citation Index (AHCI), based on four impact criteria.

Read more:

Inside MDPI

MDPI Appoints New Chief Operating Officer (COO)

Alistair Freeland returned to MDPI and assumed the role of Chief Operating Officer in November 2023, a position he previously held from 2013 to 2019. He succeeds Dr. Yu Lin, who will remain a member of MDPI’s Board of Directors, overseeing significant financial decisions for the company. I would like to express my sincere thanks to Dr. Yu Lin for his service as COO.

Alistair brings extensive experience not only in scholarly publishing but also in technology and business management. Prior to rejoining MDPI, he was associated with SIX Group, the entity responsible for Switzerland's financial market infrastructure. There, he played a pivotal role in developing the blockchain-based platform SDX (SIX Digital Exchange), which has gained traction among major Swiss banks and the Swiss National Bank.

As COO, Alistair will collaborate with the MDPI management team to improve the practices and services we offer to scholarly communities. I am pleased to welcome Alistair back to MDPI and look forward to his contributions going forward.

Coming Together for Science

MDPI’s 2024 In-Person Academic Events Schedule

MDPI's Conference Team is dedicated to organizing and hosting in-person academic events across Europe, Asia-Pacific, and North America. We recognize conferences as invaluable platforms for scientific collaboration, scholarly exchange, discussions on contemporary topics, networking, and forging collaborations.

Here's a glimpse of the notable events we currently have scheduled for 2024:

14–16 February, 2024
Viruses 2024 – A World of Viruses
Location: Barcelona, Spain
We are honoured to feature Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes as keynote speakers for this 5th edition.
Event details

24–26 April, 2024
4th MMCS – Harnessing the Power of New Drug Modalities 
Location: Barcelona, Spain
Esteemed speakers include Prof. Arun K. Ghosh, the mind behind the Darunavir molecule, and Prof. Paul Brennan, CSO of Alzheimer's Research UK Oxford Drug Discovery Institute.
Event details

28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location:
Athens, Greece
We look forward to welcoming renowned experts like Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Event details

1–4 August, 2024
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science
Location: Singapore
The AI Sensors 2024 Conference will unite innovators and experts in the realms of sensors, sensing technology, and artificial intelligence.
Event details

Upcoming events with details to be announced:

  • September 2024, Materials 2024 – Basel, Switzerland
  • 1921 September 2024, International Conference on Nanomaterials Sciences 2024 – Beijing, China
  • October 2024, ncRNA 2024 – Basel, Switzerland
  • November 2024, Pharmaceuticals 2024 – Barcelona, Spain
  • 2226 November 2024, International Conference on Science of Electronics – Wuhan, China
  • Stay tuned for more details on the Sustainable Publishing Forum 2024.

Click here for all upcoming MDPI events.

Organize Your Event with MDPI’s Sciforum

Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.

Closing Thoughts

Reflecting on 2023 and Looking Ahead to 2024

As we approach 2024, I reflect on the incredible journey we’ve had together at MDPI this year. The past 12 months have been marked by ambitious projects and initiatives to improve our internal processes, and a commitment to continue delivering top-notch services to our stakeholders. I’d like to thank each and every one of our staff members for contributing to the positive experiences our stakeholders have reported in our surveys. Your dedication to speed, efficiency, and effective communication with our stakeholders is very much recognized and appreciated.

Becoming a stronger organisation

While we have encountered challenges in 2023, it’s important to understand that these are a part of our growth process. Difficulties provide us with opportunities to reflect, address problems at their roots, and ultimately evolve into a stronger organization. Our stakeholders expect us to overcome tough times, and it’s an expectation that we have for ourselves.

I extend my sincere appreciation to every MDPI employee, from our editorial office and IT department to marketing, indexing, IOAP, societies, Scientific Office board, products, production, conferences, finance, operations, admin, and beyond. To our newest team members, a warm welcome; to our longstanding colleagues, your dedication is invaluable.

“I am committed to taking MDPI to a new level of excellence.”

Interacting with many of you during my visits to our offices and representing MDPI at external events has been a personal highlight. I am deeply grateful to Dr. Lin for entrusting me with the role of CEO of MDPI. Looking forward, I am committed to working closely with our management team to lead MDPI and take it to a new level of excellence, aiming to establish it as the most trusted publisher in open access worldwide. This is a collective endeavour, with each of us shaping MDPI’s reputation. I therefore encourage us to take pride in our work, as it represents not only our craft but also MDPI as a whole.

Accountability and communication

As we look forward to 2024, there’s a lot to be excited about. Together, we’ll navigate challenges, seize growth opportunities, and refine our practices. To solidify MDPI’s position as the premier open access publisher globally, we must bolster accountability, improve stakeholder communication, share MDPI’s best practices, champion the open access philosophy, and educate stakeholders about our mission, methodologies, and motivations.

Thank you for engaging with the CEO Letter over the past six months of 2023. I will continue to release this newsletter as a method of sharing the great work being done at MDPI. Please feel free to connect directly with any insights or questions.

Here’s to a joyous and prosperous 2024!

Stefan Tochev
Chief Executive Officer
MDPI AG

25 December 2023
Journal of Personalized Medicine | Top 10 Cited Papers in 2022 in the Section “Omics/Informatics”


We are pleased to invite you to read the top 10 cited papers in 2022 in Journal of Personalized Medicine (ISSN: 2075-4426) in the Section “Omics/Informatics”. The list of papers is as follows:

1. “Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems”
by Roxana Filip, Roxana Gheorghita Puscaselu, Liliana Anchidin-Norocel, Mihai Dimian and Wesley K. Savage
J. Pers. Med. 2022, 12(8), 1295; https://doi.org/10.3390/jpm12081295
Available online: https://www.mdpi.com/2075-4426/12/8/1295

2. “Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases”
by Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti and Sebastiano Cavallaro
J. Pers. Med. 2022, 12(5), 770; https://doi.org/10.3390/jpm12050770
Available online: https://www.mdpi.com/2075-4426/12/5/770

3. “CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach”
by Nirjhar Bhattacharyya, Samriddhi Gupta, Shubham Sharma, Aman Soni, Sali Abubaker Bagabir, Malini Bhattacharyya, Atreyee Mukherjee, Atiah H. Almalki, Mustfa F. Alkhanani, Shafiul Haque et al.
J. Pers. Med. 2022, 12(3), 393; https://doi.org/10.3390/jpm12030393
Available online: https://www.mdpi.com/2075-4426/12/3/393

4. “miR-155: A Potential Biomarker for Predicting Mortality in COVID-19 Patients”
by Reut Kassif-Lerner, Keren Zloto, Nadav Rubin, Keren Asraf, Ram Doolman, Gidi Paret and Yael Nevo-Caspi
J. Pers. Med. 2022, 12(2), 324; https://doi.org/10.3390/jpm12020324
Available online: https://www.mdpi.com/2075-4426/12/2/324

5. “Computational Models for Clinical Applications in Personalized Medicine—Guidelines and Recommendations for Data Integration and Model Validation”
by Catherine Bjerre Collin, Tom Gebhardt, Martin Golebiewski, Tugce Karaderi, Maximilian Hillemanns, Faiz Muhammad Khan, Ali Salehzadeh-Yazdi, Marc Kirschner, Sylvia Krobitsch, EU-STANDS4PM consortium and Lars Kuepfer
J. Pers. Med. 2022, 12(2), 166; https://doi.org/10.3390/jpm12020166
Available online: https://www.mdpi.com/2075-4426/12/2/166

6. “The Penn Medicine BioBank: Towards a Genomics-Enabled Learning Healthcare System to Accelerate Precision Medicine in a Diverse Population”
by Anurag Verma, Scott M. Damrauer, Nawar Naseer, JoEllen Weaver, Colleen M. Kripke, Lindsay Guare, Giorgio Sirugo, Rachel L. Kember, Theodore G. Drivas, Scott M. Dudek et al.
J. Pers. Med. 2022, 12(12), 1974; https://doi.org/10.3390/jpm12121974
Available online: https://www.mdpi.com/2075-4426/12/12/1974

7. “Three-Dimensional Semantic Segmentation of Diabetic Retinopathy Lesions and Grading Using Transfer Learning”
by Natasha Shaukat, Javeria Amin, Muhammad Sharif, Faisal Azam, Seifedine Kadry and Sujatha Krishnamoorthy
J. Pers. Med. 2022, 12(9), 1454; https://doi.org/10.3390/jpm12091454
Available online: https://www.mdpi.com/2075-4426/12/9/1454

8. “Image Analysis in Digital Pathology Utilizing Machine Learning and Deep Neural Networks”
by Paris Amerikanos and Ilias Maglogiannis
J. Pers. Med. 2022, 12(9), 1444; https://doi.org/10.3390/jpm12091444
Available online: https://www.mdpi.com/2075-4426/12/9/1444

9. “Epigenetics in Precision Nutrition”
by Xiang Li and Lu Qi
J. Pers. Med. 2022, 12(4), 533; https://doi.org/10.3390/jpm12040533
Available online: https://www.mdpi.com/2075-4426/12/4/533

10. “Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?”
by Claire Deligne, Sylvaine You and Roberto Mallone
J. Pers. Med. 2022, 12(4), 542; https://doi.org/10.3390/jpm12040542
Available online: https://www.mdpi.com/2075-4426/12/4/542

15 December 2023
Journal of Personalized Medicine | Highly Cited Special Issues in the Section “Mechanisms of Diseases” in 2022


We are pleased to invite you to read the highly cited Special Issues in 2022 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), in the Section “Mechanisms of Diseases”. We hope this announcement will provide useful information for this field.

The Special Issues list is as follows:

Personalized Medicine for COVID-19 Patients-Clinical Considerations

Edited by Dr. Paraskevi Katsaounou, Prof. Dr. Dimitrios B. Georgopoulos and Dr. Nikoletta Rovina

Views: 75000+ | Cited by 230+

Cardiovascular Disease Prevention in the Era of Personalized Medicine

Edited by Dr. Konstantinos Tziomalos

Views: 49000+ | Cited by 150+

Personalized Medicine in the Field of Inflammatory Skin Disorders

Edited by Dr. Mircea Tampa, Prof. Dr. Monica Neagu, Prof. Dr. Constantin Caruntu and Prof. Dr. Simona Roxana Georgescu

Views: 48000+ | Cited by 190+

Personalized Medicine for Parkinson's Disease: New Concepts and Future of Individualized Management

Edited by Dr. Nataliya Titova and Prof. Dr. Kallol Ray Chaudhuri

Views: 44000+ | Cited by 90+

Asthma: From Phenotypes to Personalized Medicine

Edited by Prof. Dr. Petros Bakakos

Views: 26000+ | Cited by 70+

Personalized Molecular Neurobiology of Brain Mapping of Global Pain and Mental Illness

Edited by Prof. Dr. Kenneth Blum, Dr. Babak Kateb, Dr. Vicky Yamamoto, Prof. Dr. Igor Elman, Dr. Mark S. Gold and Dr. Kai-Uwe Lewandrowski

Views: 37000+ | Cited by 60+

You are welcome to view all the Special Issues and submit relevant papers to the Journal of Personalized Medicine. If you have any questions, you can contact the Editorial Office at [email protected].

Journal of Personalized Medicine Editorial Office

30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI Spain Summit


Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.

On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.

With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.

The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.

The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.

Connecting with Editorial Board Members


Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."

Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.

From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.

As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.

Open Access in Spain

In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.

For further details of Spain's OA policy and the history of government mandates, click here.

Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus. 

A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!


MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.

I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.

Impactful Research

769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023

Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.

Click here to view the full list of 769 Editorial Board Members.

Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.

Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!

Inside MDPI

Corporate Marketing and Communications Strategy Session


Members of MDPI’s Corporate Marketing & Communications team.

For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.

This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.

We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.

The strategy session also serves as a team-building activity, during which the team voted on bowling!

Strategy Session

In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.

To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.

I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.

Coming Together for Science

ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home


Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.

When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.

In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.

While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.

The press release below provides further details.

Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023

ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.  

This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.

Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.

Closing Thoughts

November is Men’s Health Awareness Month


Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.

November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.

I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.

Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.

Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.

Healthy men help build healthy families and a healthy society

Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.

From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.

Mindfulness

Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:

Stefan Tochev
Chief Executive Officer
MDPI AG

29 November 2023
Journal of Personalized Medicine | Top 15 Cited Papers on Disease Biomarkers in 2022


We are pleased to invite you to read the following 15 most highly cited papers published on the topic of disease biomarkers in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in 2022.

1. “Emerging Biomarkers for Early Detection of Chronic Kidney Disease”
by Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir and Joško Božić
J. Pers. Med. 2022, 12(4), 548; https://doi.org/10.3390/jpm12040548
Available online: https://www.mdpi.com/2075-4426/12/4/548

2. “Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents”
by Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland S. Croner and Ulf D. Kahlert
J. Pers. Med. 2022, 12(3), 478; https://doi.org/10.3390/jpm12030478
Available online: https://www.mdpi.com/2075-4426/12/3/478

3. “Multi-Omics Profiling Approach to Asthma: An Evolving Paradigm”
by Yadu Gautam, Elisabet Johansson and Tesfaye B. Mersha
J. Pers. Med. 2022, 12(1), 66; https://doi.org/10.3390/jpm12010066
Available online: https://www.mdpi.com/2075-4426/12/1/66

4. “Deep Learning-Based Diagnosis of Alzheimer’s Disease”
by Tausifa Jan Saleem, Syed Rameem Zahra, Fan Wu, Ahmed Alwakeel, Mohammed Alwakeel, Fathe Jeribi and Mohammad Hijji
J. Pers. Med. 2022, 12(5), 815; https://doi.org/10.3390/jpm12050815
Available online: https://www.mdpi.com/2075-4426/12/5/815

5. “The Importance of SNPs at miRNA Binding Sites as Biomarkers of Gastric and Colorectal Cancers: A Systematic Review”
by Fatemeh Hajibabaie, Navid Abedpoor, Nazanin Assareh, Mohammad Amin Tabatabaiefar, Laleh Shariati and Ali Zarrabi
J. Pers. Med. 2022, 12(3), 456; https://doi.org/10.3390/jpm12030456
Available online: https://www.mdpi.com/2075-4426/12/3/456

6. “Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases”
by Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti and Sebastiano Cavallaro
J. Pers. Med. 2022, 12(5), 770; https://doi.org/10.3390/jpm12050770
Available online: https://www.mdpi.com/2075-4426/12/5/770

7. “Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy”
by Riccardo Di Santo, Maria Vaccaro, Sabrina Romanò, Flavio Di Giacinto, Massimiliano Papi, Gian Ludovico Rapaccini, Marco De Spirito, Luca Miele, Umberto Basile and Gabriele Ciasca
J. Pers. Med. 2022, 12(6), 949; https://doi.org/10.3390/jpm12060949
Available online: https://www.mdpi.com/2075-4426/12/6/949

8. “CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach”
by Nirjhar Bhattacharyya, Samriddhi Gupta, Shubham Sharma, Aman Soni, Sali Abubaker Bagabir, Malini Bhattacharyya, Atreyee Mukherjee, Atiah H. Almalki, Mustfa F. Alkhanani, Shafiul Haque et al.
J. Pers. Med. 2022, 12(3), 393; https://doi.org/10.3390/jpm12030393
Available online: https://www.mdpi.com/2075-4426/12/3/393

9. “Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease”
by Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama and Nobuko Matsushima
J. Pers. Med. 2022, 12(3), 444; https://doi.org/10.3390/jpm12030444
Available online: https://www.mdpi.com/2075-4426/12/3/444

10. “miR-155: A Potential Biomarker for Predicting Mortality in COVID-19 Patients”
by Reut Kassif-Lerner, Keren Zloto, Nadav Rubin, Keren Asraf, Ram Doolman, Gidi Paret and Yael Nevo-Caspi
J. Pers. Med. 2022, 12(2), 324; https://doi.org/10.3390/jpm12020324
Available online: https://www.mdpi.com/2075-4426/12/2/324

11. “Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP”
by Elena Cantone, Eugenio De Corso, Filippo Ricciardiello, Claudio Di Nola, Giusi Grimaldi, Viviana Allocca and Gaetano Motta
J. Pers. Med. 2022, 12(8), 1215; https://doi.org/10.3390/jpm12081215
Available online: https://www.mdpi.com/2075-4426/12/8/1215

12. “Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer”
by Michael J. Duffy and John Crown
J. Pers. Med. 2022, 12(1), 99; https://doi.org/10.3390/jpm12010099
Available online: https://www.mdpi.com/2075-4426/12/1/99

13. “Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers”
by Fabiana Ciciriello, Marcel J. C. Bijvelds, Federico Alghisi, Kelly F. Meijsen, Luca Cristiani, Claudio Sorio, Paola Melotti, Alessandro G. Fiocchi, Vincenzina Lucidi and Hugo R. De Jonge
J. Pers. Med. 2022, 12(4), 632; https://doi.org/10.3390/jpm12040632
Available online: https://www.mdpi.com/2075-4426/12/4/632

14. “Personalized Management of Myocarditis and Inflammatory Cardiomyopathy in Clinical Practice”
by Agata Tymińska, Krzysztof Ozierański, Aleksandra Skwarek, Agnieszka Kapłon-Cieślicka, Anna Baritussio, Marcin Grabowski, Renzo Marcolongo and Alida LP Caforio
J. Pers. Med. 2022, 12(2), 183; https://doi.org/10.3390/jpm12020183
Available online: https://www.mdpi.com/2075-4426/12/2/183

15. “From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine”
by Laura Maintz, Thomas Bieber, Helen D. Simpson and Anne-Laure Demessant-Flavigny
J. Pers. Med. 2022, 12(6), 893; https://doi.org/10.3390/jpm12060893
Available online: https://www.mdpi.com/2075-4426/12/6/893

21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023


We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.

This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.

Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!


Abate, Antonio
Aguilera, Ruth V.
Ahmed, Warish
Ahn, Myung-Ju
An, Qiaoshi
Anasori, Babak
Andersson, Dan I.
Angeletti, Silvia
Annabi, Nasim
Antinori, Spinello
Ariga, Katsuhiko
Asa, Sylvia L.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Balsamo, Gianpaolo
Bandodkar, Amay J.
Banks, William A.
Bao, Yan-Ping
Barba, Francisco J.
Barnes, Peter J.
Barnholtz-Sloan, Jill S.
Barrow, Colin J.
Bashir, Ali Kashif
Basit, Abdul W.
Bassetti, Matteo
Batley, Jacqueline
Battino, Maurizio
Behnood, Ali
Benediktsson, Jon Atli
Biondi, Antonio
Bjarnsholt, Thomas
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boczkaj, Grzegorz
Bogers, Marcel
Bonomo, Robert A.
Boyd, Robert W.
Boyer, Cyrille
Braeckmans, Kevin
Bragazzi, Nicola Luigi
Bu, Wenbo
Bursać Kovačević, Danijela
Bush, Ashley I.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cambria, Erik
Cao, Guozhong
Cao, Xingzhong
Capasso, Raffaele
Carvalho, Andre F.
Casper, Jonathan
Castellanos-Gomez, Andres
Cavalli, Giacomo
Chai, Siang-Piao
Chan, Jasper Fuk-Woo
Chan, Timothy A.
Chang, Chih-Hao
Chang, Guoqing
Chao, Dongliang
Chen, Bo
Chen, Chaoji
Chen, Fahu
Chen, Gang
Chen, Jianmin
Chen, Jun
Chen, Jun
Chen, Jun
Chen, Lidong
Chen, Lingxin
Chen, Min
Chen, Mou
Chen, Peng
Chen, Qian
Chen, Qianwang
Chen, Shaowei
Chen, Shuangming
Chen, Wei
Chen, Xiaobo
Chen, Yimin
Chen, Yu
Chen, Yulin
Chen, Zhong
Chen, Zonghai
Cheng, Gong
Cheng, Huanyu
Cheng, Laifei
Cheng, Qiang
Chew, Kit Wayne
Chiclana, Francisco
Choi, Wonyong
Choi, Young Hae
Chowdhary, Anuradha
Cichocki, Andrzej
Clevers, Hans
Coops, Nicholas C.
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Creutzig, Felix
Crommie, Michael F.
Cuadrado, Antonio
Cui, Haiying
Cui, Yi
Curigliano, Giuseppe
Dai, Sheng
Dai, Shifeng
Daiber, Andreas
Davies, Michael J.
Davis, Thomas P.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Delord, Jean-Pierre
Demaria, Marco
Deng, Xiangzheng
Desneux, Nicolas
Dikic, Ivan
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Ding, Jianxun
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Chung-Li
Dou, Shi Xue
Dragicevic, Tomislav
Du, Bo
Du, Qian
Du, Yonghua
Duan, Xidong
Dufresne, Alain
Dummer, Reinhard
Edwards, David
Elaissari, Abdelhamid
ElMasry, Gamal
Enjuanes, Luis
Fabbro, Doriano
Facchetti, Antonio
Fan, Junliang
Fan, Kelong
Fan, Xiulin
Fan, Zhanxi
Fang, Baizeng
Fang, Chuanglin
Fang, Yongjin
Fasano, Alessio
Feng, Liangzhu
Feng, Xuning
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Filippi, Massimo
Flavian, Carlos
Fortino, Giancarlo
Fowler, Michael
Franceschi, Claudio
Frattini, Federico
Friston, Karl J.
Fu, Gengtao
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gao, Feng
Gao, Huijun
Gao, Huile
Gao, Peng
Gao, Wei
Garbe, Claus
Garg, Abhishek D.
Gasbarrini, Antonio
Gastaldelli, Amalia
Gautier, Emmanuel L.
Genevet, Patrice
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghaffari, Roozbeh
Ghamisi, Pedram
Giacobbe, Daniele Roberto
Giampieri, Francesca
Gillies, Robert J.
Godos, Justyna
Gogotsi, Yury
Golding, Nick
Gong, Jinlong
Gong, Peng
Gong, Yongji
Govindan, Kannan
Gozal, David
Grancini, Giulia
Grant, William B.
Graus, Francesc
Green, Douglas R.
Grosso, Giuseppe
Gu, Meng
Gu, Zhanjun
Guan, Cao
Gueimonde, Miguel
Gui, Guan
Guigo, Roderic
Guo, Hengyu
Guo, Jianping
Guo, Lin
Guo, Song
Guo, Yan
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Hagger, Martin S.
Hall, C. Michael
Han, Fudong
Han, Heesup
Hanes, Justin
Hartung, Hans-Peter
He, Bao-Jie  
He, Debiao
He, Hongwen
He, Jiaqing
He, Jie
He, Jr-Hau
He, Qiong
He, Xiangming
He, Xijun
He, Zhili
Heneka, Michael T.
Herrera, Francisco
Herrera-Estrella, Luis
Herrera-Viedma, Enrique
Hetz, Claudio
Holick, Michael F.
Hong, Danfeng
Hong, Xuechuan
Hsueh, Po-Ren
Hu, Bin
Hu, Enyuan
Hu, Jin-Song
Hu, Weida
Hu, Wenbin
Hu, Xiaosong
Huang, Baibiao
Huang, Hongwei
Huang, Jianliang
Huang, Jianping
Huang, Peng
Huang, Xin
Hubacek, Klaus
Hussain, Saddam
Italiano, Antoine
Iwata, Hiroji
Jaeschke, Hartmut
Jain, Atul

Jaiswal, Amit K.
Jankovic, Joseph
Janssens, Ivan A.
Jelezko, Fedor
Jeon, Byong-Hun
Ji, Guangbin
Ji, Qiang
Ji, Wei
Ji, Xiaobo
Ji, Xiaoyuan
Jiang, Bin
Jiang, Hong
Jiang, Junjun
Jiang, Lianzhou
Jiang, Qing
Jiang, Shibo
Jiang, Yuyan
Jiang, Zhongyi
Jiao, Licheng
Jin, Shi
Jin, Zhong
Kalantar-zadeh, Kourosh
Kamal, Mohammad Amjad
Kaner, Richard B.
Kaneti, Yusuf Valentino
Kang, Zhenhui
Karagiannidis, George K.
Karniadakis, George Em
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Kepp, Oliver
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kildishev, Alexander V.
Kim, Haegyeom
Kim, Jeonghun
Kim, Jin-Hoi
Kim, Jong Seung
Kim, Ki-Hyun
Kirkwood, John M.
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Kong, Baohua
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kroemer, Guido
Kuang, Dai-Bin
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Prashant
Kumar, Sudhir
Kurths, Juergen
Kurzrock, Razelle
Kuzyakov, Yakov
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lan, Ke
Lancellotti, Patrizio
Landi, Francesco
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Chengkuo
Lee, Jechan
Lee, Jin-Wook
Lee, Pooi See
Lee, Sang Soo
Lehmann, Johannes
Lei, Yaguo
Li, Bin
Li, Chunzhong
Li, Dongsheng
Li, Feng
Li, Hai
Li, Heng
Li, Hongyi
Li, Hui
Li, Jinghong
Li, Jun
Li, Li
Li, Linlin
Li, Neng
Li, Ning
Li, Shuai
Li, Shutao
Li, Wei
Li, Wentao
Li, Xiang
Li, Xuecao
Li, Xuelong
Li, Yat
Li, Yurui
Li, Zhijun
Liang, Chao
Liang, Shuquan
Liaw, Peter K.
Lin, Jun
Lin, Yuehe
Lippi, Giuseppe
Lister, Ryan
Liu, Chengmei
Liu, Gang
Liu, Hong
Liu, Hui
Liu, Jian
Liu, Jinyan
Liu, Jun
Liu, Meilin
Liu, Pan
Liu, Wei
Liu, Xianhu
Liu, Xiaoping
Liu, Xuejun
Liu, Yang
Liu, Yu
Liu, Yuan
Lonardo, Amedeo
Long, Hualou
Long, Ying
Lu, Bingan
Lu, Junling
Lu, Lu
Lu, Nanshu
Lu, Rongxing
Lucey, Brian
Lucieer, Arko
Lugato, Emanuele
Lund, Henrik
Luo, Yangchao
Luo, Yi
Luo, Zisheng
Lv, Wei
Lyons, Timothy W.
Ma, Haile
Ma, Jianmin
Ma, Jun
Ma, Tianyi
Ma, Wei
Ma, Yanming
Madabhushi, Anant
Mahmoudi, Morteza
Mai, Liqiang
Mai, Wenjie
Makridakis, Spyros
Mandala, Mario
Mantovani, Alberto
Mao, Jianfeng
Mao, Like
Mardani, Abbas
Mathivanan, Suresh
Matyjaszewski, Krzysztof
McCabe, Matthew F.
McCauley, Darren
McClements, David Julian
Mei, Lin
Melenhorst, Jan Joseph
Melero, Ignacio
Meyerholz, David K.
Mierlo, Joeri Van
Miroshnichenko, Andrey E.
Mittler, Ron
Mu, Shichun
Mubarak, Mohammad S.
Mueller, Lukas A.
Muhammad, Khan
Mumtaz, Shahid
Munekata, Paulo Eduardo Sichetti
Nakagawa, Shinichi
Nauen, Ralf
Newman, David J.
Niaura, Raymond S.
Nidheesh, P. V.
Niu, Ben
Nussinov, Ruth
O'Connor, David
Odintsov, Sergei D.
Omri, Anis
Orsini, Nicola
Ostrikov, Kostya (Ken)
Oswald, Isabelle P.
Oudard, Stephane
Ouyang, Minggao
Ozcan, Aydogan
Pan, Anlian
Pan, Anqiang
Pan, Caofeng
Pan, Genxing
Pan, Likun
Pan, Quan-Ke
Pan, Xiaoqing
Pandolfi, Pier Paolo
Parati, Gianfranco
Pateiro, Mirian
Peng, Qiang
Peng, Qing
Peng, Shushi
Perc, Matjaz
Perlin, David S.
Perlman, Stanley
Petruzzelli, Antonio Messeni
Pitt, Bertram
Pöhlmann, Stefan
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Potenza, Marc N.
Preat, Veronique
Prinsep, Michele R.
Pu, Kanyi
Putnik, Predrag
Qin, Yuanwei
Qiu, Jieshan
Qu, Xiaogang
Ragauskas, Arthur J.
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Rao, Zhonghao
Recio, Isidra
Ren, Jinsong
Rengel, Zed
Rho, Junsuk
Riahi, Keywan
Ribeiro-Soriano, Domingo
Richardson, Paul G.
Robert, Caroline
Rocca, Maria A.
Rodriguez-Manas, Leocadio
Rojas, Orlando J.
Rojo, Teofilo
Roubaud, David
Saad, Fred
Saad, Walid
Sadorsky, Perry
Saliba, Michael
Sander, Chris
Sangaiah, Arun Kumar
Santamouris, Mattheos
Santoro, Gabriele
Scaldaferri, Franco
Schatzberg, Alan F.
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scott, Daniel
Serruys, Patrick W.
Setzer, William N.
Shahzad, Babar
Shao, Shuai
Shao, Zongping
Shen, Guozhen
Shen, Liyin

Shen, Zexiang
Shi, Peng
Shi, Yi
Siano, Pierluigi
Simões, Manuel
Sing, Swee Leong
Singh, Vijay P.
Smagghe, Guy
Smith, Lee
Soffietti, Riccardo
Song, Houbing
Song, Jibin
Song, Yu
Sood, Anil K.
Souto, Eliana B.
Stadler, Marc
Stanley, H. Eugene
Stephanopoulos, Gregory
Sternberg, Cora N.
Stoumpos, Constantinos C.
Stunnenberg, Hendrik G.
Su, Shiliang
Sun, Baoguo
Sun, Cuixia
Sun, Fengchun
Sun, Hongqi
Sun, Jie
Sun, Lijun
Sun, Litao
Sun, Runcang
Sun, Yanjuan
Sun, Zaicheng
Sun, Zhipei
Sureda, Antoni
Svenning, Jens-Christian
Tan, Chaoliang
Tan, Weihong
Tang, Chuan-He
Tang, Chuyang
Tang, Dianping
Tang, Yongbing
Tanzi, Rudolph E.
Terpos, Evangelos
Teschendorff, Andrew E.
Tian, He
Timsit, Jean-Francois
Tiwari, Aviral Kumar
Tohge, Takayuki
Tousoulis, Dimitris
Tran, Lam-Son Phan
Tress, Wolfgang
Trivedi, Pankaj
Tsao, Rong
Tully, Mark A.
Tung, Chen-Ho
Van der Bruggen, Bart
Vandenbroucke, Roosmarijn E.
Vangronsveld, Jaco
Varsani, Arvind
Vatanen, Tommi
Verbeke, Kristin
Vermote, Eric
Verpoorte, Robert
Vieta, Eduard
Vincent, Jean-Louis
Vita, Antonio
Wan, Jiafu
Wan, Shaohua
Wanek, Wolfgang
Wang, Bin
Wang, Bo
Wang, Chao
Wang, Chuanyi
Wang, Chunsheng
Wang, Dan
Wang, Feng
Wang, Gongming
Wang, Guoxiu
Wang, Haihui
Wang, Hao
Wang, Huanqing
Wang, Huanting
Wang, Hui
Wang, Jian
Wang, Jie
Wang, Jing
Wang, John
Wang, Joseph
Wang, Lianzhou
Wang, Lihui
Wang, Meng
Wang, Peng
Wang, Pengfei
Wang, Qi
Wang, Qi
Wang, Qiang
Wang, Qilin
Wang, Qin
Wang, Qing
Wang, Shaojian
Wang, Sibo
Wang, Tao
Wang, Ying
Wang, Yong
Wang, Zhen
Wang, Zhong Lin
Wang, Zhongrui
Wang, Zifa
Wang, Zuankai
Wei, Haotong
Wei, Leyi
Wei, Zhixiang
Wei, Zhongbao
Weissleder, Ralph
Weitschies, Werner
Wen, Guanghui
Wesemael, Bas van
Willerslev, Eske
Witlox, Frank
Wu, Haijun
Wu, Hao Bin
Wu, Hui
Wu, Jun
Wu, Qinglin
Wu, Shuilin
Wu, Xiaojun
Wu, Yongzhen
Wu, Yuping
Wu, Zheng-Guang
Wu, Zhong-Shuai
Xia, Jianguo (Jeff)
Xia, Meimei
Xia, Xinhui
Xia, Yongyao
Xia, Zhiguo
Xiang, Quanjun
Xiao, Fuyuan
Xiao, Jie
Xin, Sen
Xing, Baoshan
Xing, Wei
Xiong, Rui
Xu, Hui
Xu, Li Da
Xu, Ping
Xu, Yi-Jun
Xu, Zhenjiang Zech
Yan, Chong
Yan, He
Yan, Huaicheng
Yan, Kai
Yan, Ruqiang
Yang, Bing
Yang, Chenguang
Yang, Hongshun
Yang, Hui
Yang, Jian
Yang, Jianping
Yang, Jie
Yang, Jun
Yang, Kai
Yang, Shihe
Yang, Xiaofeng
Yang, Xinsong
Yang, Yun-Gui
Yao, Yonggang
Yigitcanlar, Tan
Yin, Shen
Yin, Shou-Wei
Yin, Yulong
Yin, Zongyou
Yokoya, Naoto
Young, Allan H.
Yu, Guihua
Yu, Jun
Yu, Le
Yu, Minghao
Yu, Shu-Hong
Yu, Wei
Yu, Wenwu
Yuan, Qiangqiang
Yuan, Yifei
Yuan, Yuan
Yuen, Chau
Zeadally, Sherali
Zhai, Tianyou
Zhang, Bing
Zhang, Dengsong
Zhang, Fan
Zhang, Fusuo
Zhang, Guangyu
Zhang, Guowen
Zhang, Hengjie
Zhang, Hongjie
Zhang, Hui
Zhang, Lai-Chang
Zhang, Lefei
Zhang, Lei
Zhang, Liangpei
Zhang, Lijun
Zhang, Min
Zhang, Peng
Zhang, Qiang
Zhang, Qiaobao
Zhang, Qichun
Zhang, Shicheng
Zhang, Shujun
Zhang, Tierui
Zhang, Wei
Zhang, Weili
Zhang, Xian-Ming
Zhang, Xiaodong
Zhang, Xiaogang
Zhang, Xiaoling
Zhang, Yang
Zhang, Yaobin
Zhang, Yi
Zhang, Yi-Zhou
Zhang, Yong
Zhang, Yu Shrike
Zhang, Yue-Jun
Zhang, Yuelin
Zhang, Zheng
Zhang, Zhicheng
Zhang, Zhien
Zhao, Guochun
Zhao, Jie
Zhao, Li-Dong
Zhao, Qing
Zhao, Yi
Zheng, Hao
Zheng, Weitao
Zheng, Yufeng
Zhong, Cheng
Zhou, Jie
Zhou, Jizhong
Zhou, Kun
Zhou, Liang
Zhou, Peng
Zhou, Qi
Zhou, Wei
Zhou, Weiqi
Zhu, Chengzhou
Zhu, Hongwei
Zhu, Junfa
Zhu, Jun-Jie
Zhu, Lei
Zhu, Mingshan
Zhu, Quanxin
Zhu, Yi
Zhu, Yongfa
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan
Zou, Ruqiang
Zuo, Chao

14 November 2023
Journal of Personalized Medicine | Top 15 Cited Papers on Precision Oncology in 2022


We are pleased to invite you to read the highly cited papers in 2022 from the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), on the topic of precision oncology. The paper list is as follows:

1. “Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems”
by Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari et al.
J. Pers. Med. 2022, 12(7), 1073; https://doi.org/10.3390/jpm12071073
Available online: https://www.mdpi.com/2075-4426/12/7/1073

2. “Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents”
by Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland S. Croner and Ulf D. Kahlert
J. Pers. Med. 2022, 12(3), 478; https://doi.org/10.3390/jpm12030478
Available online: https://www.mdpi.com/2075-4426/12/3/478

3. “Identification of Early Esophageal Cancer by Semantic Segmentation”
by Yu-Jen Fang, Arvind Mukundan, Yu-Ming Tsao, Chien-Wei Huang and Hsiang-Chen Wang
J. Pers. Med. 2022, 12(8), 1204; https://doi.org/10.3390/jpm12081204
Available online: https://www.mdpi.com/2075-4426/12/8/1204

4. “Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges”
by Francisco Silva, Tania Pereira, Inês Neves, Joana Morgado, Cláudia Freitas, Mafalda Malafaia, Joana Sousa, João Fonseca, Eduardo Negrão, Beatriz Flor de Lima et al.
J. Pers. Med. 2022, 12(3), 480; https://doi.org/10.3390/jpm12030480
Available online: https://www.mdpi.com/2075-4426/12/3/480

5. “Design and Development of an Intelligent Clinical Decision Support System Applied to the Evaluation of Breast Cancer Risk”
by Manuel Casal-Guisande, Alberto Comesaña-Campos, Inês Dutra, Jorge Cerqueiro-Pequeño and José-Benito Bouza-Rodríguez
J. Pers. Med. 2022, 12(2), 169; https://doi.org/10.3390/jpm12020169
Available online: https://www.mdpi.com/2075-4426/12/2/169

6. “Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy”
by Riccardo Di Santo, Maria Vaccaro, Sabrina Romanò, Flavio Di Giacinto, Massimiliano Papi, Gian Ludovico Rapaccini, Marco De Spirito, Luca Miele, Umberto Basile and Gabriele Ciasca
J. Pers. Med. 2022, 12(6), 949; https://doi.org/10.3390/jpm12060949
Available online: https://www.mdpi.com/2075-4426/12/6/949

7. “CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach”
by Nirjhar Bhattacharyya, Samriddhi Gupta, Shubham Sharma, Aman Soni, Sali Abubaker Bagabir, Malini Bhattacharyya, Atreyee Mukherjee, Atiah H. Almalki, Mustfa F. Alkhanani, Shafiul Haqu et al.
J. Pers. Med. 2022, 12(3), 393; https://doi.org/10.3390/jpm12030393
Available online: https://www.mdpi.com/2075-4426/12/3/393

8. ”Construction of a miRNA-Based Nomogram Model to Predict the Prognosis of Endometrial Cancer”
by Leyi Ni, Chengyun Tang, Yuning Wang, Jiaming Wan, Morgan G. Charles, Zilong Zhang, Chen Li, Ruijie Zeng, Yiyao Jin, Penghao Song et al.
J. Pers. Med. 2022, 12(7), 1154; https://doi.org/10.3390/jpm12071154
Available online: https://www.mdpi.com/2075-4426/12/7/1154

9. “Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer”
by Alexandros Laios, Evangelos Kalampokis, Racheal Johnson, Amudha Thangavelu, Constantine Tarabanis, David Nugent and Diederick De Jong
J. Pers. Med. 2022, 12(4), 607; https://doi.org/10.3390/jpm12040607
Available online: https://www.mdpi.com/2075-4426/12/4/607

10. “Thyroid Diseases and Breast Cancer”
by Enke Baldini, Augusto Lauro, Domenico Tripodi, Daniele Pironi, Maria Ida Amabile, Iulia Catalina Ferent, Eleonora Lori, Federica Gagliardi, Maria Irene Bellini, Flavio Forte et al.
J. Pers. Med. 2022, 12(2), 156; https://doi.org/10.3390/jpm12020156
Available online: https://www.mdpi.com/2075-4426/12/2/156

11. “Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with Cancer”
by Michael J. Duffy and John Crown
J. Pers. Med. 2022, 12(1), 99; https://doi.org/10.3390/jpm12010099
Available online: https://www.mdpi.com/2075-4426/12/1/99

12. “CD24: A Novel Target for Cancer Immunotherapy”
by Emmanouil Panagiotou, Nikolaos K. Syrigos, Andriani Charpidou, Elias Kotteas and Ioannis A. Vathiotis
J. Pers. Med. 2022, 12(8), 1235; https://doi.org/10.3390/jpm12081235
Available online: https://www.mdpi.com/2075-4426/12/8/1235

13. “Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials”
by Sudarshawn Damodharan, Montserrat Lara-Velazquez, Brooke Carmen Williamsen, Jeffrey Helgager and Mahua Dey
J. Pers. Med. 2022, 12(5), 840; https://doi.org/10.3390/jpm12050840
Available online: https://www.mdpi.com/2075-4426/12/5/840

14. “Multi-Class Classification of Breast Cancer Using 6B-Net with Deep Feature Fusion and Selection Method”
by Muhammad Junaid Umer, Muhammad Sharif, Seifedine Kadry and Abdullah Alharbi
J. Pers. Med. 2022, 12(5), 683; https://doi.org/10.3390/jpm12050683
Available online: https://www.mdpi.com/2075-4426/12/5/683

15. “Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective”
by Danijel Galun, Dragana Mijac, Aleksandar Filipovic, Aleksandar Bogdanovic, Marko Zivanovic and Dragan Masulovic
J. Pers. Med. 2022, 12(2), 149; https://doi.org/10.3390/jpm12020149
Available online: https://www.mdpi.com/2075-4426/12/2/149

1 November 2023
MDPI Insights: The CEO's Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access Week 2023 – the Global Drive to Open Continues

As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.

International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.

Core principles of OA publishing

Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.

One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.

OA holds the potential to democratize knowledge, advance science, and drive positive societal change.

Policy driving change

Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the USEU and China

OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.

For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.

MDPI is proud to lead the transition to open access.

Read more:

Impactful Research

Spotlight on Smart Cities

Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.

As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.

Highly cited papers in Smart Cities

Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.

1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.

2. “A Review on Electric Vehicles: Technologies and Challenges
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.

3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.

4. “Artificial Intelligence Techniques in Smart Grid: A Survey
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.

5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.

Testimonial

“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators. – Dr. Luís Rosa, University of Minho

Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility

Inside MDPI

MDPI Manchester office, UK Visit


Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.

In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.

Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.

I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.

The UK by numbers

The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.

As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.

According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.

We are currently hiring EEs in various locations worldwide.

English Editing at MDPI

Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.

While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.

Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.

Testimonials

“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam

“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño

Read more:

Coming Together for Science

STM and Frankfurt Book Fair

Attending STM

MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.

Meeting with Web of Science

On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.

“We discussed ways to improve our communication and collaboration.”

I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.

75th Frankfurt Book Fair


Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.

For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.

MDPI Books

Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?

The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.

If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.

Closing Thoughts

MDPI Strategy Meeting

As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.

Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.

“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”

As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!

Stefan Tochev
Chief Executive Officer
MDPI AG

27 October 2023
Journal of Personalized Medicine | 2022 Impact Factor of 3.4 Officially Released


We are glad to announce that the 2022 Impact Factor for the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) is officially released! The journal’s Impact Factor is 3.4, ranking 67/169 (Q2) in the category “Medicine, General & Internal” and 42/106 (Q2) in the category “Health Care Sciences & Services”.

For JCR details, please visit the following link: https://jcr.clarivate.com/jcr-jp/journal-profile?journal=J%20PERS%20MED&year=2022&fromPage=%2Fjcr%2Fhome.

JPM is indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, and other databases. More details can be found on the journal's website: https://www.mdpi.com/journal/jpm.

The performance of the journal is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We want to take this opportunity to thank all of you who have contributed to the journal.

19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues


MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.

In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!

Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.

The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.

Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.

Promoting the values of accessibility, transparency, and collaboration

Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations. 

Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways. 

One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges. 

Funders' policies are getting aligned with open science

Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the USEU and China

Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. 

Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing. 

For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change. 

MDPI is proud to be a leader in the transition to open access.

18 October 2023
Meet Us at Neuroscience 2023, 11–15 November 2023, Washington, DC, USA


Neuroscience 2023 will be held from 11 to 15 November 2023 in Washington, DC, USA. The conference is organized by the Society for Neuroscience.

The conference will gather scientists, clinicians, and decision makers from around the world, creating a platform for the communication of knowledge and the sharing of groundbreaking research on the brain as well as nervous system. As stated in the introduction to the conference, you can “Present new research. Exchange ideas. Expand collaborations. Strengthen your career.”

As one of the exhibitors of Neuroscience 2022 last year, MDPI will be a part of Neuroscience 2023 this year, and looks forward to meeting our scholars as well as new friends, hoping to impress you with our open access publishing model face-to-face.

The following MDPI journals will be represented:

  • Brain Sciences.
  • JCM.
  • Cells.
  • NeuroSci.
  • J. Intell.
  • Neuroglia.
  • JPM.
  • Biomedicines.
  • Clinics and Practice.
  • Diagnostics.
  • Neurology International.
  • Pathophysiology.
  • Psych.

If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.sfn.org/meetings/neuroscience-2023.

13 October 2023
Meet Us at the 34th Annual Meeting of the Japanese Society of Clinical Sports Medicine, 11–12 November 2023, Tokyo, Japan


MDPI will be attending the 34th Annual Meeting of the Japanese Society of Clinical Sports Medicine, which will be held from 11 to 12 November in Tokyo, Japan.

The theme of this academic conference is "Cooperation and Evolution". As many academic conferences have been held online due to the coronavirus pandemic, we are now realizing that one of the most important aspects of academic conferences is the face-to-face exchange of information inside and outside the academic venue. This academic conference will aim to promote the future progress of sports medicine by disseminating the research results of each person who has made progress during the coronavirus pandemic and by bringing together many participants for full discussions.

The following MDPI journals will be represented:

  • Sports;
  • Medicina;
  • JPM;
  • Nutrients;
  • JCM;
  • IJERPH;
  • STD;
  • Geriatrics.

If you are planning to attend this conference, please feel free to stop by our booth and chat with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.34rinspo.jp/index.html.

2 October 2023
MDPI Insights: The CEO's Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Access in China

It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.

Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!

Open Access Policy in China

As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.

Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.

In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.

In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.

MDPI Offices in China

 While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.


Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.

In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

Our Strength is in Our People

With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.

In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.

Impactful Research

MDPI Awards

To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.

In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.

Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.

To learn more about MDPI Awards and to find out which are currently available, please click here.

MDPI Awards to Scholars from China

Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.

MDPI’s Tu Youyou Award


Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).

In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.

The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.

2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu

Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.

Highly Cited Articles by Chinese Scholars Published in MDPI

Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.

Read more:

Inside MDPI

Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.

Marketing Department in China

During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.

I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.

Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.

Coming Together for Science

Collaborations, Scholarships and Meetings

MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.

Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.

Scholarships in China

Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).

Meeting with the Society of Chinese University Journals (CUJS)


Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.

I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.

We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.

MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.

Meeting with National Science Library, Chinese Academy of Sciences (NSLC)


Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.

We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our  IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.

In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.

The Numbers

As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.

At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.

Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.

Closing Thoughts

Final Reflections on our MDPI Offices in Beijing and Wuhan


Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.

I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.

Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.

95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).

91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.

Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.

Hospitality and Service

Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.

I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.

Stefan Tochev
Chief Executive Officer
MDPI AG

25 September 2023
Meet Us at the Gerontological Society of America (GSA) 2023 Annual Scientific Meeting, 8–12 November 2023, Tampa, Florida, USA


MDPI will attend the Gerontological Society of America (GSA) 2023 Annual Scientific Meeting. The Gerontological Society of America is the oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging.

The GSA 2023 Annual Scientific Meeting draws professionals in the field of aging on a global scale. Attendees represent specialties including geriatrics, biological sciences, nursing, nutrition, medicine, social work, economics, policy, psychology, and more. The Annual Scientific Meeting offers an extensive amount of stimulating and high-level scholarship, from a diverse variety of aging research disciplines. It is this new, enriching knowledge that will inform policy, practice, and research for years to come.

The following MDPI journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth #119 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.gsa2023.org.

22 September 2023
Journal of Personalized Medicine | Media Partnership with the Biomarkers Europe 2023 Conference, 14–15 November 2023, Berlin, Germany


Gain insights into biomarker approaches and accelerate timelines in drug development for oncology and immuno-related therapies at Oxford Global’s Biomarkers Europe 2023 conference. Hear from and meet with the visionary leading experts in biomarker discovery, development, and analysis, expand your knowledge and discuss future priorities in the advancement and acceleration of drug development in oncology and immuno-related therapies.

View the agenda here.

Register here.

Co-located with Targets & Cell Types in Immuno-Oncology Europe 2023 and Precision Oncology Europe 2023 this is the event to attend to stay ahead of the research and scientific innovations.

For more information contact [email protected].

22 September 2023
Journal of Personalized Medicine | Media Partnership with the Precision Oncology Europe 2023 Conference, 14–15 November 2023, Berlin, Germany


Advance key molecular characterizations for the emergence of more targeted and precise treatments in oncology at Oxford Global’s Precision Oncology Europe 2023 conference. Hear from and meet with visionary leading figures in precision oncology, expand your knowledge and discuss future priorities in how companies are innovating in precision medicine, digital pathology, and molecular testing to accelerate timelines and reduce risk in drug development.

View the agenda here.

Register here.

Co-located with Targets & Cell Types in Immuno-Oncology Europe 2023 and Biomarkers Europe 2023, this is the event to attend to stay ahead of the research and scientific innovations.

For more information contact [email protected].

22 September 2023
Journal of Personalized Medicine | Media Partnership with the 7th Annual Biomarkers US 2023 Conference, 12–13 October 2023, San Diego, USA


Gain a US perspective on the latest technologies and novel biomarkers driving forward translational research and precision medicine at Oxford Global’s 7th Annual Biomarkers US 2023 conference. The event will bring together over 300 visionary leaders to discuss the latest innovations in the field. Meet key decision makers representing leading pharma, biotech, and academic organizations working in the biomarker industry across multiple therapeutic areas.

View the agenda here.

Register here.

Co-located with the 5th Annual Advances in Immuno-Oncology USA Congress, if you wish to stay ahead of research and scientific innovations, this is the event to attend.

For more information, contact [email protected].

20 September 2023
Meet Us at the 109th Radiological Society of North America Scientific Assembly and Annual Meeting (RSNA 2023), 26–29 November 2023, Chicago, USA


Conference: RSNA 2023
Organization: The Radiological Society of North America
Date: 26–29 November 2023
Place: McCormick Place, 2301 S. Lake Shore Drive, Chicago, IL 60616 USA
Booth: #1103

The Radiological Society of North America (RSNA) is a non-profit organization. RSNA’s annual meeting provides radiology professionals and industry partners with endless opportunities to learn, connect, exchange ideas, and see the latest technology in action. This year’s theme—Leading through Change—focuses on how radiology professionals can be intentional and proactive while leading teams and organizations through change.

The following MDPI journals will be represented as exhibitors:

  • Diagnostics;
  • JPM;
  • Tomography;
  • JCM;
  • Osteology;
  • Radiation;
  • Cancers.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.rsna.org/annual-meeting.

14 September 2023
Journal of Personalized Medicine | Top 20 Cited Papers in 2021


1. “The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application”
by Jun Wu
J. Pers. Med. 2021, 11(8), 771; https://doi.org/10.3390/jpm11080771
Available online: https://www.mdpi.com/2075-4426/11/8/771

2. “Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment”
by Md Abdus Subhan, Satya Siva Kishan Yalamarty, Nina Filipczak, Farzana Parveen and Vladimir P. Torchilin
J. Pers. Med. 2021, 11(6), 571; https://doi.org/10.3390/jpm11060571
Available online: https://www.mdpi.com/2075-4426/11/6/571

3. “Digital Twins: From Personalised Medicine to Precision Public Health”
by Maged N. Kamel Boulos and Peng Zhang
J. Pers. Med. 2021, 11(8), 745; https://doi.org/10.3390/jpm11080745
Available online: https://www.mdpi.com/2075-4426/11/8/745

4. “The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects”
by Hiroshi Maeda
J. Pers. Med. 2021, 11(3), 229; https://doi.org/10.3390/jpm11030229
Available online: https://www.mdpi.com/2075-4426/11/3/229

5. “A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration”
by Vincenzo D’Agostino, Ferdinando Caranci, Alberto Negro, Valeria Piscitelli, Bernardino Tuccillo, Fabrizio Fasano, Giovanni Sirabella, Ines Marano, Vincenza Granata, Roberta Grassi et al.
J. Pers. Med. 2021, 11(4), 285; https://doi.org/10.3390/jpm11040285
Available online: https://www.mdpi.com/2075-4426/11/4/285

6. “Breast Cancer Treatments: Updates and New Challenges”
by Anna Burguin, Caroline Diorio and Francine Durocher
J. Pers. Med. 2021, 11(8), 808; https://doi.org/10.3390/jpm11080808
Available online: https://www.mdpi.com/2075-4426/11/8/808

7. “Breast Cancer Type Classification Using Machine Learning”
by Jiande Wu and Chindo Hicks
J. Pers. Med. 2021, 11(2), 61; https://doi.org/10.3390/jpm11020061
Available online: https://www.mdpi.com/2075-4426/11/2/61

8. “Making Radiomics More Reproducible across Scanner and Imaging Protocol Variations: A Review of Harmonization Methods”
by Shruti Atul Mali, Abdalla Ibrahim, Henry C. Woodruff, Vincent Andrearczyk, Henning Müller, Sergey Primakov, Zohaib Salahuddin, Avishek Chatterjee and Philippe Lambin
J. Pers. Med. 2021, 11(9), 842; https://doi.org/10.3390/jpm11090842
Available online: https://www.mdpi.com/2075-4426/11/9/842

9. “Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect”
by Dong Huang, Lingna Sun, Leaf Huang and Yanzuo Chen
J. Pers. Med. 2021, 11(2), 124; https://doi.org/10.3390/jpm11020124
Available online: https://www.mdpi.com/2075-4426/11/2/124

10. “Comparing the Impact of COVID-19 on Nurses’ Turnover Intentions before and during the Pandemic in Qatar”
by Abdulqadir J. Nashwan, Ahmad A. Abujaber, Ralph C. Villar, Ananth Nazarene, Mahmood M. Al-Jabry and Evangelos C. Fradelos
J. Pers. Med. 2021, 11(6), 456; https://doi.org/10.3390/jpm11060456
Available online: https://www.mdpi.com/2075-4426/11/6/456

11. “Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review”
by Johanna Raymond, Laurent Imbert, Thibault Cousin, Thomas Duflot, Rémi Varin, Julien Wils and Fabien Lamoureux
J. Pers. Med. 2021, 11(1), 37; https://doi.org/10.3390/jpm11010037
Available online: https://www.mdpi.com/2075-4426/11/1/37

12. “Current Trends in Advanced Alginate-Based Wound Dressings for Chronic Wounds”
by Andreea Barbu, Bogdan Neamtu, Marius Zăhan, Gabriela Mariana Iancu, Ciprian Bacila and Vioara Mireșan
J. Pers. Med. 2021, 11(9), 890; https://doi.org/10.3390/jpm11090890
Available online: https://www.mdpi.com/2075-4426/11/9/890

13. “Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer”
by Matteo Ferro, Evelina La Civita, Antonietta Liotti, Michele Cennamo, Fabiana Tortora, Carlo Buonerba, Felice Crocetto, Giuseppe Lucarelli, Gian Maria Busetto, Francesco Del Giudice et al.
J. Pers. Med. 2021, 11(3), 237; https://doi.org/10.3390/jpm11030237
Available online: https://www.mdpi.com/2075-4426/11/3/237

14. “The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis”
by Faven Butler, Ali Alghubayshi and Youssef Roman
J. Pers. Med. 2021, 11(3), 231; https://doi.org/10.3390/jpm11030231
Available online: https://www.mdpi.com/2075-4426/11/3/231

15. “TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma”
by Alessandro Granito, Antonio Facciorusso, Rodolfo Sacco, Laura Bartalena, Cristina Mosconi, Ugo Vittorio Cea, Alberta Cappelli, Matteo Antonino, Francesco Modestino, Nicolò Brandi et al.
J. Pers. Med. 2021, 11(10), 1041; https://doi.org/10.3390/jpm11101041
Available online: https://www.mdpi.com/2075-4426/11/10/1041

16. “Artificial Intelligence and COVID-19 Using Chest CT Scan and Chest X-ray Images: Machine Learning and Deep Learning Approaches for Diagnosis and Treatment”
by Roberta Fusco, Roberta Grassi, Vincenza Granata, Sergio Venanzio Setola, Francesca Grassi, Diletta Cozzi, Biagio Pecori, Francesco Izzo and Antonella Petrillo
J. Pers. Med. 2021, 11(10), 993; https://doi.org/10.3390/jpm11100993
Available online: https://www.mdpi.com/2075-4426/11/10/993

17. “Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)”
by Jennifer D. Brooks, Hermann Nabi, Irene L. Andrulis, Antonis C. Antoniou, Jocelyne Chiquette, Philippe Després, Peter Devilee, Michel Dorval, Arnaud Droit, Douglas F. Easton et al.
J. Pers. Med. 2021, 11(6), 511; https://doi.org/10.3390/jpm11060511
Available online: https://www.mdpi.com/2075-4426/11/6/511

18. “How Do Machines Learn? Artificial Intelligence as a New Era in Medicine”
by Oliwia Koteluk, Adrian Wartecki, Sylwia Mazurek, Iga Kołodziejczak and Andrzej Mackiewicz
J. Pers. Med. 2021, 11(1), 32; https://doi.org/10.3390/jpm11010032
Available online: https://www.mdpi.com/2075-4426/11/1/32

19. “Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types”
by Minghui Li, Jing Yuan, Gang Lv, Jacob Brown, Xiangxiang Jiang and Zhiqiang Kevin Lu
J. Pers. Med. 2021, 11(11), 1106; https://doi.org/10.3390/jpm11111106
Available online: https://www.mdpi.com/2075-4426/11/11/1106

20. “Treatment-Resistant Depression Revisited: A Glimmer of Hope”
by Angelos Halaris, Emilie Sohl and Elizabeth A. Whitham
J. Pers. Med. 2021, 11(2), 155; https://doi.org/10.3390/jpm11020155
Available online: https://www.mdpi.com/2075-4426/11/2/155

6 September 2023
Recap of Awards Granted to Scholars in 2022


MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

30 August 2023
MDPI Insights: The CEO's Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Our Commitment to Sustainability

As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.

In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.

MDPI and the Sustainable Development Goals (SDGs)

In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.

“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]

As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:

MDPI journals specializing in sustainability-related topics:

  • 2009: Sustainability
  • 2012: Resources
  • 2013: Climate
  • 2014: Environments
  • 2016: Recycling
  • 2019: Clean Technologies
  • 2020: Sustainable Chemistry
  • 2021: Wind, Biomass, Conservation, Pollutants, Solar
  • 2022: Waste, Microplastics

Read more:

Impactful Research

Highly Cited Articles in Sustainability

In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.

We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.

“Sustainability received a 2022 CiteScore of 5.8”

While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.

Highly Cited Papers in Sustainability

Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.

1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?
Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)

This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.

2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety
Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)

This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.

3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review
Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)

This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.

4. Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions
Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)

This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.

Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).

Read more:

Inside MDPI

President of Ireland Authors Editorial in MDPI Journal Sustainability

It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:

This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.

The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.

As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.

Read the completed editorial here:

Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683

Coming Together for Science

The World Sustainability Forum 2023

The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.

This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:

  • The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
  • The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
  • The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.

MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research

The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:

  1. The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
  2. The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.

The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.

2023 World Sustainability Award Winners

  1. Professor Michael R. Templeton
  2. Professor Tom Lyon
  3. Dr Krithi K. Karanth

Interviews with 2023 Emerging Sustainability Leader Award Finalists

  • Dr. Bahareh Kamranzad
  • Dr. Youjin Kim
  • Dr. Julia Lohmann

As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.

Read more:

Closing Thoughts

“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier

I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.

MDPI’s Interaction with Elsevier

In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.

“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”

Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.

It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.

‘Fully OA’ Organizations Dedicated to Open Access

MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.

This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.

As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”

Stefan Tochev
Chief Executive Officer
MDPI AG

30 August 2023
Recruiting Reviewer Board Members for Journal of Personalized Medicine


We are recruiting Reviewer Board Members for Journal of Personalized Medicine (JPM, ISSN: 2075-4426). If you are an active researcher in the field and are passionate about promoting the publication of cutting-edge research, please contact the Journal of Personalized Medicine Editorial Office ([email protected]) to apply for this role.

Journal of Personalized Medicine is an international, peer-reviewed, open access journal on personalized medicine, published monthly online by MDPI. The aims and scope of the journal can be found at the following link: https://www.mdpi.com/journal/jpm/about. Journal of Personalized Medicine publishes cutting-edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).

The benefits of joining our Reviewer Board are as follows:

  • We will announce your entry information on the journal's Reviewer Board;
  • We award discounts for comprehensive and timely reviews. These vouchers can be used for all MDPI journals;
  • You will receive a personalized reviewer certificate;
  • Review frequency is flexible and based on your schedule;
  • You can showcase your peer reviews and editorial contributions to our journal readers.

If you are interested in this position, please send your application, including a full academic CV, to the Journal of Personalized Medicine Editorial Office ([email protected]). We look forward to collaborating with you.

25 August 2023
Meet Us at the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference, 30 October–2 November 2023, Atlanta, USA


MDPI will attend the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference. The 2023 annual meeting of ACRM is the world’s largest interdisciplinary rehabilitation research event. Rehabilitation professionals and community members from around the globe are encouraged to join. With 150+ inter-professional groups at ACRM, including community groups, committees, and task forces, the 100th anniversary conference is planning 4 powerful plenaries, 15+ symposia, 300+ educational sessions, symposia and lectures, and 600+ scientific papers and digital poster presentations, etc.

To enhance patient care, the presentation of science by researchers is required, and to inform and improve research, feedback from the clinicians is required. The aim of the ACRM 100th annual conference is to encourage attendees to join the discussions and collaborations in order to help move the field of physical medicine and rehabilitation forward.

The following MDPI journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth #413 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://conference.acrm.org/.

 

24 August 2023
Meet Us at the ASHG Annual Meeting 2023, 1–5 November 2023, Washington D.C., USA


MDPI will attend the ASHG Annual Meeting 2023, held in Washington, D.C., USA, from 1 to 5 November 2023.

The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.

The following MDPI journals will be represented:

  • Genes;
  • JPM;
  • Biomolecules;
  • Medicina;
  • Diagnostics;
  • Cancers;
  • Biomedicines;
  • Humans;
  • Applied Biosciences;
  • DNA;
  • IJMS;
  • Brain Sciences;
  • Cardiogenetics;
  • Vaccines;
  • Life;
  • Epigenomes;
  • BioTech;
  • Biology;
  • CIMB;
  • Biomedinformatics.

If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.ashg.org/meetings/.

18 August 2023
Meet Us at the American Academy of Pediatrics 2023 National Conference & Exhibition, 20–24 October 2023, Washington, USA


MDPI will attend the American Academy of Pediatrics 2023 National Conference & Exhibition. This event will be held in Washington D.C. for five days from Friday, 20 October, to Tuesday, 24 October 2023.

The following MDPI journals will be represented:

  • Children;
  • JCM;
  • Medicina;
  • Healthcare;
  • IJERPH;
  • JPM;
  • Clinpract;
  • Diagnostics;
  • Medicines.

If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://aapexperience.org/.

18 August 2023
MDPI’s 2022 Young Investigator Awards in Medicine and Pharmacology—Winners Announced


MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.

We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

  • Yuyan Jiang, Stanford University, USA
  • Billy Wai-Lung Ng, Chinese University of Hong Kong, China

Cancers:

  • Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
  • Miranda Fidler-Benaoudia, University of Calgary, Canada

Current Oncology:

  • Bishal Gyawali, Queen’s University, Canada

Healthcare:

  • Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong

JCM:

  • Jan Bednarsch, Universitätsmedizin Berlin, Germany

JPM:

  • Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
  • Jerome Lechien, University of Mons, Belgium

Pharmaceuticals:

  • Daniele Bertoglio, University of Antwerp, Belgium

Pharmaceutics:

  • Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

TropicalMed:

  • Haley Adcox, Virginia Commonwealth University, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.

For more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Travel Awards in Medicine and Pharmacology—Winners Announced


We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.

MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Antibiotics:

  • Filip Jansåker, Lund University, Lund, Sweden
  • Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Cancers:

  • Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
  • Luigi Russo, Italian Institute of Technology (IIT), Italy

Current Oncology:

  • Sneha Sethi, University of Adelaide, Australia
  • Xiyin Wang, Indiana University School of Medicine, USA

Dentistry Journal:

  • Sonia Nath, University of Adelaide, Australia
  • Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania

Diagnostics:

  • Adrien Holzgreve, The University Hospital of Munich, Germany

Hemato:

  • Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy

JCDD:

  • Susanna Cooper, St. George’s University of London, UK
  • Renée Tillie, Maastricht University Medical Center, the Netherlands

JCM:

  • Max Lennart Eckstein, University of Bayreuth, Germany
  • Lorenzo Bertani, University of Pisa, Italy

Pharmaceutics:

  • Yuxue Cao, University of Queensland, Australia
  • Flávia Sousa, Italian Institute of Technology, Italy

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Medicine and Pharmacology—Winners Announced


In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

  • Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
  • Violeta Popovici, Ovidius University of Constanta, Romania
  • Yosra A. Helmy, University of Kentucky, USA

Cancers:

  • Antonio G. Solimando, Aldo Moro University of Bari, Italy
  • Linlin Guo, The Ohio State University Medical Center, USA
  • Ravindra Deshpande, Wake Forest School of Medicine, USA
  • Songli Zhu, Fred Hutchinson Cancer Research Center, USA
  • Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
  • Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
  • Chenghui Li, University of Arkansas for Medical Sciences, USA
  • Laurentiu Pop, University of Texas Southwestern Medical Center, USA
  • Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
  • Rafał Watrowski, University of Freiburg, Germany
  • Ruben C. Petreaca, The Ohio State University, USA
  • Ruchi Roy, Rush University Medical Center, USA
  • Salvatore Cocuzza, University of Catania, Italy
  • Santosh Kumar Singh, Morehouse School of Medicine, USA
  • Sergei Boichuk, Kazan State Medical University, Russia
  • Simon John Christoph Soerensen, Stanford University, USA
  • Takuya Koie, Gifu University, Japan
  • Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
  • Teruki Nii, Kyushu University, Japan
  • Tomasz Marjanski, Medical University of Gdansk, Poland

Current Oncology:

  • Kristen Haase, The University of British Columbia, Canada
  • Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
  • Makoto Endo, Kyushu University, Japan

Healthcare:

  • Tefera Tadesse, Addis Ababa University, Ethiopia
  • Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
  • Ryuichi Ohta, Unnan City Hospital, Japan

JCM:

  • Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
  • José-María Sánchez-González, University of Seville, Spain
  • Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece

JPM:

  • Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
  • Rodolfo Reda, Sapienza University of Rome, Italy
  • Giulio Francesco Romiti, Sapienza University of Rome, Italy
  • Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
  • James Walter, 1Hines VA Hospital, USA; 2 Loyola Medical Center, USA

Medical Sciences:

  • Vasiliki Tsigkou, Sotiria Hospital, Greece

Pharmaceutics:

  • Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
  • Bhupendra Prajapati, Ganpat University, India
  • Van-An Duong, Gachon University, Republic of Korea
  • Ashish Agrawal, Indian Institute of Technology (BHU), India

Tomography:

  • Aydin Eresen, University of California Irvine, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

18 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Medicine and Pharmacology—Winners Announced


MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Cancers:

  • “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”

by João Pedro da Silva Machado Lobo, University of Porto, Portugal

  • “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”

by Adrià Cañellas Socias, University of Barcelona, Spain

Healthcare:

  • “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”

by Shireen Mentor, University of Cape Town, South Africa

JPM:

  • “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”

by Roberta Magnano San Lio, University of Catania, Italy

Pharmaceutics:

  • “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”

by Shirin Tavakoli, University of Helsinki, Finland

TropicalMed:

  • “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”

by Quinten Ducarmon, Leiden University Medical Center, the Netherlands

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

For more MDPI awards, please click here.

18 August 2023
MDPI’s Best Paper Awards in Medicine and Pharmacology—Winners Announced in 2022


The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.

We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

Dentistry Journal:

Healthcare:

JCM:

JPM:

Pharmaceutics:

Pharmacy:

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

27 July 2023
MDPI Insights: The CEO's Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Open Peer Review Reports

Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.

MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.

Start and Growth of Open Peer Review at MDPI

The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.

As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.

Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.

Benefits of Open Peer Review

The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.

As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.

Impactful Research

MDPI Papers Cited in the News – IJERPH edition

Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.

During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.

Highly Cited Journal Publications

IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:

  • International Journal of Environmental Research and Public Health: 3509 mentions
  • Nutrients: 2698 mentions
  • International Journal of Molecular Sciences: 1701 mentions
  • Journal of Clinical Medicine: 1131 mentions
  • Viruses: 1111 mentions

These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.

Example of Recent Mentions

During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:

The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper:Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments

Harvard Business Review: “How to Take Better Breaks at Work, According to Research
IJERPH paper:Canine-Assisted Therapy Improves Well-Being in Nurses

National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way
IJERPH paper:Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease

Inside MDPI

MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process

At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.

Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.

To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.

The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.

In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.

Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.

Read more:

Coming Together for Science

The Future of IJERPH

On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.

While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.

Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.

Journal Achievements

In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:

  • Founded by Prof. Dr. Paul B. Tchounwou in 2004
  • Indexed in PubMed in 2008
  • Received its first Impact Factor in 2012
  • Published its 5000th paper in 2017
  • Over 60,000 papers published as at June 30, 2023
  • 131,628,173 paper views in 2018–2022
  • Over 28,000 mentions in prominent news outlets
  • 17,000 papers cited 10 times or more as at June 30, 2023
  • No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
  • Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.

These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.

Closing Thoughts

MDPI’s Impact in Spain

During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.

Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.

The Numbers

Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).

Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.

Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.

Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.

Testimonials

I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:

Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)

Stefan Tochev
Chief Executive Officer
MDPI AG

26 July 2023
Prof. Dr. Yves A. Lussier Appointed Section Editor-in-Chief of Section “Mechanisms of Diseases” in Journal of Personalized Medicine

We are pleased to announce that Prof. Dr. Yves A. Lussier has been appointed Section Editor-in-Chief of the Section “Mechanisms of Diseases” in the Journal of Personalized Medicine (JPM, ISSN 2075-4426).

Prof. Dr. Yves A. Lussier

Name: Prof. Dr. Yves A. Lussier
Affiliations: Department of Biomedical Informatics and Center for Genomic Medicine, University of Utah Eccles School of Medicine, Salt Lake CIty, UT 84108, USA
Interests: micro-cohorts in clinical trials; single-subject studies; N-of-1 trials; personal genomics; translational bioinformatics; phenomics; clinical informatics; ontologies; therapeutic biomarkers and signatures

Prof. Dr. Yves A. Lussier, MD, FACMI, is the Chair of Biomedical Informatics at the University of Utah School of Medicine, USA. As a professional engineer and physician-scientist, he is an international expert in translational bioinformatics and a pioneer in research informatics techniques including systems biology, data representation through ontologies, and high-throughput methods in personalized medicine.

We wish Prof. Dr. Lussier every success in his position as Section Editor-in-Chief and we look forward to his contributions to the continued success of the journal.

26 July 2023
Journal of Personalized Medicine | Top 20 Cited Papers in 2022

1. “A Multi-Agent Deep Reinforcement Learning Approach for Enhancement of COVID-19 CT Image Segmentation”
by Hanane Allioui, Mazin Abed Mohammed, Narjes Benameur, Belal Al-Khateeb, Karrar Hameed Abdulkareem, Begonya Garcia-Zapirain, Robertas Damaševičius and Rytis Maskeliūnas
J. Pers. Med. 2022, 12(2), 309; https://doi.org/10.3390/jpm12020309
Available online: https://www.mdpi.com/2075-4426/12/2/309

2. “Emergency Department Overcrowding: Understanding the Factors to Find Corresponding Solutions”
by Gabriele Savioli, Iride Francesca Ceresa, Nicole Gri, Gaia Bavestrello Piccini, Yaroslava Longhitano, Christian Zanza, Andrea Piccioni, Ciro Esposito, Giovanni Ricevuti and Maria Antonietta Bressan
J. Pers. Med. 2022, 12(2), 279; https://doi.org/10.3390/jpm12020279
Available online: https://www.mdpi.com/2075-4426/12/2/279

3. “Artificial Intelligence-Driven Prediction Modeling and Decision Making in Spine Surgery Using Hybrid Machine Learning Models”
by Babak Saravi, Frank Hassel, Sara Ülkümen, Alisia Zink, Veronika Shavlokhova, Sebastien Couillard-Despres, Martin Boeker, Peter Obid and Gernot Michael Lang
J. Pers. Med. 2022, 12(4), 509; https://doi.org/10.3390/jpm12040509
Available online: https://www.mdpi.com/2075-4426/12/4/509

4. “Correlation between Peri-Implant Marginal Bone Loss Progression and Peri-Implant Sulcular Fluid Levels of Metalloproteinase-8”
by Renzo Guarnieri, Alessio Zanza, Maurilio D’Angelo, Dario Di Nardo, Andrea Del Giudice, Alessandro Mazzoni, Rodolfo Reda and Luca Testarelli
J. Pers. Med. 2022, 12(1), 58; https://doi.org/10.3390/jpm12010058
Available online: https://www.mdpi.com/2075-4426/12/1/58

5. “Usefulness of Magnetic Mallet in Oral Surgery and Implantology: A Systematic Review”
by Francesco Bennardo, Selene Barone, Camillo Vocaturo, Ludovica Nucci, Alessandro Antonelli and Amerigo Giudice
J. Pers. Med. 2022, 12(1), 108; https://doi.org/10.3390/jpm12010108
Available online: https://www.mdpi.com/2075-4426/12/1/108

6. “Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems”
by Stefano Marletta, Nicola Fusco, Enrico Munari, Claudio Luchini, Alessia Cimadamore, Matteo Brunelli, Giulia Querzoli, Maurizio Martini, Elena Vigliar, Romano Colombari et al.
J. Pers. Med. 2022, 12(7), 1073; https://doi.org/10.3390/jpm12071073
Available online: https://www.mdpi.com/2075-4426/12/7/1073

7. “COVID-19 Detection in CT/X-ray Imagery Using Vision Transformers”
by Mohamad Mahmoud Al Rahhal, Yakoub Bazi, Rami M. Jomaa, Ahmad AlShibli, Naif Alajlan, Mohamed Lamine Mekhalfi and Farid Melgani
J. Pers. Med. 2022, 12(2), 310; https://doi.org/10.3390/jpm12020310
Available online: https://www.mdpi.com/2075-4426/12/2/310

8. “Emerging Biomarkers for Early Detection of Chronic Kidney Disease”
by Maja Mizdrak, Marko Kumrić, Tina Tičinović Kurir and Joško Božić
J. Pers. Med. 2022, 12(4), 548; https://doi.org/10.3390/jpm12040548
Available online: https://www.mdpi.com/2075-4426/12/4/548

9. “LungNet22: A Fine-Tuned Model for Multiclass Classification and Prediction of Lung Disease Using X-ray Images”
by F. M. Javed Mehedi Shamrat, Sami Azam, Asif Karim, Rakibul Islam, Zarrin Tasnim, Pronab Ghosh and Friso De Boer
J. Pers. Med. 2022, 12(5), 680; https://doi.org/10.3390/jpm12050680
Available online: https://www.mdpi.com/2075-4426/12/5/680

10. “Precision Nomothetic Medicine in Depression Research: A New Depression Model, and New Endophenotype Classes and Pathway Phenotypes, and A Digital Self”
by Michael Maes
J. Pers. Med. 2022, 12(3), 403; https://doi.org/10.3390/jpm12030403
Available online: https://www.mdpi.com/2075-4426/12/3/403

11. “Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe”
by Denis Horgan, Giuseppe Curigliano, Olaf Rieß, Paul Hofman, Reinhard Büttner, Pierfranco Conte, Tanja Cufer, William M. Gallagher, Nadia Georges, Keith Kerr et al.
J. Pers. Med. 2022, 12(1), 72; https://doi.org/10.3390/jpm12010072
Available online: https://www.mdpi.com/2075-4426/12/1/72

12. “Relationship between Epicardial and Coronary Adipose Tissue and the Expression of Adiponectin, Leptin, and Interleukin 6 in Patients with Coronary Artery Disease”
by Olga V. Gruzdeva, Yulia A. Dyleva, Ekaterina V. Belik, Maxim Y. Sinitsky, Aleksandr N. Stasev, Aleksandr N. Kokov, Natalia K. Brel, Evgenia O. Krivkina, Evgenia E. Bychkova, Roman S. Tarasov et al.
J. Pers. Med. 2022, 12(2), 129; https://doi.org/10.3390/jpm12020129
Available online: https://www.mdpi.com/2075-4426/12/2/129

13. “Endotypes of Prematurity and Phenotypes of Bronchopulmonary Dysplasia: Toward Personalized Neonatology”
by Maria Pierro, Karen Van Mechelen, Elke van Westering-Kroon, Eduardo Villamor-Martínez and Eduardo Villamor
J. Pers. Med. 2022, 12(5), 687; https://doi.org/10.3390/jpm12050687
Available online: https://www.mdpi.com/2075-4426/12/5/687

14. “Sensory Ion Channel Candidates Inform on the Clinical Course of Pancreatic Cancer and Present Potential Targets for Repurposing of FDA-Approved Agents?”
by Wenjie Shi, Chen Li, Thomas Wartmann, Christoph Kahlert, Renfei Du, Aristotelis Perrakis, Thomas Brunner, Roland S. Croner and Ulf D. Kahlert
J. Pers. Med. 2022, 12(3), 478; https://doi.org/10.3390/jpm12030478
Available online: https://www.mdpi.com/2075-4426/12/3/478

15. “Dendrimers, an Emerging Opportunity in Personalized Medicine?”
by Anne-Marie Caminade
J. Pers. Med. 2022, 12(8), 1334; https://doi.org/10.3390/jpm12081334
Available online: https://www.mdpi.com/2075-4426/12/8/1334

16. “Sex Differences in Response to Treatment with Glucagon-like Peptide 1 Receptor Agonists: Opportunities for a Tailored Approach to Diabetes and Obesity Care”
by Elpiniki Rentzeperi, Stavroula Pegiou, Theocharis Koufakis, Maria Grammatiki and Kalliopi Kotsa
J. Pers. Med. 2022, 12(3), 454; https://doi.org/10.3390/jpm12030454
Available online: https://www.mdpi.com/2075-4426/12/3/454

17. “Should Neurosurgeons Try to Preserve Non-Traditional Brain Networks? A Systematic Review of the Neuroscientific Evidence”
by Nicholas B. Dadario and Michael E. Sughrue
J. Pers. Med. 2022, 12(4), 587; https://doi.org/10.3390/jpm12040587
Available online: https://www.mdpi.com/2075-4426/12/4/587

18. “Identification of Early Esophageal Cancer by Semantic Segmentation”
by Yu-Jen Fang, Arvind Mukundan, Yu-Ming Tsao, Chien-Wei Huang and Hsiang-Chen Wang
J. Pers. Med. 2022, 12(8), 1204; https://doi.org/10.3390/jpm12081204
Available online: https://www.mdpi.com/2075-4426/12/8/1204

19. “Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms”
by Chiara Villa, Eleonora Rivellini, Marialuisa Lavitrano and Romina Combi
J. Pers. Med. 2022, 12(1), 29; https://doi.org/10.3390/jpm12010029
Available online: https://www.mdpi.com/2075-4426/12/1/29

20. “Current Status, Issues and Future Prospects of Personalized Medicine for Each Disease”
by Yuichi Yamamoto, Norihiro Kanayama, Yusuke Nakayama and Nobuko Matsushima
J. Pers. Med. 2022, 12(3), 444; https://doi.org/10.3390/jpm12030444
Available online: https://www.mdpi.com/2075-4426/12/3/444

21 July 2023
Journal of Personalized Medicine Receives an Updated Impact Factor of 3.4


We are glad to announce the new Impact Factor of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) is 3.4. This information is available in JCR Help Data, which includes the total number of citations, the JIF and the 5-year JIF, and can be found using the following link: https://jcr.help.clarivate.com/Content/data-updates.htm.

As for the official update of the Impact Factor, Clarivate stated that the journal profile and full set of data will be included in the JCR data reload in October of this year.

13 July 2023
Journal of Personalized Medicine Impact Factor Delay

As of 28 June 2023, new journal impact factors (IFs) were released. However, we were informed by ClarivateTM that for some journals, Journal of Personalized Medicine (JPM, ISSN: 2075-4426) included, there has been a delay. Unfortunately, this is the reason that the new IF is not present on the journal webpage, nor can it be found on JCR. With that in mind, we would like to inform you that the new IF for JPM will be announced in the next few weeks. Please note that the journal is listed in the official JCR 2022 journal list available for download here.

11 July 2023
MDPI’s Newly Launched Journals in June 2023

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal topics (selected)
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue growth and development;
diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.

7 July 2023
Journal of Personalized Medicine Webinar | Applied Invasive Coronary Physiology for Diagnosis and Tailored Treatment of Coronary Microvascular Disease, 12 July 2023


Coronary physiological assessment is a rapidly developing field in cardiology. Precise invasive or less-invasive (image based) physiological evaluation can provide reliable support for the tailored treatment of coronary macro- and microvascular coronary diseases and consequently have an important impact on the efficacy and safety of therapy.

In our webinar, we summarize the current scientific results concerning the advances of specific coronary microvascular indices determined via both invasive and less invasive methods. The relevance of clinical implications and therapeutical options will be discussed as well, including specific patient populations, e.g., ACS, CCS, (M)INOCA and COVID-19 cases.

Date: 12 July 2023 at 10:00 a.m. CEST
Webinar ID: 898 6464 8512

Register now for free!

Program:

Speaker/Presentation Time in CEST
Dr. Gábor Tamás Szabó
Welcome and brief introduction
10:00–10:05 a.m.
Dr. Zsolt Piróth
Invasive methods for the assessment of coronary flow reserve and the microcirculation
10:05–10:25 a.m.
Dr. Yongzhen Fan
Computational approach to assess coronary microcirculation
10:25–10:45 a.m.
Q&A Session 10:45–10:55 a.m.
Dr. Zsolt Kőszegi
Closing remarks and summary
10:55–11:00 a.m.

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we’ll let you know when the recording is available to watch.

Webinar Chairs and Keynote Speakers:

  • Dr. Gábor Tamás Szabó, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary and Center for Biomedical Research and Translational Surgery, Medical University Vienna, Vienna, Austria;
  • Dr. Zsolt Kőszegi, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary and Szabolcs – Szatmár – Bereg County Hospitals and University Teaching Hospital, Nyíregyháza, Hungary;
  • Dr. Zsolt Piróth, Gottsegen National Cardiovascular Center, 29 Haller Str., Budapest, Hungary;
  • Dr. Yongzhen Fan, Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, China.

Relevant Special Issue:
Applied Invasive Coronary Physiology for Tailored Treatment of Coronary Artery Disease
Guest Editors: Dr. Gábor Tamás Szabó and Dr. Zsolt Kőszegi

3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

The Future is Open, and MDPI is Leading the Way

I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.

1 Million Published Articles

2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.

Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.

Liberating Science

As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.

In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:

"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”

Impactful Research

MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases

MDPI journals are indexed in every single top database in the world.

As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.

Continued Growth of MDPI Journals

The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.

Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.

Read more

Interview with Indexing Manager—Constanze Shelhorn

Inside MDPI

Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science

At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.

Increased Visibility for Preprints

I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.

Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.

Read more

What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?

Coming Together for Science

The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications

In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.

Working Together

Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.

Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.

Managing Events With Sciforum

If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!

Read more

Sciforum: forthcoming events
Spotlight on Antioxidants

Closing Thoughts

Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang

Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team

During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.

I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.

Testimonials

If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:

“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet

Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection

Stefan Tochev
Chief Executive Officer
MDPI AG

29 June 2023
Meet Us at the 38th Annual Meeting of the Japanese Society for Infection Prevention and Control, 20–22 July 2023, Yokohama, Japan


MDPI will be attending the 38th Annual Meeting of the Japanese Society for Infection Prevention and Control (JSIPC), which will be held from 20 to 22 July 2023, in Yokohama, Japan.

JSIPC was founded in 1986 as the Japanese Society for Environmental Infection (JSEI). The first annual meeting was attended by about 230 participants. Over the last 30 years, the number of annual meeting participants has notably increased to over 7,000, with the membership total exceeding 9,500. JSIPC was founded to address not only the primary issue of nosocomial infection, but all other infectious diseases caused by environmental changes. The theme of the 38th Annual Meeting of the Japanese Society for Infection Prevention and Control is “Professionalism”. The conference will cover various topics related to infection prevention and control, such as occupational safety and health, oral health, environmental health, infectious disease, antibiotic administration, vaccination, antibiotic resistance and misuse, and health education.

The following MDPI journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth (#B21) and have a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link: http://jsipc38.umin.jp/.

28 June 2023
2022 Impact Factors for MDPI Journals

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Journal Impact Factor Rank Quartile Category
Vaccines 7.8 Q1 Immunology
Medicine, Research & Experimental
Antioxidants 7.0 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 6.0 Q2 Cell Biology
Nutrients 5.9 Q1 Nutrition & Dietetics
International Journal of Molecular Sciences 5.6 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Journal of Theoretical and Applied Electronic Commerce Research 5.6 Q2 Business
Biomolecules 5.5 Q1 Biochemistry & Molecular Biology
Biosensors 5.4 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Fractal and Fractional 5.4 Q1 Mathematics, Interdisciplinary Applications
Marine Drugs 5.4 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Pharmaceutics 5.4 Q1 Pharmacology & Pharmacy
Nanomaterials 5.3 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Cancers 5.2 Q2 Oncology
Foods 5.2 Q1 Food Science & Technology
Polymers 5.0 Q1 Polymer Science
Remote Sensing 5.0 Q1 Geosciences, Multidisciplinary
Q2 Remote Sensing
Imaging Science & Photographic Technology
Environmental Sciences
Antibiotics 4.8 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Drones 4.8 Q2 Remote Sensing
Journal of Functional Biomaterials 4.8 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.7 Q1 Pharmacology & Pharmacy
Q2 Biochemistry & Molecular Biology
Medicine, Research & Experimental
Journal of Fungi 4.7 Q2 Mycology
Microbiology
Viruses 4.7 Q2 Virology
Bioengineering 4.6 Q2 Engineering, Biomedical
Gels 4.6 Q1 Polymer Science
Molecules 4.6 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Pharmaceuticals 4.6 Q2 Pharmacology & Pharmacy
Chemistry, Medicinal
Toxics 4.6 Q1 Toxicology
Q2 Environmental Sciences
Biomimetics 4.5 Q1 Engineering, Multidisciplinary
Q2 Materials Science, Biomaterials
Microorganisms 4.5 Q2 Microbiology
Plants 4.5 Q1 Plant Sciences
Biology 4.2 Q2 Biology
Chemosensors 4.2 Q2 Instruments & Instrumentation
Chemistry, Analytical
Electrochemistry
Membranes 4.2 Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Polymer Science
Toxins 4.2 Q1 Toxicology
Q2 Food Science & Technology
Metabolites 4.2 Q2 Biochemistry & Molecular Biology
Batteries 4.0 Q2 Electrochemistry
Materials Science, Multidisciplinary
Q3 Energy & Fuels
Catalysts 3.9 Q2 Chemistry, Physical
Journal of Clinical Medicine 3.9 Q2 Medicine, General & Internal
Land 3.9 Q2 Environmental Studies
Sensors 3.9 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Sustainability 3.9 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Green & Sustainable Science & Technology (SSCI)
Buildings 3.8 Q2 Construction & Building Technology
Engineering, Civil
Agronomy 3.7 Q1 Agronomy
Q2 Plant Sciences
Fermentation 3.7 Q2 Biotechnology & Applied Microbiology
Pathogens 3.7 Q2 Microbiology
Agriculture 3.6 Q1 Agronomy
Diagnostics 3.6 Q2 Medicine, General & Internal
Genes 3.5 Q2 Genetics & Heredity
Journal of Intelligence 3.5 Q2 Psychology, Multidisciplinary
Lubricants 3.5 Q2 Engineering, Mechanical
Processes 3.5 Q2 Engineering, Chemical
Coatings 3.4 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
ISPRS International Journal of Geo-Information 3.4 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Materials 3.4 Q2 Metallurgy & Metallurgical Engineering
Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Micromachines 3.4 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Water 3.4 Q2 Water Resources
Environmental Sciences
Brain Sciences 3.3 Q3 Neurosciences
Energies 3.2 Q3 Energy & Fuels
Fire 3.2 Q1 Forestry
Q2 Ecology
Life 3.2 Q2 Biology
Current Issues in Molecular Biology 3.1 Q3 Biochemistry & Molecular Biology
Horticulturae 3.1 Q1 Horticulture
Animals 3.0 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Insects 3.0 Q1 Entomology
Atmosphere 2.9 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Electronics 2.9 Q2 Engineering, Electrical & Electronic
Physics, Applied
Q3 Computer Science, Information Systems
Forests 2.9 Q1 Forestry
Inorganics 2.9 Q2 Chemistry, Inorganic & Nuclear
Journal of Marine Science and Engineering 2.9 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Metals 2.9 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Tropical Medicine and Infectious Disease 2.9 Q2 Tropical Medicine
Parasitology
Q3 Infectious Diseases
Universe 2.9 Q2 Astronomy & Astrophysics
Physics, Particles & Fields
Healthcare 2.8 Q2 Health Policy & Services (SSCI)
Q3 Health Care Sciences & Services (SCIE)
Applied Sciences 2.7 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Crystals 2.7 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Entropy 2.7 Q2 Physics, Multidisciplinary
Magnetochemistry 2.7 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Symmetry 2.7 Q2 Multidisciplinary Sciences
Actuators 2.6 Q2 Instruments & Instrumentation
Engineering, Mechanical
Aerospace 2.6 Q1 Engineering, Aerospace
Behavioral Sciences 2.6 Q2 Psychology, Multidisciplinary
Current Oncology 2.6 Q3 Oncology
Machines 2.6 Q2 Engineering, Mechanical
Q3 Engineering, Electrical & Electronic
Medicina 2.6 Q3 Medicine, General & Internal
Separations 2.6 Q3 Chemistry, Analytical
Minerals 2.5 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Children 2.4 Q2 Pediatrics
Diversity 2.4 Q2 Biodiversity Conservation
Q3 Ecology
Journal of Cardiovascular Development and Disease 2.4 Q3 Cardiac & Cardiovascular Systems
Mathematics 2.4 Q1 Mathematics
Photonics 2.4 Q3 Optics
Veterinary Sciences 2.4 Q1 Veterinary Sciences
Fishes 2.3 Q2 Marine & Freshwater Biology
Fisheries
Axioms 2.0 Q2 Mathematics, Applied
Systems 1.9 Q2 Social Sciences, Interdisciplinary
Tomography 1.9 Q3 Radiology, Nuclear Medicine & Medical Imaging


Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)

 

14 June 2023
Journal of Personalized Medicine Receives an Increased CiteScore of 2.6

We are pleased to inform you that the Journal of Personalized Medicine’s 2022 CiteScore is 2.6. JPM’s CiteScore ranks 153 among 309 titles (Q2) in the “Medicine (miscellaneous)” category, continuing to build momentum in its field. We would like to extend our congratulations to all concerned.

For more journal statistics, please visit https://www.mdpi.com/journal/jpm/stats

25 May 2023
Meet Us at the 60th European Renal Association (ERA) Congress, 15–17 June 2023, Milan, Italy

Conference: 60th European Renal Association (ERA) Congress

Date: 15–17 June 2023

Location: Milan, Italy

MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.

The following MDPI journals will be represented:

  • JCM;
  • JPM;
  • Kidney and Dialysis;
  • Diagnostics;
  • Clinics and Practice;
  • Uro;
  • Cells;
  • BioChem;
  • Transplantology.
If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.era-online.org/events/milan-2023/.

16 May 2023
Meet Us at the 19th Annual International Conference of the Metabolomics Society, 18–22 June 2023, Niagara Falls, Ontario, Canada


Conference: 19th Annual International Conference of the Metabolomics Society

Date: 18–22 June 2023

Place: Niagara Falls Convention Centre, 6815 Stanley Avenue, Niagara Falls, Ontario, Canada L2G 3Y9

Booth: #T12

MDPI will be attending the 19th Annual International Conference of the Metabolomics Society, which will be held from 18 to 22 June 2023 in downtown Niagara Falls, Canada, at the Niagara Falls Convention Centre.

The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. It will cover the major scientific themes of: technology advances; computational metabolomics, statistics, and bioinformatics; metabolomics in health and disease; and metabolomics of plants, food, environment and microbes. A special theme for this conference will focus on mental health, drug addiction and medicinal cannabis. The scientific program will include plenary and keynote talks, three parallel scientific sessions, interactive poster sessions, sponsor lunches, other networking events and a specially organized parallel session to promote metabolomics research in industry. A strong line-up of both introductory and advanced workshops will take place on Sunday, 18 June, and the morning of Monday, 19 June. To complement the exciting scientific program, the conference will offer a welcome reception, vibrant early career events, a conference dinner and other engaging social activities.

The following MDPI journals will be represented:

Please do not hesitate to reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.metabolomics2023.org/.

10 May 2023
Meet Us at the ATS (American Thoracic Society) Conference 2023, 21–23 May 2023, Washington DC, USA


Conference: ATS (American Thoracic Society) Conference 2023
Date: 21–23 May 2023
Location: Washington DC, USA

MDPI will be attending ATS 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has been organized by the American Thoracic Society, and it will showcase the latest advances and discoveries in respiratory science, patient care and global respiratory health. At the conference, specialists will share and discuss the latest research and its applications to clinical, basic, and translational science in pulmonary, critical care, and sleep medicine.

The following MDPI journals will be represented:

If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person at booth #2606, and answering any questions that you may have. For more information about the conference, please visit the following website: https://conference.thoracic.org/.

5 May 2023
Meet Us at the 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023), 29 June–1 July 2023, Copenhagen, Denmark


Conference: 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023)
Date: 29 June–1 July 2023
Location: Copenhagen, Denmark

MDPI will be attending ESCAP 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is organized by the European Society for Child and Adolescent Psychiatry. The theme of the conference is “Mental health of children and adolescents”. At the conference, specialists will share and discuss the latest research and applications of environmental and chemical substances in relation to society.

The following MDPI journals will be represented:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escap2023.eu/.

21 April 2023
Journal of Personalized Medicine Webinar | Metabolic Syndrome and Cardiovascular Disease, 26 April 2023


Metabolic syndrome pathophysiology is multifactorial and involves abdominal obesity, hyperinsulinemia, and hyperglycemia. The activation of lipoprotein lipase and the inhibition of secretion of very low-density lipoproteins are central factors. Atherogenic dyslipidemia is causally linked to cardiovascular disease. At the same time, there is new evidence regarding genetic predisposition in metabolic syndrome causation. From early studies on twins to genome-wide association studies, the genetic origin of metabolic syndrome was found to span different genetic loci. Thus, environmental factors play a key role. Knowledge of increased genetic susceptibility to the syndrome permits a personalized approach to treatment and prevention. In this context, oxidative stress augments and Nrf-2 pathways are involved, the activation of which are equally favorable targets for oxidative stress suppression after treatment with natural product derivatives and phytotherapy. This attempt can also reduce the costs and side effects.

In the current webinar, firstly, lipid metabolism dysfunction in the pathogenesis of metabolic syndrome will be discussed. Genes and metabolic syndrome heritability will be analyzed, focusing on specific genes along with interaction with environmental factors. Last but not least, specific benefits from natural products’ utilization in the treatment of metabolic syndrome will be presented along with molecular pathways modification and cell signal regulation from phytotherapy.

Date: 26 April 2023 at 10:00 a.m. CEST
Webinar ID: 843 2926 3596

Register now for free!

Speaker/Presentation Time in CEST
Dr. Konstantinos Tsarouhas
Chair Introduction
10:00–10:10 am
Dr. Genovefa Kolovou
Lipids Contribution in Metabolic Syndrome
10:10–10:30 am
Dr. Lina Florentin
Genetic Aspects of Metabolic Syndrome and Cardiovascular Implications
10:30–10:50 am
Dr. Ramin Rezaee
Value of Natural Products in Cardiometabolic Medicine
10:50–11:10 am
Q&A 11:10–11:25 am
Dr. Konstantinos Tsarouhas
Closing of Webinar
11:25–11:30 am

After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording is available to watch.


Webinar Chair and Keynote Speakers:

  • Dr. Konstantinos Tsarouhas, Department of Cardiology, University Hospital of Larissa, Larissa, Greece.
  • Dr. Genovefa Kolovou, Preventive Cardiology, Lipoprotein apheresis Unit and Lipid Disorders Clinic, Metropolitan Hospital, Athens Greece.
  • Dr. Lina Florentin, A-Lab Genetic and Genomic Centre, Athens, Greece.
  • Dr. Ramin Rezaee, International UNESCO Center for Health-Related Basic Sciences and Human Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, Assistant Professor.

Relevant Special Issue:

30 March 2023
Meet Us at the European Human Genetics Conference 2023 (ESHG 2023), 10–13 June 2023, Glasgow, UK


MDPI will be attending the European Human Genetics Conference 2023 (ESHG 2023), held in Glasgow, UK, from 10 to 13 June 2023.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth #824. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please visit the following link: https://2023.eshg.org/.

29 March 2023

Meet Us at the 112th Annual Meeting of the Japanese Society of Pathology, 13–15 April 2023, Shimonoseki, Japan


Conference
: The 112th Annual Meeting of the Japanese Society of Pathology
Date: 13–15 April 2023
Place: Shimonoseki, Japan

MDPI will be attending the 112th Annual Meeting of the Japanese Society of Pathology as an exhibitor. This meeting will be held in Shimonoseki, Japan, from 13 to 15 April 2023. This conference is held every year, and the theme of the 112th edition is “Doors to Overcoming Intractable Diseases: Potential of Pathology and Pathological Diagnostics”. The aim of this meeting is to provide an opportunity for all the members who chose the path of pathology to engage in hot discussions and introduce new perspectives to pathology and diagnostic pathology.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://site2.convention.co.jp/112jsp/english/.

29 March 2023
Meet Us at the 19th World Congress of Basic & Clinical Pharmacology 2023, 2–7 July 2023, Glasgow, Scotland

This conference organized by the British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) will be held in Glasgow, Scotland, from 2 July to 7 July 2023. The topic of the conference focuses on pharmacology and drug discovery, research, and development, and the conference will include six days of symposia, keynote lectures, workshops, and debates. Discover the latest in pharmacology research and developments across 10 content themes.

Pharmaceuticals (ISSN: 1424-8247) is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. Pharmaceuticals will participate in this event as an exhibitor together with nine other MDPI journals, among which Pharmaceuticals, Journal of Personalized Medicine and Biomedicines will have journal representatives at our booth.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us at our booth #A22. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://wcp2023.org/ or contact the Pharmaceuticals Editorial Office at [email protected].

16 March 2023
Meet Us at the Chinese Academic Conference on Tumor Biomarker, 7–9 April 2023, Shanghai, China


MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

  • Biomedicines;
  • Cancers;
  • Cells;
  • Diagnostics;
  • Current Oncology;
  • JPM;
  • JCM;
  • Onco;
  • CIMB;
  • BioMedInformatics.

If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please follow the link below: https://biomarker2022.sciconf.cn/cn/web/index/13496.

13 March 2023
MDPI’s Newly Launched Journals in December 2022

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

Journal

Founding Editor-in-Chief

Journal Topics (Selected)

Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue

grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article

Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue

pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article

Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue

receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article

Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue

drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article

Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue

higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to [email protected].

7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.

3 March 2023
Recruiting Co-Editor-in-Chief for the Journal of Personalized Medicine


Journal of Personalized Medicine (JPM; ISSN: 2075-4426) is an international journal published monthly online by the leading open access publisher MDPI with Prof. Dr. David Alan Rizzieri serving as the Editor-in-Chief. JPM publishes cutting-edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, and ‘omics association analysis). To ensure the continued efficient and high-quality production of our journal, we are currently seeking nominations and applications for the position of Co-Editor-in-Chief to assist Prof. Dr. David Alan Rizzieri.

The responsibilities of the Co-Editor-in-Chief include the following:

  • Advising on the strategic development of the journal;
  • Nominating/inviting Guest Editors and optionally delegating to them the authority to make final acceptance decisions for submitted articles;
  • Nominating and leading the Editorial Board;
  • Promoting the journal at scientific conferences or through other venues.

As an Co-Editor-in-Chief, you will have the unique opportunity to network and communicate with scholars in the personalized medicine community, building long-term relationships and establishing your influence within your discipline. Appointed members will also receive an Editor Certificate confirming this role. In addition, you will have the opportunity to publish two paper per year free of charge in JPM. The term for this position is two years and can be renewed.

If you are a researcher in a related field and are passionate about participating in the publication of cutting-edge research, please do not hesitate to get in touch about joining the Editorial Board (https://www.mdpi.com/journal/jpm). To apply for this position, please contact the Journal of Personalized Medicine Editorial Office ([email protected]) with the following two files attached:

  • A full academic CV;
  • A short cover letter that details your interests and enthusiasm for the position.

JPM Editorial Office

21 February 2023
Journal of Personalized Medicine | New Section “Life-Stage-Specific Medicine (LSSM)” Established

The Journal of Personalized Medicine (JPM, ISSN: 2075-4426) editorial team is pleased to announce the launch of a new Section, “Life-Stage-Specific Medicine (LSSM)”. The aim of this Section is to offer a platform for researchers and professionals in the field of personalized medicine on which they can demonstrate the influence of genetic and environmental factors on different life stages, in addition to how different life stages affect disease development, treatments, and longevity.

Topics could include, but are not limited to, the following:

  • Disease development of different life stages and responses to disease treatments;
  • Hormone levels in different life stages and their impact on disease development and treatments;
  • The immune system at different life stages and its relationship with disease development, drugs, and disease treatments;
  • Changes in hormone levels and immune statements during translations of life stages;
  • How the length of life stages affects the total lifespan of humans;
  • Clinical practice, clinical trials, and drug dosages with regard to the principal law of lifespan (PLOSP);
  • Racial and sex differences in terms of life stages and lifespan;
  • Menopause; puberty; and reproduction.

We are currently recruiting Editorial Board Members (EBMs) for this Section. If you are an active researcher in this field and are passionate about publishing cutting-edge research, please contact us at [email protected]. Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload/786489cd3ae44f21e922b7fa879d33fc?form%5Bjournal_id%5D=65.

JPM Editorial Office

21 February 2023
Meet Us at the 143rd Annual Meeting of the Pharmaceutical Society of Japan, 25–28 March 2023, Sapporo, Japan


Conference: 143rd Annual Meeting of the Pharmaceutical Society of Japan
Date: 25–28 March 2023
Place: Sapporo, Japan

MDPI will be attending the 143rd Annual Meeting of the Pharmaceutical Society of Japan as the exhibitor. This meeting will be held at Hokkaido University, Sapporo, Japan, from 25 to 28 March 2023. The organizing committee comprises the Faculty of Pharmaceutical Sciences, Hokkaido University. The theme of the 143rd annual meeting is "PharmaScience: Integration for Breakthroughs". Through this meeting, we wish to contribute to the progress of research leading to the development of innovative drugs and therapies by bringing together researchers from various research fields.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://confit.atlas.jp/guide/event/pharm143/top.

16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

14 February 2023
Meet Us at the 11th National Conference on Bioinformatics and Systems Biology, 25–27 February 2023, Guangzhou, China


Conference
: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China

MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ccbsb2022.casconf.cn/.

22 December 2022
Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

  • Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
  • Writing a brief promotion plan for the Special Issue;
  • Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
  • Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

  • Conducting a final check before the Special Issue is published online;
  • Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
  • Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
  • Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
  • Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

1 Million Infographic

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

4 November 2022
Meet Us at the 27th Congress of the Chinese Pediatric Society, 15–18 December 2022, Changsha, China

MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.

27th Congress of Chinese Pediatric Society

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have. 

For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.

25 October 2022
Journal of Personalized Medicine | Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.

This program intends to provide an opportunity for early career scientists to enhance their editing, networking, and organizational skills, and to work closely with our journal to gain more editorial experience. Early career scientists who have novel ideas for new Special Issues in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Editorial Board of JPM, or from other well-established research institutes or laboratories.

If you are interested in this opportunity, please send your Special Issue proposal to the JPM Editorial Office ([email protected]), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

In addition to the new Special Issue Mentor Program, JPM will continue to welcome all Special Issue proposals based on hot research topics.

 

28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.

To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.

We invite you to view the event recording:

During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:

In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.

You can find the Podcast here.

We hope you enjoy the contents!

23 September 2022
Recruiting Section Editors-in-Chief for the Journal of Personalized Medicine


The Journal of Personalized Medicine (JPM, ISSN: 2075-4426) is an international, peer-reviewed, open access journal on personalized medicine that is published monthly online by MDPI. To develop different research areas and continue to attract high-quality papers, JPM is recruiting Section Editors-in-Chief. More details can be found at https://www.mdpi.com/journal/jpm/sections.

At present, the following Sections have not yet found suitable scholars to lead them:

We are now recruiting Section Editors-in-Chief (SEiC) for these Sections. If you are an active researcher in one of the aforementioned fields and are passionate about publishing cutting-edge research, please do not hesitate to contact us at: [email protected]/[email protected]. You can find more information on our homepage: https://www.mdpi.com/journal/jpm.

The Section Editor-in-Chief has the following responsibilities:

  • Making decisions on whether a manuscript can be accepted based on the reports we collect;
  • Reviewing a small number of papers per year and managing the Section together with other journal editors;
  • Promoting JPM and increasing its visibility at related academic conferences.

We believe that by combining our rigorous editorial policies with your expertise, we can build a high-quality journal. We thank you in advance for your interest and look forward to collaborating with you in the future.

JPM Editorial Office

7 September 2022
Meet Us at the ASHG Annual Meeting 2022 (ASHG 2022), 25–29 October 2022, Los Angeles, USA


MDPI will be attending ASHG 2022, held in Los Angeles, USA, from 25 to 29 October 2022.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth: #1844. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link:

https://www.ashg.org/meetings/2022-annual-meeting/.

28 July 2022
Meet Us at EuroBioFilms 2022, 31 August–3 September 2022, Palma de Mallorca, Spain


MDPI will be attending EuroBioFilms 2022 (EBF), hosted by the ESCMID Study Group for Biofilms (ESGB), which will be held from 31 August to 3 September 2022 in Palma de Mallorca, Spain. The conference will be held at the Meliá Palma Marina Hotel, Av. de Gabriel Roca, 29, 07014 Palma, Balearic Islands.

The multidisciplinary program will cover many subjects and will be a mix of basic and clinical biofilm-related topics. Leading scientists in the field will be present as keynote speakers and/or chairpersons. Oral presentations will be presented during various parallel sessions. On 31st of August, several educational preconference workshops will be organized.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit the following link: https://eurobiofilms2022.com/, or contact the Antibiotics Editorial Office at [email protected].

28 June 2022
2021 Impact Factors - Released

The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

Journal Impact Factor Rank Category
Antioxidants 7.675 Q1 Food Science & Technology
Biochemistry & Molecular Biology
Chemistry, Medicinal
Cells 7.666 Q2 Cell Biology
Nutrients 6.706 Q1 Nutrition & Dietetics
Cancers 6.575 Q1 Oncology
Pharmaceutics 6.525 Q1 Pharmacology & Pharmacy
International Journal of Molecular Sciences 6.208 Q1 Biochemistry & Molecular Biology
Q2 Chemistry, Multidisciplinary
Marine Drugs 6.085 Q1 Chemistry, Medicinal
Pharmacology & Pharmacy
Biomolecules 6.064 Q2 Biochemistry & Molecular Biology
Batteries * 5.938 Q2 Electrochemistry
Energy & Fuels
Materials Science, Multidisciplinary
Viruses 5.818 Q2 Virology
Biosensors 5.743 Q1 Chemistry, Analytical
Instruments & Instrumentation
Q2 Nanoscience & Nanotechnology
Journal of Fungi 5.724 Q1 Mycology
Q2 Microbiology
Nanomaterials 5.719 Q1 Physics, Applied
Q2 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Nanoscience & Nanotechnology
Metabolites 5.581 Q2 Biochemistry & Molecular Biology
Foods 5.561 Q1 Food Science & Technology
Drones * 5.532 Q2 Remote Sensing
Remote Sensing 5.349 Q1 Geosciences, Multidisciplinary
Imaging Science & Photographic Technology
Q2 Remote Sensing
Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 5.318 Q2 Business
Antibiotics 5.222 Q1 Pharmacology & Pharmacy
Q2 Infectious Diseases
Pharmaceuticals 5.215 Q1 Pharmacology & Pharmacy
Q2 Chemistry, Medicinal
Biology 5.168 Q1 Biology
Fermentation 5.123 Q2 Biotechnology & Applied Microbiology
Toxins 5.075 Q1 Toxicology
Q2 Food Science & Technology
Bioengineering * 5.046 Q2 Engineering, Biomedical
Polymers 4.967 Q1 Polymer Science
Journal of Clinical Medicine 4.964 Q2 Medicine, General & Internal
Vaccines 4.961 Q2 Immunology
Medicine, Research & Experimental
Molecules 4.927 Q2 Chemistry, Multidisciplinary
Biochemistry & Molecular Biology
Microorganisms 4.926 Q2 Microbiology
Journal of Functional Biomaterials * 4.901 Q2 Engineering, Biomedical
Materials Science, Biomaterials
Biomedicines 4.757 Q2 Medicine, Research & Experimental
Pharmacology & Pharmacy
Biochemistry & Molecular Biology
Plants 4.658 Q1 Plant Sciences
International Journal of Environmental Research and Public Health 4.614 Q1 Public, Environmental & Occupational Health (SSCI)
Q2 Public, Environmental & Occupational Health (SCIE)
Environmental Sciences (SCIE)
Membranes 4.562 Q1 Polymer Science
Q2 Engineering, Chemical
Materials Science, Multidisciplinary
Chemistry, Physical
Pathogens 4.531 Q2 Microbiology
Catalysts 4.501 Q2 Chemistry, Physical
Toxics 4.472 Q2 Toxicology
Environmental Sciences
Gels 4.432 Q1 Polymer Science
Journal of Cardiovascular Development and Disease 4.415 Q2 Cardiac & Cardiovascular Systems
Chemosensors 4.229 Q1 Instruments & Instrumentation
Q2 Chemistry, Analytical
Q3 Electrochemistry
Genes 4.141 Q2 Genetics & Heredity
Diagnostics 3.992 Q2 Medicine, General & Internal
Agronomy 3.949 Q1 Agronomy
Plant Sciences
Land 3.905 Q2 Environmental Studies
Sustainability 3.889 Q2 Environmental Sciences (SCIE)
Environmental Studies (SSCI)
Q3 Green & Sustainable Science & Technology (SCIE)
Q4 Green & Sustainable Science & Technology (SSCI)
Sensors 3.847 Q2 Instruments & Instrumentation
Chemistry, Analytical
Engineering, Electrical & Electronic
Materials 3.748 Q1 Metallurgy & Metallurgical Engineering
Q2 Physics, Applied
Physics, Condensed Matter
Q3 Materials Science, Multidisciplinary
Chemistry, Physical
Biomimetics * 3.743 Q2 Engineering, Multidisciplinary
Q3 Materials Science, Biomaterials
Tropical Medicine and Infectious Disease * 3.711 Q1 Tropical Medicine
Q2 Parasitology
Q3 Infectious Diseases
Lubricants * 3.584 Q2 Engineering, Mechanical
Fractal and Fractional 3.577 Q1 Mathematics, Interdisciplinary Applications
Water 3.530 Q2 Water Resources
Q3 Environmental Sciences
Micromachines 3.523 Q2 Instruments & Instrumentation
Physics, Applied
Chemistry, Analytical
Q3 Nanoscience & Nanotechnology
Journal of Personalized Medicine 3.508 Q2 Medicine, General & Internal
Health Care Sciences & Services
Agriculture 3.408 Q1 Agronomy
Processes 3.352 Q2 Engineering, Chemical
Separations 3.344 Q2 Chemistry, Analytical
Magnetochemistry 3.336 Q2 Chemistry, Inorganic & Nuclear
Q3 Chemistry, Physical
Materials Science, Multidisciplinary
Brain Sciences 3.333 Q3 Neurosciences
Buildings 3.324 Q2 Construction & Building Technology
Engineering, Civil
Forests 3.282 Q1 Forestry
Energies 3.252 Q3 Energy & Fuels
Life 3.251 Q2 Biology
Coatings 3.236 Q2 Materials Science, Coatings & Films
Physics, Applied
Q3 Materials Science, Multidisciplinary
Animals 3.231 Q1 Agriculture, Dairy & Animal Science
Veterinary Sciences
Journal of Intelligence * 3.176 Q2 Psychology, Multidisciplinary
Fishes 3.170 Q1 Marine & Freshwater Biology
Q2 Fisheries
Healthcare 3.160 Q2 Health Policy & Services (SSCI)
Health Care Sciences & Services (SCIE)
Inorganics * 3.149 Q2 Chemistry, Inorganic & Nuclear
Insects 3.139 Q1 Entomology
Atmosphere 3.110 Q3 Meteorology & Atmospheric Sciences
Environmental Sciences
Current Oncology 3.109 Q3 Oncology
ISPRS International Journal of Geo-Information 3.099 Q2 Geography, Physical
Q3 Computer Science, Information Systems
Remote Sensing
Diversity 3.029 Q2 Biodiversity Conservation
Ecology
Tomography 3.000 Q3 Radiology, Nuclear Medicine & Medical Imaging
Current Issues in Molecular Biology 2.976 Q3 Biochemistry & Molecular Biology
Medicina 2.948 Q3 Medicine, General & Internal
Symmetry 2.940 Q2 Multidisciplinary Sciences
Horticulturae 2.923 Q1 Horticulture
Machines 2.899 Q2 Engineering, Mechanical
Engineering, Electrical & Electronic
Systems * 2.895 Q2 Social Sciences, Interdisciplinary
Applied Sciences 2.838 Q2 Engineering, Multidisciplinary
Physics, Applied
Q3 Chemistry, Multidisciplinary
Materials Science, Multidisciplinary
Children 2.835 Q2 Pediatrics
Minerals 2.818 Q2 Mining & Mineral Processing
Mineralogy
Geochemistry & Geophysics
Universe 2.813 Q2 Astronomy & Astrophysics
Q3 Physics, Particles & Fields
Journal of Marine Science and Engineering 2.744 Q1 Engineering, Marine
Q2 Oceanography
Engineering, Ocean
Entropy 2.738 Q2 Physics, Multidisciplinary
Fire * 2.726 Q2 Forestry
Q3 Ecology
Metals 2.695 Q2 Metallurgy & Metallurgical Engineering
Q3 Materials Science, Multidisciplinary
Electronics 2.690 Q3 Engineering, Electrical & Electronic
Computer Science, Information Systems
Physics, Applied
Crystals 2.670 Q2 Crystallography
Q3 Materials Science, Multidisciplinary
Aerospace 2.660 Q1 Engineering, Aerospace
Mathematics 2.592 Q1 Mathematics
Photonics 2.536 Q3 Optics
Actuators 2.523 Q2 Instruments & Instrumentation
Q3 Engineering, Mechanical
Veterinary Sciences 2.518 Q2 Veterinary Sciences
Behavioral Sciences * 2.286 Q3 Psychology, Multidisciplinary
Axioms * 1.824 Q2 Mathematics, Applied

For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.

 

* Journals given their first Impact Factor in 2022

Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)

 

20 June 2022
MDPI’s 2021 Young Investigator Awards in “Medicine & Pharmacology”—Winners Announced

MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.

We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

  • Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
  • Mateusz Maciejczyk, Medical University of Bialystok, Poland

Current Oncology:

  • Matteo Lambertini, University of Genova, Italy

Dentistry Journal:

  • Helen Rogers, Newcastle University, UK

Healthcare:

  • Amir Karami, University of South Carolina, USA

Journal of Clinical Medicine:

  • Andrea Palermo, Campus Bio-Medico University, Italy

Journal of Personalized Medicine:

  • Simone Di Franco, University of Palermo, Italy
  • Catriona Hippman, University of Calgary, Canada

Medicina:

  • Veeru Kasivisvanathan, University College London, UK
  • Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy

Pharmaceutics:

  • Qi Zhou, Purdue University, USA

20 June 2022
MDPI’s 2021 Travel Awards in “Medicine & Pharmacology”—Winners Announced

We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.

MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Biomedicines:

  • Soheil Saeedi, University of Zurich, Switzerland

Dentistry Journal:

  • Shawn Alexander Hallett, University of Michigan, USA

Medicines:

  • Claire Albert, Yale University, USA

Pharmaceuticals:

  • Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
  • Patrick Jim Küppers, University Hospital Bonn, Germany

20 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Medicine & Pharmacology”—Winners Announced

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.

Cancers:

  • Antonio G. Solimando, University of Bari Aldo Moro, Italy
  • Chenghui Li, University of Arkansas for Medical Sciences, USA
  • Joaquim Carreras, Tokai University, Japan
  • Pierfrancesco Franco, University of Turin School of Medicine, Italy
  • Laurentiu Pop, University of Texas Southwestern Medical Center, USA

Current Oncology:

  • Margaret Fitch, University of Toronto, Canada
  • Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada

Healthcare:

  • Naser Alsharairi, Griffith University, Australia
  • Peter W. Choate, Mount Royal University, Canada
  • Qin Xiang Ng, National University of Singapore, Singapore

Journal of Clinical Medicine:

  • Giulio Francesco, Sapienza University of Rome, Italy
  • Sebastian Schnaubelt, Medical University of Vienna, Austria
  • Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA

Journal of Personalized Medicine:

  • Onofrio Laselva, University of Foggia, Italy
  • Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
  • Vladimir Vladimirov, Virginia Commonwealth University, USA
  • Mauro Giuffrè, University of Trieste, Italy

Medical Sciences:

  • Erika Palmieri, National Cancer Institute at Frederick, USA

Tomography:

  • Anjul Khadria, California Institute of Technology, Pasadena, USA

20 June 2022
MDPI’s 2021 Best Paper Awards in “Medicine & Pharmacology”—Winners Announced

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.

We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.

MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm

Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055

by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado

Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045

Dentistry Journal:

by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky

Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029

by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin

Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115

Healthcare:

by Chantal Huisman and Helianthe Kort

Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031

by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal

Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037

Journal of Clinical Medicine:

by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy

Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135

by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya

Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025

by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal

Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019

Medicina:

by Borros Arneth

Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015

by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián

Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356

Pharmaceutics:

by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.

Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148

by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu

Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140

9 June 2022
2021 CiteScores - Released


The 2021 citation metrics have been officially released in Scopus!

We are pleased to announce that 182 MDPI journals are included, of which:

● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.

The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:

Journal

CiteScore

Quartile

Category

Non-coding RNA

10.1

Q1

Genetics

Journal of Functional Biomaterials

10.0

Q1

Biomedical Engineering

Marine Drugs

8.1

Q1

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Batteries

7.9

Q1

Electrical and Electronic Engineering

Nutrients

7.9

Q1

Nutrition and Dietetics

Remote Sensing

7.4

Q1

General Earth and Planetary Sciences

Drones

7.2

Q1

Computer Science Applications

International Journal of Molecular Sciences

6.9

Q1

Inorganic Chemistry

Journal of Sensor and Actuator Networks

6.9

Q1

Computer Networks and Communications

Cells

6.7

Q1

General Biochemistry, Genetics and Molecular Biology

Nanomaterials

6.6

Q1

General Chemical Engineering

Toxins

6.6

Q1

Health, Toxicology and Mutagenesis

Viruses

6.6

Q1

Infectious Diseases

Antioxidants

6.5

Q1

Food Science

Fibers

6.5

Q1

Civil and Structural Engineering

Resources

6.4

Q1

Nature and Landscape Conservation

Sensors

6.4

Q1

Instrumentation

Big Data and Cognitive Computing

6.1

Q1

Management Information Systems

Molecules

5.9

Q1

Chemistry (miscellaneous)

Polymers

5.7

Q1

Polymers and Plastics

Biosensors

5.6

Q1

Engineering (miscellaneous)

Catalysts

5.5

Q1

General Environmental Science

Smart Cities

5.5

Q1

Urban Studies

Future Internet

5.4

Q2

Computer Networks and Communications

Beverages

5.3

Q1

Food Science

Fermentation

5.3

Q1

Plant Science

Environments

5.2

Q1

Ecology, Evolution, Behavior and Systematics

Inventions

5.2

Q1

General Engineering

Journal of Open Innovation: Technology, Market, and Complexity

5.1

Q1

Development

Colloids and Interfaces

5.0

Q1

Chemistry (miscellaneous)

Energies

5.0

Q1

Control and Optimization

ISPRS International Journal of Geo-Information

5.0

Q1

Geography, Planning and Development

Sustainability

5.0

Q1

Geography, Planning and Development

Fire

4.9

Q1

Forestry

Robotics

4.9

Q1

Control and Optimization

Soil Systems

4.9

Q1

Soil Science

Geosciences

4.8

Q1

General Earth and Planetary Sciences

Journal of Manufacturing and Materials Processing

4.8

Q1

Mechanical Engineering

Tropical Medicine and Infectious Disease

4.8

Q1

Public Health, Environmental and Occupational Health

Water

4.8

Q1

Geography, Planning and Development

International Journal of Environmental Research and Public Health

4.5

Q1

Public Health, Environmental and Occupational Health

Sports

4.5

Q1

Physical Therapy, Sports Therapy and Rehabilitation

Entropy

4.4

Q1

Mathematical Physics

Journal of Clinical Medicine

4.4

Q1

General Medicine

Symmetry

4.3

Q1

General Mathematics

Cosmetics

4.2

Q1

Surgery

Foods

4.1

Q1

Health Professions (miscellaneous)

Journal of Fungi

4.1

Q1

Plant Science

ChemEngineering

4.0

Q1

General Engineering

Forests

4.0

Q1

Forestry

Journal of Intelligence

4.0

Q1

Education

Antibiotics

3.9

Q1

General Pharmacology, Toxicology and Pharmaceutics

Cryptography

3.9

Q1

Applied Mathematics

Behavioral Sciences

3.8

Q1

Development

Buildings

3.8

Q1

Architecture

Metals

3.8

Q1

Metals and Alloys

Publications

3.5

Q1

Communication

Social Sciences

3.4

Q1

General Social Sciences

Mathematics

2.9

Q1

General Mathematics

Fractal and Fractional

2.8

Q1

Analysis

Animals

2.7

Q1

General Veterinary

Axioms

2.6

Q1

Algebra and Number Theory

Heritage

1.8

Q1

Conservation

Religions

1.0

Q1

Religious Studies

Philosophies

0.9

Q1

Philosophy

Source: 2021 CiteScores™ (Elsevier)

8 June 2022
Journal of Personalized Medicine | Webinar on Radiation Response Biomarkers for Individualised Cancer Treatments, 15 June 2022


Date
: 15 June 2022
Time: 14:30 (CEST)
Webinar ID: 871 1746 2760
Register here: https://jpm-1.sciforum.net/
Participation fee: None
Language: English
Webinar keywords: radiation, radiotherapy, sensitivity, radiation oncology, biomarkers, cancer, X-rays
Link to related Special Issue: https://www.mdpi.com/journal/jpm/special_issues/radiation_cancer

Webinar Chair and Speakers:

Chair:

  • Dr. Christophe Badie, Cancer Mechanisms and Biomarkers Group, UK Health Security Agency, Harwell Campus, UK

Speakers:

  • Dr. Elisa Placidi, UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, Italy
  • Prof. Dr. Susan M. Bailey, Department of Environmental & Radiological Health Sciences, Cancer Biology & Comparative Oncology University Program of Research and Scholarly Excellence, Colorado State University, USA

If you have any questions about this webinar, please contact [email protected].

We look forward to your participation in this event.

JPM Editorial Office

16 March 2022
Welcoming New Editorial Board Members of Journal of Personalized Medicine

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426):

Name: Dr. Cristian Ripoli
Affiliation: Department of Neuroscience, Faculty of Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy

Name: Dr. Jeonghyun Ahn
Affiliation: Department of Cell Biology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA 

Name: Dr. Sheng Ho
Affiliation: Department of Radiation Oncology, Chi Mei Medical Center, Graduate Institute of Medical Science, Chang Jung Christian University, Tainan 710, Taiwan

Name: Dr. Ming-Chao Tsai
Affiliation: 1. Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan
2. Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan 83301, Taiwan

Name: Dr. Erik Wilms
Affiliation: Hospital Pharmacy, The Hague Hospitals, 2545 AB The Hague, The Netherlands

Name: Dr. Sara Bravaccini
Affiliation: IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, via Maroncelli 40, 47014 Meldola, Italy

Name: Prof. Dr. Giovanni Squadrito
Affiliation: Department of Clinical and Experimental Medicine, University of Messina, 98100 Messina, Italy

Name: Prof. Dr. Alfredo Berruti
Affiliation: Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica, Brescia, Italy 

Name: Prof. Dr. Cheng-Hsien Lu
Affiliation: 1. Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung and Chang Gung University 123, Ta-Pei Road, Niao Sung district, Kaohsiung City 83304, Taiwan
2. Department of Biological Science, National Sun Yat-sen University, Kaohsiung City 80424, Taiwan

Name: Dr. Ceres Fernandez Rozadilla
Affiliation: 1. Grupo de Medicina Xenómica, Universidade de Santiago de Compostela (USC), 15706 Santiago de Compostela, Spain
2. Instituto de Investigación Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain

Name: Dr. Francesca Stillitano
Affiliation: Cardiovascular Department, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands

Name: Dr. Hui-Hua Hsiao
Affiliation: Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

Name: Prof. Dr. Juan J. Salazar Corral
Affiliation: Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Departamento Oftalmología y ORL, Universidad Complutense de Madrid, Madrid, Spain

Name: Dr. Margarida Maria Fernandes Baptista e Silva
Affiliation: Department of Biochemistry and Human Biology, Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal

Name: Dr. Sara Llufriu
Affiliation: Center of Neuroimmunology, Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Institut d’Investigacions Biomediques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, 08036 Barcelona, Spain

Name: Prof. Dr. Won Hyuk Chang
Affiliation: Department of Physical & Rehabilitation Medicine, Center for Prevention and Rehabilitation, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea

Name: Dr. Mircea Tampa
Affiliation: Department of Dermatology, “Carol Davila” University of Medicine and Pharmacy, 020021 Bucharest, Romania

We wish them every success both in their research and in the development of the journal.

Further details about the Editorial Board can be found at: https://www.mdpi.com/journal/jpm/editors

JPM Editorial Office

17 January 2022
Journal of Personalized Medicine | Top 10 Cited Papers

We are pleased to announce the list of the Top 10 Cited Papers published in 2020 and 2021 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426):

1. “Wise Management of Ovarian Cancer: On the Cutting Edge
by Stergios Boussios, Christos Mikropoulos, Eleftherios Samartzis, Peeter Karihtala, Michele Moschetta, Matin Sheriff, Afroditi Karathanasi, Agne Sadauskaite, Elie Rassy and Nicholas Pavlidis

2. “XGBoost Improves Classification of MGMT Promoter Methylation Status in IDH1 Wildtype Glioblastoma
by Nguyen Quoc Khanh Le, Duyen Thi Do, Fang-Ying Chiu, Edward Kien Yee Yapp, Hui-Yuan Yeh and Cheng-Yu Chen

3. “Applications of Machine Learning Predictive Models in the Chronic Disease Diagnosis
by Gopi Battineni, Getu Gamo Sagaro, Nalini Chinatalapudi and Francesco Amenta

4. “Molecular and Cellular Mechanisms Affected in ALS
by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya Geetha Vijayakumar, William J. Duddy and Stephanie Duguez

5. “A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine Administration
by Vincenzo D’Agostino, Ferdinando Caranci, Alberto Negro, Valeria Piscitelli, Bernardino Tuccillo, Fabrizio Fasano, Giovanni Sirabella, Ines Marano, Vincenza Granata, Roberta Grassi, Davide Pupo and Roberto Grassi

6. “Gallstone Disease, Obesity and the Firmicutes/Bacteroidetes Ratio as a Possible Biomarker of Gut Dysbiosis
by Irina N. Grigor’eva

7. “A Research on the Classification and Applicability of the Mobile Health Applications
by Ivan Miguel Pires, Gonçalo Marques, Nuno M. Garcia, Francisco Flórez-Revuelta, Vasco Ponciano and Salome Oniani

8. “The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery—Personal Remarks and Future Prospects
by Hiroshi Maeda

9. “Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network
by Georgia L. Wiesner, Alanna Kulchak Rahm, Paul Appelbaum, Sharon Aufox, Sarah T. Bland, Carrie L. Blout, Kurt D. Christensen, Wendy K. Chung, Ellen Wright Clayton, Robert C. Green, Margaret H. Harr, Nora Henrikson, Christin Hoell, Ingrid A. Holm, Gail P. Jarvik, Iftikhar J. Kullo, Philip E. Lammers, Eric B. Larson, Noralane M. Lindor, Maddalena Marasa, Melanie F. Myers, Josh F. Peterson, Cynthia A. Prows, James D. Ralston, Hila Milo Rasouly, Richard R. Sharp, Maureen E. Smith, Sara L. Van Driest, Janet L. Williams, Marc S. Williams, Julia Wynn and Kathleen A. Leppig

10. “Biomarkers for Alzheimer’s Disease Early Diagnosis
by Eva Ausó, Violeta Gómez-Vicente and Gema Esquiva

Further details about the Top 10 Cited Papers can be found at the following link:
https://www.mdpi.com/journal/jpm/stats.

JPM Editorial Office

15 December 2021
Welcoming New Editorial Board Members of Journal of Personalized Medicine

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine (ISSN: 2075-4426):

Name: Prof. Dr. Ping-Ho Chen
Affiliation: School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, No. 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan

Name: Dr. Waqar Rashid
Affiliation: Medical School, University of Sussex, Brighton, UK

Name: Prof. Dr. Richard Rokyta
Affiliation: Department of Cardiology, University Hospital and Faculty of Medicine in Pilsen, Charles University,  304 60 Pilsen, Czech Republic

Name: Prof. Dr. Marco Aiello
Affiliation: Institute for Architecture of Application Systems Service Computing

Name: Prof. Dr. Xiaomei Cong
Affiliation: School of Nursing, University of Connecticut, Storrs, CT, USA

Name: Prof. Dr. Hong-Sheng Wang
Affiliation: College of Medicine, University of Cincinnati, Cincinnati, OH, USA

Name: Dr. Sigve Nakken
Affiliation: Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

Name: Prof. Dr. Jochen Schneider
Affiliation: Department of Medical Translational Research, University of Luxembourg, Esch-sur-Alzette, Luxembourg

Name: Prof. Dr. Paraskevi Katsaounou
Affiliations: 1. Pulmonary Dept of First ICU Clinic, Evangelismos Hospital, 10676 Athens, Greece
2. School of Medicine, National and Kapodistrian University of Athens, 10561 Athens, Greece

Name: Dr. Ivo Bokoski
Affiliation: Digestive Endoscopy Unit, Fondazione Policlinico Universitario agostino Gemelli IRCCS, Largo A. Gemelli, 00168 Roma, Italy

Name: Prof. Dr. Carmen Burtea
Affiliation: Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, Faculty of Medicine and Pharmacy, University of Mons, Avenue Maistriau 19, Mendeleev Building, B-7000 Mons, Belgium

Name: Dr. Domenico Di Raimondo
Affiliation: Division of Internal Medicine and Stroke Care, Department of Promoting Health, Maternal-Infant, Excellence and Internal and Specialized Medicine (Promise) G. D'Alessandro, University of Palermo, Palermo, Italy

Name: Dr. Norio Yamamoto
Affiliations: 1. Department of Orthopedic Surgery, Miyamoto Orthopedic Hospital, Okayama, Japan
2. Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Name: Dr. Lea Bentur
Affiliation: Pediatric Pulmonary Institute, Ruth Children Hospital, Rambam Health Care Center, Haifa, Israel

We wish them every success both in their research and in the development of the journal.

Further details about the Editorial Board can be found at: https://www.mdpi.com/journal/jpm/editors

JPM Editorial Office

10 December 2021
Welcoming New Section Editors-in-Chief of Journal of Personalized Medicine

We are pleased to announce that Prof. Dr. Kenneth P.H. Pritzker has been appointed Section Editor-in-Chief of “Clinical Medicine, Cell, and Organism Physiology”, Prof. Dr. K. Ray Chaudhuri has been appointed Section Editor-in-Chief of “Methodology, Drug and Device Discovery”, and Prof. Dr. Enrico Mini has been appointed Section Editor-in-Chief of “Pharmacogenetics” in the Journal of Personalized Medicine (JPM; ISSN 2075-4426). We look forward to their contribution to the continued success of the journal.

Name: Prof. Dr. Kenneth P.H. Pritzker
Affiliation: Professor Emeritus, Department of Laboratory Medicine and Pathobiology, Department of Surgery, University of Toronto, 6 Queens Pk Crescent W, F, Toronto, ON M5S 3H2, Canada
Interests: biomineralization: normal and pathological; pathogenesis of degenerative joint diseases, osteoarthritis; pathogenesis of crystal deposits in tissues; connective tissues as biomaterials; novel biomaterials; biomedical applications of fullerenes; connective tissue neoplasia; ribosomal RNA and its pathology; neoplasia risk assessment using novel biomarkers and histo-/cytomorphometry; ultrasound enabled histologic and cytologic technologies; novel biomarkers for spondylitis and other chronic inflammatory diseases; abiotic stress



Name
: Prof. Dr. K. Ray Chaudhuri
Affiliation: Department of Basic and Clinical Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, King's College London, Cutcombe Road, London SE5 9RT, UK
Interests: Parkinson's disease; movement disorders

 

 

 

Name: Prof. Dr. Enrico Mini
Affiliation: Department of Health Sciences, Universita degli Studi di Firenze, Florence, Italy
Interests: gastrointestinal cancers; tumor drug resistance; biomarkers; pharmacogenetics; pharmacogenomics; translational studies

 



JPM
Editorial Office

8 December 2021
Journal of Personalized Medicine | Introducing Editor's Choice Articles


On behalf of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426), we would like to introduce a new feature, "Editor's choice articles", to highlight outstanding papers published in the journal. The Editor’s choice articles will be selected by the editors, and will include original articles that contain important and impactful findings, as well as review articles that are excellently written. With the introduction of this feature, readers can expect timely and useful highlights of recent articles in the journal, and deserving authors will receive more attention for their excellent contributions. We hope that this feature will enhance your reading pleasure and experience with JPM.

JPM Editorial Office

1 December 2021
JPM Editorial Board Members Receive "2021 Highly Cited Researchers" Distinction

It is our great honor to congratulate the Editorial Board Members of JPM (ISSN: 2075-4426) who have been distinguished as Highly Cited Researchers in 2021 by Clarivate, according to the Web of Science data. We would like to express our gratitude for the immense impact the named researchers continue to have on scientific progress and our journal’s development.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists in the past decade. The impactful papers of these researchers are among the top 1% in the citation distribution of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.



Name: Prof. Dr. Adam J. Guastella

Affiliation: Brain and Mind Centre, The University of Sydney, Camperdown, NSW 2050, Australia

 

 


Name: Prof. Dr. Matthias Schwab

Affiliation: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and Department of Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology and Interfaculty Center for Pharmacogenomics and Drug Research (ICEPHA), University Hospital, Tuebingen Auerbachstrasse 112, 70376 Stuttgart, Germany

 


Name: Dr. Stuart A. Scott

Affiliation: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

 



The full list of Highly Cited Researchers for 2021 can be accessed at the following webpage in the Web of Science: https://recognition.webofscience.com/awards/highly-cited/2021/.

We would like to extend our sincerest congratulations to these individuals. In addition, we would like to acknowledge the professional support and valuable publications from all of our academic editors. 

JPM Editorial Office

22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction

It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.

Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.

Abate, Antonio
Abatzoglou, John T.
Abbaszadeh, Mostafa
Acharya, U. Rajendra
Acharya, Viral V.
Agarwal, Ravi P.
Ahn, Myung-Ju
Airoldi, Laura
Ali, Imran
Allakhverdiev, Suleyman I.
Aluko, Rotimi E.
Anasori, Babak
Andersson, Dan I.
Andes, David
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Arqub, Omar Abu
Aschner, Michael
Assaraf, Yehuda G.
Astruc, Didier
Atala, Anthony
Atanasov, Atanas G.
Atangana, Abdon
Bahram, Mohammad
Bakris, George L.
Balandin, Alexander A.
Baleanu, Dumitru
Balsamo, Gianpaolo
Bando, Yoshio
Banks, William A.
Bansal-Travers, Maansi
Barba, Francisco J.
Barros, Lillian
Basit, Abdul W.
Baskonus, Haci Mehmet
Bassetti, Matteo
Battino, Maurizio
Bell, Jordana T.
Bellomo, Nicola
Benediktsson, Jon Atli
Benelli, Giovanni
Benjakul, Soottawat
Bhatnagar, Amit
Biddle, Stuart J. H.
Biondi, Antonio
Biondi-Zoccai, Giuseppe
Bjarnsholt, Thomas
Blaabjerg, Frede
Blaschke, Thomas
Blay, Jean-Yves
Blumwald, Eduardo
Blunt, John W.
Boffetta, Paolo
Bogers, Marcel
Bonomo, Robert A.
Bowman, David M.J.S.
Boyer, Cyrille
Brestic, Marian
Brevik, Eric C.
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cai, Xingjuan
Cai, Jianchao
Calhoun, Vince D.
Calin, George
Cao, Jinde
Cao, Guozhong
Carvalho, Andre F.
Castellanos-Gomez, Andres
Cerqueira, Miguel Ângelo Parente Ribeiro
Chang, Jo-Shu
Chang, Chih-Hao
Chastin, Sebastien
Chau, Kwok-wing
Chemat, Farid
Chen, Xiaobo
Chen, YangQuan
Chen, Jianmin
Chen, Chaoji
Chen, Min
Chen, Qi
Chen, Jun
Chen, Xi
Chen, Peng
Chen, Yulin
Chen, Bo
Chen, Chen
Chen, Zhi-Gang
Chen, Wei-Hsin
Chen, Gang
Chen, Yongsheng
Chen, Xiang
Chen, Yimin
Chen, Runsheng
Chen, Lidong
Chen, Shaowei
Chen, Qian
Chen, Yu
Chen, Shuangming
Chiclana, Francisco
Cho, Sun Young
Choi, Wonyong
Chowdhary, Anuradha
Choyke, Peter L.
Cichocki, Andrzej
Corella, Dolores
Corma, Avelino
Cortes, Javier
Cortes, Jorge
Costanza, Robert
Crommie, Michael F.
Cui, Yi
Cui, Haiying
Cui, Qinghua
Cummings, Kenneth Michael
Dai, Shifeng
Dai, Sheng
Daiber, Andreas
Davis, Steven J.
Dawson, Ted M.
de la Fuente-Nunez, Cesar
Decker, Eric Andrew
Dekel, Avishai
Demaria, Marco
Deng, Yong
Deng, Xiangzheng
DePinho, Ronald A.
Desneux, Nicolas
Dimopoulos, Meletios-Athanasios
Ding, Aijun
Dionysiou, Dionysios D.
Dokmeci, Mehmet Remzi
Dolgui, Alexandre
Dong, Fan
Dou, Shi Xue
Dou, Letian
Du, Qian
Du, Bo
Dube, Shanta Rishi
Dufresne, Alain
Dummer, Reinhard
Dupont, Didier
Edwards, David
Elaissari, Abdelhamid
Elhoseny, Mohamed
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estévez, Mario
Fabbro, Doriano
Facchetti, Antonio
Fan, Zhanxi
Fang, Chuanglin
Fasano, Alessio
Fečkan, Michal
Felser, Claudia
Feng, Liangzhu
Fensholt, Rasmus
Ferdinandy, Péter
Fernandez-Lafuente, Roberto
Ferreira, Isabel C. F. R.
Filippi, Massimo
Fisher, Helen
Fortino, Giancarlo
Fosso Wamba, Samuel
Franceschi, Claudio
Fujita, Hamido
Fujita, Masayuki
Gai, Francesco
Gaisford, Simon
Galanakis, Charis M.
Galluzzi, Lorenzo
Galvano, Fabio
Gan, Ren-You
Gan, Lihua
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Minrui
Gao, Huijun
Gao, Wei
Gao, Huile
Garbe, Claus
Garcia, Hermenegildo
Gasbarrini, Antonio
Gasco, Laura
Gautret, Philippe
Geng, Yong
Gerdts, Gunnar
Geschwind, Daniel H.
Ghadimi, Noradin
Ghaffari, Roozbeh
Ghamisi, Pedram
Giampieri, Francesca
Glick, Bernard R.
Gnant, Michael
Goel, Ajay
Gogotsi, Yury
Goldewijk, Kees Klein
Gong, Jinlong
Gong, Yongji
Govindan, Kannan
Granato, Daniel
Grancini, Giulia
Green, Douglas R.
Grosso, Giuseppe
Gu, Ke
Guan, Cao
Guastella, Adam J.
Guerrero, Josep M.
Gui, Guan
Guizani, Mohsen
Guo, Zaiping
Gupta, Rangan
Gutzmer, Ralf
Haase, Dagmar
Habibi-Yangjeh, Aziz
Hagemann, Stefan
Hagger, Martin
Hamblin, Michael R.
Hammoudeh, Shawkat
Han, Heesup
Hanes, Justin
Harrison, Roy M.
Hartung, Hans-Peter
Hasanuzzaman, Mirza
He, Jr-Hau
He, Hongwen
He, Jiaqing
He, Debiao
Henseler, Jörg
Herrera, Francisco
Herrera-Viedma, Enrique
Hetz, Claudio
Ho Kim, Jung
Holmes, Elaine
Hossain, Ekram
Hsueh, Po-Ren
Hu, Xiaosong
Hu, Wenbin
Huang, Jianping
Huang, Hongwei
Huang, Yu
Huang, Jianying
Huang, Peng
Huang, Baibiao
Huang, Shaoming
Hubacek, Klaus

Iqbal, Hafiz M. N.
Ismail, Ahmad Fauzi
Izzo, Angelo A.
Jacobson, Kenneth A.
Jain, Atul
Jankovic, Joseph
Jelezko, Fedor
Ji, Xiaobo
Ji, Guangbin
Jiang, Hai-Long
Jiang, Lei
Jiang, Junjun
Jiang, Qing
Jiang, Shibo
Jin, Shi
Jones, Peter A.
Kalantar-zadeh, Kourosh
Kaner, Richard B.
Kannan, Kurunthachalam
Kappos, Ludwig
Karagiannidis, George K.
Karimi, Hamid Reza
Karimi-Maleh, Hassan
Karp, Peter D.
Kataoka, Kazunori
Katritch, Vsevolod
Kawi, Sibudjing
Keesstra, Saskia
Kepp, Oliver
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kiessling, Fabian
Kim, Ki-Hyun
Kim, Haegyeom
Kim, Jeonghun
Kim, Jong Seung
Kirkwood, John M.
Kisi, Ozgur
Kivshar, Yuri
Klenk, Hans-Peter
Ko, Wen-Chien
Konopleva, Marina Y.
Kontoyiannis, Dimitrios P.
Koonin, Eugene V.
Kou, Gang
Krausmann, Fridolin
Krebs, Frederik C.
Kroemer, Guido
Kuca, Kamil
Kudo, Masatoshi
Kuhn, Jens H.
Kumar, Devendra
Kumar, Alan Prem
Kumar, Sudhir
Kumar Sangaiah, Arun
Kurths, Juergen
Kuznetsov, Nikolay V.
Kuzyakov, Yakov
Kwan, Mei-Po
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lammers, Twan
Lamuela-Raventos, Rosa M.
Lancellotti, Patrizio
Landi, Francesco
Laurent, Sophie
Lavie, Carl J.
Laxminarayan, Ramanan
Lee, Sang Soo
Lee, Jin-Wook
Lee, Pooi See
Lehmann, Johannes
Lei, Yaguo
Lei, Ting
Leng, Lijian
Leung, Dennis Y. C.
Leung, Victor C. M.
Levine, Ross
Li, Wei
Li, Jie
Li, Jinghong
Li, Jun
Li, Heng
Li, Gang
Li, Yat
Li, Peng
Li, Hailong
Li, Changpin
Li, Yan
Li, Yurui
Li, Xiaodi
Li, Hong
Li, Shutao
Li, Hongyi
Li, Zhijun
Li, Peiyue
Lin, Yuehe
Lin, Hongjun
Lin, Lin
Lip, Gregory Y. H.
Liu, Jian
Liu, Meng
Liu, Hong
Liu, Tao
Liu, Lei
Liu, Jianxing
Liu, Wei
Liu, Gang
Liu, Yang
Liu, Peide
Lockhart, Shawn R.
Long, Hualou
Löscher, Wolfgang
Lu, Jun
Lu, Jianquan
Lu, Nanshu
Lucey, Brian
Lund, Henrik
Luo, Jun
Luo, Yi
Luo, Jingshan
Luo, Yangchao
Lupton, Deborah
Luque, Rafael
Lv, Wei
Lvov, Yuri M.
Lyons, Timothy W.
Ma, Tianyi
Ma, Jun
Ma, Jiayi
Ma, Wen-Xiu
Ma, Yanming
Maggioni, Aldo Pietro
Mahmood, Nasir
Mahmoudi, Morteza
Mai, Liqiang
Mallavarapu, Megharaj
Mandala, Mario
Mardani, Abbas
Marengo, Jose
Maria Rossolini, Gian
Martinoia, Enrico
Mathiesen, Brian Vad
Mathivanan, Suresh
Mattick, John S.
Matyjaszewski, Krzysztof
McCabe, Matthew E.
McCauley, Darren
McClements, David Julian
Melcher, Karsten
Melenhorst, Jan Joseph
Melero, Ignacio
Mezzetti, Bruno
Mirjalili, Seyedali
Mishchenko, Artem
Mittler, Ron
Moreau, Philippe
Motohashi, Hozumi
Mousavi Khaneghah, Amin
Mu, Shichun
Mueller, Lukas A.
Mueller-Roeber, Bernd
Muenzel, Thomas
Muhammad, Khan
Munger, J. William
Nauen, Ralf
Naushad, Mu.
Negri, Eva
Nemeroff, Charles B.
Newman, David J.
Niaura, Raymond S.
Nie, Feiping
Nieto, Juan J.
Novara, Agata
Nunkoo, Robin
Ogino, Shuji
Olabi, Abdul-Ghani
Ong, Hwai Chyuan
O'Regan, Donal
Orsini, Nicola
Ouyang, Minggao
Ozcan, Aydogan
Pacher, Pal
Pan, Xiaoqing
Pan, Likun
Pan, Quan-Ke
Pang, Huan
Pavela, Roman
Pedrycz, Witold
Pei, Yanzhong
Peng, Shushi
Peng, Qing
Peng, Mugen
Perc, Matjaz
Perez-Alvarez, Jose Angel
Perlin, David S.
Piquero, Alex R.
Polasky, Stephen
Pommier, Yves
Poor, H. Vincent
Postolache, Mihai
Potenza, Marc N.
Poulter, Benjamin
Preat, Veronique
Prinsep, Michele R.
Pu, Hong-Bin
Putnik, Predrag
Qiu, Jieshan
Qu, Xiaogang
Quiles, José L.
Rabczuk, Timon
Ramakrishna, Seeram
Ramkissoon, Haywantee
Ran, Jingrun
Recio, Isidra
Reiter, Russel J.
Remuzzi, Giuseppe
Ren, Jinsong
Ren, Jun
Riahi, Keywan
Richardson, Paul G.
Rignot, Eric
Rimm, David
Rinn, John L.
Robert, Caroline
Rodriguez, Rosa M.
Rojo, Teofilo
Ros, Emilio
Rosen, Marc A.
Roubaud, David
Russo, Alessandro
Russo, Gian Luigi

Saad, Fred
Saad, Walid
Sadorsky, Perry
Sander, Chris
Santamouris, Mattheos
Santoro, Gabriele
Saraiva, Jorge A.
Sarchiapone, Marco
Scalbert, Augustin
Schloter, Michael
Schneider, Gisbert
Schubert, Ulrich S.
Schulz, Rainer
Schwab, Matthias
Schweizer, Frank
Scolyer, Richard A.
Scorrano, Luca
Scott, David
Scott, Stuart A.
Scott, Daniel
Serra-Majem, Lluis
Sethi, Gautam
Shabala, Sergey
Shaheen, Sabry M.
Shao, Zongping
Sharma, Gaurav
Shen, Guozhen
Shen, Hao
Sheremet, Mikhail A.
Shi, Peng
Shi, Yumeng
Shoenfeld, Yehuda
Siano, Pierluigi
Sillanpaa, Mika
Simões, Manuel
Simpson, Richard J.
Singh, Bhupinder Pal
Singh, Vijay P.
Smagghe, Guy
Song, Yu
Song, Houbing
Sood, Anil K.
Srivastava, Hari M.
Stadler, Marc
Stadler, Peter F.
Stanley, H. Eugene
Stoumpos, Constantinos C.
Strano, Michael S.
Stunnenberg, Hendrik G.
Su, [email protected]
Su, Chun-Yi
Subramanian, S. V.
Sun, Zhipei
Sun, Fengchun
Sun, Hongqi
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Szabo, Csaba
Szallasi, Arpad
Szolnoki, Attila
Tacke, Frank
Tan, Weihong
Tan, Chaoliang
Tang, Hua
Tang, Chuyang
Tang, Chuan-He
Tanzi, Rudolph E.
Teichmann, Sarah
Telenti, Amalio
Thakur, Vijay Kumar
Thiele, Holger
Tian, Jie
Tohge, Takayuki
Tran, Lam-Son Phan
Truhlar, Donald G.
Tsao, Rong
Tsuda, Kenichi
Tukker, Arnold
Tung, Chen-Ho
Turskis, Zenonas
Urquhart, Andrew
Valko, Marian
Van Breusegem, Frank
Van de Wiele, Tom
van der Werf, Guido
van Wesemael, Bas
Vangronsveld, Jaco
Varma, Rajender S.
Varsani, Arvind
Varshney, Rajeev K.
Vasilakis, Nikos
Vasilakos, Athanasios V.
Vasquez, Juan C.
Vatanen, Tommi
Ventura, Marco
Vermote, Eric
Veronese, Nicola
Verpoorte, Robert
Vethaak, A. Dick
Vieta, Eduard
Vincent, Jean-Louis
Wagner, Wolfgang
Walton, Vaughn M.
Wan, Jiafu
Wan, Shaohua
Wang, Qi
Wang, Joseph
Wang, Meng
Wang, Tao
Wang, Yuan
Wang, Xin
Wang, Chao
Wang, Yong
Wang, Jun
Wang, Erkang
Wang, Sibo
Wang, Jian
Wang, Ning
Wang, John
Wang, Qin
Wang, Shaojian
Wang, Guoxiu
Wang, Huanting
Wang, Chunsheng
Wang, Gongming
Wang, Zhong Lin
Wang, Lianzhou
Wang, Shaobin
Wang, Yang
Wang, Zifa
Wei, Zhixiang
Wei, Leyi
Weissleder, Ralph
Wen, Guanghui
Wiens, John J.
Wigneron, Jean-Pierre
Willerslev, Eske
Wishart, David S.
Witlox, Frank
Wu, Jun
Wu, Tom
Wu, Hao Bin
Wu, Hui
Wu, Haijun
Wu, Zhongbiao
Wu, Zhong-Shuai
Wu, Zheng-Guang
Xia, Meimei
Xia, Xinhui
Xiang, Quanjun
Xiao, Jianbo
Xiao, Jie
Xie, Jian-Hua
Xin, Sen
Xing, Baoshan
Xiong, Rui
Xu, Bin
Xu, Li Da
Xu, Yi-Jun
Xu, Hui
Xu, Zeshui
Yamauchi, Yusuke
Yan, Huaicheng
Yan, Kai
Yang, Chenguang
Yang, Xiao-Jun
Yang, Bing
Yang, Yun-Gui
Yang, Jie
Yang, Jian
Yang, Xinsong
Yang, Shihe
Yang, Yi
Yang, Yang
Yao, Jen-Chih
Yao, Yonggang
Yazyev, Oleg
Yin, Yulong
Yin, Zongyou
Yin, Shen
Yin, Ya-xia
Yin, Shou-Wei
Ying, Guang-Guo
Young, Allan H.
Yu, Shu-Hong
Yu, Jun
Yu, Guihua
Yu, Wenwu
Yu, Guocan
Yu, Minghao
Zarco-Tejada, Pablo J.
Zavadskas, Edmundas Kazimieras
Zeadally, Sherali
Zhai, Tianyou
Zhang, Wei
Zhang, Binlin
Zhang, Shujun
Zhang, Guoping
Zhang, Zengqiang
Zhang, Yu Shrike
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Guowen
Zhang, Min
Zhang, Yue-Jun
Zhang, Shaoqing
Zhang, Fan
Zhang, Weili
Zhang, Xiaodong
Zhang, Zhien
Zhang, Tierui
Zhang, Hongjie
Zhang, Dengsong
Zhang, Liangpei
Zhang, Dan
Zhang, Yu-Dong
Zhang, Fusuo
Zhao, Yi
Zhao, Guochun
Zhao, Li-Dong
Zheng, Hao
Zheng, Gengfeng
Zhong, Cheng
Zhou, Weiqi
Zhou, Qi
Zhou, Jizhong
Zhu, Hongwei
Zhu, Chengzhou
Zhu, Junfa
Zhu, Zhe
Zhu, Quanxin
Zhuang, Xiaodong
Zhuang, Xiaoying
Zou, Quan

The full list of 2021 Highly Cited Researchers  can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.

--- Highly Cited Researchers (HCR) is a Clarivate product.

16 November 2021
Topical Advisory Panel Established to Support Editorial Board

Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.

The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.

Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.

To qualify as a Topical Advisory Panel Member, applicants must:

  • Have expertise and experience in the field related to the journal;
  • Have received a Ph.D. in the last 10 years, approximately;
  • Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
  • Currently hold an independent research position in academia or a government institute.

If you are interested in this role, please contact the editorial office by email.

We look forward to hearing from you soon.

25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October

Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.

The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.

For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.

International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.

Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.

Read our anniversary blog post: "Sharing 'Collective Human Knowledge': The Benefits of Open Access Publication"

Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.

The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.

Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.

We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.

  • 25 October 2021
    Energies journal and Institute of Mechanics, Chinese Academy of Sciences
  • 28 October 2021
    Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
  • 29 October 2021
    Processes journal and Beijing Institute of Technology
  • 29 October 2021
    Coatings journal and Wuhan University of Technology

MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.

23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced


Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:

  • Adriana Burlea-Schiopoiu;
  • Alban Kuriqi;
  • Álvaro González-Vila;
  • Alessandro Alaimo;
  • Alexey Beskopylny;
  • Alexander Yu Churyumov;
  • Alberto Fernández-Isabel;
  • Andrea Mastinu;
  • Antonios N. Papadopoulos;
  • Anton Rassõlkin;
  • Antonio Humberto Hamad Minervino;
  • Arkadiusz Matwijczuk;
  • Artur Słomka;
  • Baojie He;
  • Bartłomiej Potaniec;
  • Bojan Đurin;
  • Camilo Arturo Rodriguez Diaz;
  • Carmelo Maria Musarella;
  • Chiachung Chen;
  • Chiman Kwan;
  • Cristian Busu;
  • Danil Pimenov;
  • Dan-Cristian Dabija;
  • Delfín Ortega-Sánchez;
  • Demetrio Antonio Zema;
  • Denis Butusov;
  • Elena Lucchi;
  • Gaurab Dutta;
  • Livia Anastasiu;
  • M. R. Safaei.

For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.

22 September 2021
MDPI Joins SDG Publishers Compact

UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.

MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.

Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.

The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.

For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
[email protected]

17 September 2021
Journal of Personalized Medicine | Compiled Book from Harvard Medical School Authors

We are happy to announce that we have compiled the Harvard papers we published between 2019 and 2020 into a book , since authors from Harvard Medical School published the greatest number of papers in JPM (ISSN: 2075-4426), and because these papers brought numerous good references to the attention of our readers. We invite you to read this book and encourage you to share it with your colleagues.

The book is available at
https://drive.google.com/file/d/1cW9NzC_QmAM7TcQKGovkZpWiO8UlsGny/view?usp=sharing.

15 September 2021
Welcoming New Editorial Board Members of Journal of Personalized Medicine

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine:

Prof. Dr. Tsuyoshi Sugiura Dr. Edward J. Modestino
Dr. Kuan-Hao Tsui Dr. Christophe Badie
Dr. Weiliang Qiu Dr. Afsane Riazi
Prof. Dr. Maximilian Rudert Dr. Rajendra D Badgaiyan
Prof. Dr. Lu Qi Prof. Dr. Igor Elman
Prof. Dr. Jules Alexandre Desmeules Dr. Gustavo Glusman
Dr. Eric R. Braverman Prof. Dr. Shang-Ming Zhou
Dr. Emilio González-Jiménez Prof. Dr. Robert Passier
Prof. Dr. Piotr Galecki Dr. Miguel Angel Ortega
Dr. Florence T. Bourgeois Prof. Dr. Jung-Wook Kim
Prof. Dr. Panayotis Thanos Prof. Dr. Andreas Schmutzler

3 August 2021
Announcement on Japanese Consumption Tax (JCT)

This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.

For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").

Contact: Setsuko Nishihara, MDPI Tokyo

9 July 2021
Prof. Dr. David Alan Rizzieri Appointed Editor-in-Chief of Journal of Personalized Medicine

We are pleased to announce that Prof. Dr. David Alan Rizzieri has been appointed Editor-in-Chief of Journal of Personalized Medicine (ISSN 2075-4426).

Prof. Dr. Rizzieri, MD, is a medical oncologist at the Duck Cancer Institute in Durham, NC, USA, and has over 30 years of experience in the medical field. He graduated from the University of Rochester School of Medicine in 1991. He is affiliated with Duke University Hospital.

He has been a member of the Combined International Bone Marrow Transplant Registry Lymphoma Writing Committee and is a member of the ALLIANCE (formerly CALGB) Leukemia Core Committee. He has served as chair or co-chair of multiple ALLIANCE lymphoma/ leukemia trials. He has led a team’s novel approaches for the care of patients using non-myeloablative allogeneic therapy to optimize a less toxic regimen for the transplant of patients with hematologic malignancies using haplo-identical, as well as matched donors. Furthermore, he has served on various NIH/NHLBI grant review committees and the ASH sub-committee on government affairs. He oversees the development and conduct of all clinical trials in adults with hematologic malignancies conducted in the Duke Cancer Institute. In recognition of his leadership and success in clinical research efforts, he was fortunate to receive the NIH “Clinical Investigator Team Leadership Award” in 2010 and was awarded the “Wendell Rosse Teaching Award” by the fellows in 2009.

He has published 457 peer-reviewed scientific papers with more than 10,000 citations. His research interests focus on the care of patients with hematologic malignancies, both with and without the use of bone marrow or stem cell transplantation. He focuses his research efforts on new approaches to manipulate minimal residual disease.

He will work closely with over 200 editorial board members from across the globe.

We warmly welcome Prof. Dr. David Alan Rizzieri in his role as Editor-in-Chief, and we look forward to him leading JPM to achieve more milestones.

30 June 2021
2020 Impact Factors - Released

The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!

We are pleased to announce that 85 MDPI journals are included, of which:

  • 10 journals received their first impact factor
  • 96% of journals increased their impact factor from 2019
  • 32 journals (38%) ranked among the top 25% of journals, in at least one category
Journal Impact Factor Rank Category
Cancers 6.639 Q1 • Oncology
Cells 6.600 Q2 • Cell Biology
Pharmaceutics 6.321 Q1 • Pharmacology & Pharmacy
Antioxidants 6.313 Q1 • Food Science & Technology 
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Biomedicines 6.081 Q1 • Medicine, Research & Experimental
• Pharmacology & Pharmacy 
• Biochemistry & Molecular Biology
International Journal of Molecular Sciences 5.924 Q1 • Biochemistry & Molecular Biology
Q2 • Chemistry, Multidisciplinary
Pharmaceuticals 5.863 Q1 • Pharmacology & Pharmacy
• Chemistry, Medicinal
Journal of Fungi 5.816 Q1 • Mycology
• Microbiology
Nutrients 5.719 Q1 • Nutrition & Dietetics
Biosensors 5.519 Q1 • Chemistry, Analytical
• Instruments & Instrumentation
Q2 • Nanoscience & Nanotechnology
Marine Drugs 5.118 Q1 • Chemistry, Medicinal
• Pharmacology & Pharmacy
Biology 5.079 Q1 • Biology
Nanomaterials 5.076 Q1 • Physics, Applied
Q2 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary 
• Nanoscience & Nanotechnology
Viruses 5.048 Q2 • Virology
Journal of Personalized Medicine 4.945 Q1 • Medicine, General & Internal
• Health Care Sciences & Services
Metabolites 4.932 Q2 • Biochemistry & Molecular Biology
Biomolecules 4.879 Q2 • Biochemistry & Molecular Biology
Remote Sensing 4.848 Q1 • Geosciences, Multidisciplinary
Q2 • Remote Sensing
• Imaging Science & Photographic Technology 
• Environmental Sciences
Gels * 4.702 Q1 • Polymer Science
Antibiotics 4.639 Q2 • Infectious Diseases
• Pharmacology & Pharmacy
Toxins 4.546 Q1 • Toxicology
• Food Science & Technology
Vaccines 4.422 Q2 • Immunology
• Medicine, Research & Experimental
Molecules 4.412 Q2 • Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Foods 4.350 Q2 • Food Science & Technology
Polymers 4.329 Q1 • Polymer Science
Journal of Clinical Medicine 4.242 Q1 • Medicine, General & Internal
Toxics 4.146 Q2 • Toxicology
• Environmental Sciences
Catalysts 4.146 Q2 • Chemistry, Physical
Microorganisms 4.128 Q2 • Microbiology
Membranes 4.106 Q1 • Polymer Science
Q2 • Engineering, Chemical
• Materials Science, Multidisciplinary 
• Chemistry, Physical
Genes 4.096 Q2 • Genetics & Heredity
Fermentation * 3.975 Q2 • Biotechnology & Applied Microbiology
Journal of Cardiovascular Development and Disease * 3.948 Q2 • Cardiac & Cardiovascular Systems
Plants 3.935 Q1 • Plant Sciences
Life 3.817 Q2 • Biology
Diagnostics 3.706 Q2 • Medicine, General & Internal
Current Oncology 3.677 Q3 • Oncology
Materials 3.623 Q1 • Metallurgy & Metallurgical Engineering
Q2 • Materials Science, Multidisciplinary
• Chemistry, Physical 
• Physics, Applied 
• Physics, Condensed Matter
Sensors 3.576 Q1 • Instruments & Instrumentation
Q2 • Chemistry, Analytical
• Engineering, Electrical & Electronic
Pathogens 3.492 Q2 • Microbiology
Agronomy 3.417 Q1 • Agronomy
• Plant Sciences
Chemosensors 3.398 Q2 • Instruments & Instrumentation
• Chemistry, Analytical
Q3 • Electrochemistry
Land 3.398 Q2 • Environmental Studies
Brain Sciences 3.394 Q3 • Neurosciences
International Journal of Environmental Research and Public Health 3.390 Q1 • Public, Environmental & Occupational Health (SSCI)
Q2 • Public, Environmental & Occupational Health (SCIE)
• Environmental Sciences (SCIE)
Tomography 3.358 Q2 • Radiology, Nuclear Medicine & Medical Imaging
Fractal and Fractional * 3.313 Q1 • Mathematics, Interdisciplinary Applications
Sustainability 3.251 Q2 • Environmental Sciences (SCIE)
• Environmental Studies (SSCI)
Q3 • Green & Sustainable Science & Technology (SCIE)
• Green & Sustainable Science & Technology (SSCI)
Water 3.103 Q2 • Water Resources
• Environmental Sciences
Journal of Theoretical and Applied Electronic Commerce Research 3.049 Q3 • Business
Energies 3.004 Q3 • Energy & Fuels
Agriculture 2.925 Q1 • Agronomy
ISPRS International Journal of Geo-Information 2.899 Q2 • Geography, Physical
• Computer Science, Information Systems
Q3 • Remote Sensing
Micromachines 2.891 Q2 • Instruments & Instrumentation
• Physics, Applied
Q3 • Chemistry, Analytical
• Nanoscience & Nanotechnology
Coatings 2.881 Q2 • Materials Science, Coatings & Films
• Physics, Applied
Q3 • Materials Science, Multidisciplinary
Children 2.863 Q2 • Pediatrics
Processes 2.847 Q3 • Engineering, Chemical
Separations 2.777 Q3 • Chemistry, Analytical
Insects 2.769 Q1 • Entomology
Animals 2.752 Q1 • Agriculture, Dairy & Animal Science
• Veterinary Sciences
Symmetry 2.713 Q2 • Multidisciplinary Sciences
Atmosphere 2.686 Q3 • Meteorology & Atmospheric Sciences
• Environmental Sciences
Applied Sciences 2.679 Q2 • Engineering, Multidisciplinary
• Physics, Applied
Q3 • Chemistry, Multidisciplinary
• Materials Science, Multidisciplinary
Photonics 2.676 Q2 • Optics
Buildings * 2.648 Q2 • Construction & Building Technology
• Engineering, Civil
Healthcare 2.645 Q2 • Health Policy & Services (SSCI)
Q3 • Health Care Sciences & Services (SCIE)
Minerals 2.644 Q2 • Mining & Mineral Processing
• Mineralogy
• Geochemistry & Geophysics
Forests 2.634 Q1 • Forestry
Crystals 2.589 Q2 • Crystallography
Q3 • Materials Science, Multidisciplinary
Entropy 2.524 Q2 • Physics, Multidisciplinary
Diversity 2.465 Q2 • Biodiversity Conservation
Q3 • Ecology
Journal of Marine Science and Engineering 2.458 Q2 • Oceanography
• Engineering, Marine 
• Engineering, Ocean
Medicina 2.430 Q2 • Medicine, General & Internal
Machines * 2.428 Q2 • Engineering, Mechanical
Q3 • Engineering, Electrical & Electronic
Electronics 2.397 Q3 • Engineering, Electrical & Electronic
• Computer Science, Information Systems 
• Physics, Applied
Fishes * 2.385 Q2 • Fisheries
• Marine & Freshwater Biology
Metals 2.351 Q2 • Metallurgy & Metallurgical Engineering
Q3 • Materials Science, Multidisciplinary
Horticulturae * 2.331 Q1 • Horticulture
Veterinary Sciences * 2.304 Q1 • Veterinary Sciences
Universe 2.278 Q3 • Physics, Particles & Fields
• Astronomy & Astrophysics
Mathematics 2.258 Q1 • Mathematics
Magnetochemistry 2.193 Q3 • Chemistry, Inorganic & Nuclear
• Chemistry, Physical 
• Materials Science, Multidisciplinary
Current Issues in Molecular Biology 2.081 Q4 • Biochemistry & Molecular Biology
Actuators 1.994 Q3 • Instruments & Instrumentation
• Engineering, Mechanical
Aerospace * 1.659 Q2 • Engineering, Aerospace

* Journals given their first Impact Factor in 2021

Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)

24 June 2021
Welcoming New Editorial Board Members of Journal of Personalized Medicine

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of Journal of Personalized Medicine:

Prof. Dr. Salvatore Scacco

Dr. Roberto Díaz Peña

Prof. Dr. Luigi Tritapepe

Prof. Dr. José Braganca

Prof. Dr. José Carmelo Adsuar Sala

Dr. Gianluca Ingrosso

Prof. Dr. Margaret DeAngelis

Dr. Matthew B. Lanktree

Dr. Jun Fang

Dr. Luigi Minafra

Prof. Dr. Chun-Jen Huang

Dr. Ruslan Dorfman

Dr. Raffaele Palmirotta

Dr. Carlo M. Petrini

Prof. Dr. Weikuan Gu

Dr. Sara M. Falzarano

Prof. Dr. Julia Bujan

Dr. Alessandro Gozzetti

Prof. Dr. H. Miles Prince

Prof. Dr. Johannes Mosbacher

Dr. Niels Bergsland

Prof. Dr. Wei Wang

Dr. Seungil Ro

Prof. Dr. Walter Kolch

Dr. Didier Ducloux

Dr. Laura B. Scheinfeldt

Prof. Dr. Marijn Speeckaert

Dr. Giorgio Malpeli

Prof. Dr. David Edvardsson

Prof. Dr. Peter Polverini

Prof. Dr. Giorgio Walter Canonica

Dr. Cristina L. Ronchi

Prof. Dr. Sabina Tangaro

Dr. Elizabeth Vafiadaki

Dr. Minna Stolt

Prof. Dr. Jochen Walter

Prof. Dr. Riitta Suhonen

Prof. Dr. Klaus Bønnelykke

Prof. Dr. Valentina Bessi

Prof. Stephen Opat

Dr. Farah R. Zahir

Dr. Christos Damaskos

Dr. Colleen A. Campbell

Prof. Roberta Granese

Prof. Dr. Tarec Christoffer El-Galaly

Dr. Amir Sherif

Prof. Dr. Roberto Grassi

Prof. Dr. Volker J. Schmidt

Prof. Chiara Bellia

Prof. Dr. Cynthia Aristei

Dr. Carla Minoia

 

28 April 2021
Book BuilderCompile a Customized E-Book from Your Favorite MDPI Open Access Content

MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.

Selections

In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.

This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.

 

We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.

Special Issue Reprints

The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool  to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.

For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.

In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.

 



Why choose MDPI Books?

In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.

If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.

Contact: Laura Wagner, MDPI Books Manager (email)

15 April 2021
MDPI Celebrates Company Milestone With 25th Anniversary Page
"We exist to help scientists achieve their own objectives"


In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.

MDPI has been a pioneer of Open Access publishing ever since the concept was first created.

In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.

Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.

Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.

MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.

19 March 2021
JPM | Welcoming New Editorial Board Members

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of JPM:

Dr. Yoshihiro Noda
Prof. Dr. Klaus Radermacher
Prof. Dr. Klaus Radermacher
Prof. Dr. Alessandra Pulliero
Dr. Nelson Yee
Prof. Dr. Margaret DeAngelis
Prof. Dr. Luca Testarelli
Prof. Dr. Toshiaki Onitsuka
Dr. Gesche Jürgens
Prof. Dr. Henrik Galbo
Prof. Dr. Moon-Soo Lee
Prof. Dr. Greg Gibson
Dr. William Duddy
Prof. Dr. Maged N. Kamel Boulos
Prof. Dr. Enrico Mini
Prof. Dr. José Agundez

Prof. Dr. Roger E. Thomas
Prof. Dr. Monique J. Roobol
Prof. Dr. Kenneth S. Ramos
Dr. Stephanie Duguez
Dr. Mayra Paolillo
Dr. Chiara Villa
Prof. Luigi Maria Larocca
Dr. Rika Maruyama
Prof. Dr. Gianluca Franceschini
Prof. Dr. Stefano Leporatti
Dr. Viviana Nociti
Prof. Luigi Maria Larocca
Dr. Stefania Nobili
Dr. Frank Vinholt Schiødt
Prof. Dr. Pim A. de Jong
Prof. Dr. Kenneth Blum

10 March 2021
Journal Selector: Helping to Find the Right MDPI Journal for Your Article


At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.

As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.

We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.

The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.

We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.

The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.

Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)

9 February 2021
The First International Electronic Conference on Clinical Medicine

We are pleased to announce that the first International Electronic Conference on Clinical Medicine (ECCM), chaired by Prof. Dr. Emmanuel Andrès, from the University Hospital of Strasbourg, France, and Prof. Dr. Michael G. Hennerici, from the University of Heidelberg, Germany, will be held on 15–30 September 2021 at Sciforum (https://sciforum.net/conference/ECCM).

The conference will cover all the multidisciplinary aspects of clinical medicine. The topics of interest include, but are not limited to, the following:

Cardiology

COVID-19

Gastroenterology and Hepatopancreatobiliary Medicine

Oncology

Infectious Diseases

Pulmonology

Hematology

Neurology and Stroke Neurology

Stomatology

Clinical Psychology

Psychiatry

Obstetrics and Gynecology

Endocrinology and Metabolism

Nephrology and Urology

Epidemiology and Public Health

Orthopedics

Dermatology

Ophthalmology

Otolaryngology

Nuclear Medicine and Radiology

Pharmacology

Anesthesiology

Emergency Medicine

The conference will be completely free of charge, both to attend and, for scholars, to upload and present their latest work on the conference platform. Accepted abstract submissions will be published in the proceedings of the conference, and authors are invited to develop their abstracts into full manuscripts, which will be considered for publication in JCM, with a 10% discount on the APC. JCM is an open access journal, published semimonthly by MDPI, in the field of clinical medicine. The journal is indexed in the Science Citation Index Expanded (SCIE IF = 3.303) and other databases. Full texts are archived in PubMed Central (PMC).

Important Dates

  • Abstract Submission: 31 May 2021
  • Acceptance Notification: 14 June 2021
  • Full Paper Submission: 12 July 2021
  • Conference Open: 15–30 September 2021

For more information on ECCM, please visit the conference website (https://sciforum.net/conference/ECCM) or contact us by email ([email protected]).

4 February 2021
JPM 2020 10th Anniversary Outstanding Reviewer Awards—Winners Announced

We are pleased to announce the winners of the JPM 2020 10th Anniversary Outstanding Reviewer Awards. The JPM Editorial Board and Editorial Team would like to express their gratitude for the time and energy dedicated by reviewers in checking the manuscripts submitted to JPM. It is due to their efforts that the high quality of the journal and quick turnaround have been maintained.

Each of them will receive a chance to publish one paper in JPM free of charge before 1 August 2021, 500 Swiss Francs, and a certificate to recognize their outstanding work. Please join us in congratulating the following winners:

Dr. Alain R. Thierry
Cancer Research Institute of Montpellier, INSERM, Montpellier, France
Research Interest: circulating DNA; clinical diagnostic and cancer; DNA auto-organization: synthetic biology, nanotechnology and gene therapy

Prof. Dr. Dirk Henrich
Department for Trauma, Hand and Reconstructive Surgery, Goethe University Frankfurt, Frankfurt, Germany
Research Interest: cell culture; gene expression; flow cytometry; primary cell culture; inflammation; resuscitation; sepsis; tissue engineering; diabetes; immunology; innate immunity; stem cell biology

Dr. Francesca Mancuso
Department of Experimental Medicine, University of Perugia, Perugia, Italy
Research Interest: diabetes; transplant immunology; microencapsulation; pancreatic islets

Dr. Jacob J. Michaelson
Department of Psychiatry, University of Iowa, Iowa City, IA, USA
Research Interest: gene expression; genomics; gene regulation; regulation of gene expression; mutation; computational biology; genome sequencing; gene expression and chromatin biology; methylation; computational genomics

For more information about JPM awards, please see the following link: https://www.mdpi.com/journal/jpm/awards

24 December 2020
JPM Has Become a Monthly Publication

We are pleased to announce that JPM became a monthly publication on 1 January, 2021. A monthly publication allows papers to be indexed in Web of Science and other indexing databases on a monthly basis rather than every 3 months, and they become searchable and are cited earlier. We also acknowledge the many valuable publications from our authors and the important contribution of our dedicated reviewers.

22 December 2020
JPM | Welcoming New Editorial Board Members

We are excited to welcome the following recognized researchers, who recently joined the Editorial Board of JPM:

Prof. Susan Bailey

Prof. Dr. Shahina Pardhan

Prof. Dr. Ramesh Narayanan

Prof. Dr. Joanna Saluk-Bijak

Prof. Dr. Simon Kasif

Dr. Stephanie Duguez

Prof. Dr. Henrik Galbo

Dr. Colleen Campbell

Dr. Justin M. Watts

Dr. Justin M. Watts

Prof. Kyung-Han Lee

Dr. Jin-Rong Zhou

Prof. Victor E. Ortega

 

22 December 2020
Get Involved with JPM’s Reviewer and Topics Boards

JPM is currently establishing its Reviewer Board and Topics Board. If you are interested in a position on the Reviewer Board or have potential candidates to recommend, please contact the JPM Editorial Office ([email protected]). We are looking forward to your support.

15 December 2020
MDPI adopts C4DISC principles to improve diversity and inclusion in scholarly communications

MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.

The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.

MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.

Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.

The Coalition is committed to:

  • eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
  • creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
  • promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
  • raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
  • supporting our members in achieving diversity and inclusion within their organizations.

14 December 2020
Article Layout and Templates Revised for Future Volumes

At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.

The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.

The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:

1) Information is displayed in the left information bar.


2) In the main text, there is a blank column on the left.


3) Small tables/figures are aligned on the left, large tables/figures are centered.

11 December 2020
2020 "Highly Cited Researchers" on MDPI Journal's Editorial Boards

We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.

Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.


Adams, Dave
Agarwal, Ravi P.
Ahn, Choon Ki
Ahn, Myung-Ju
Albrecht, Randy A.
Andersson, Dan I.
Anker, Stefan D.
Apergis, Nicholas
Ariga, Katsuhiko
Artaxo, Paulo
Balsamo, Gianpaolo
Barba, Francisco J.
Benediktsson, Jon Atli
Benelli, Giovanni
Bhatnagar, Amit
Bialystok, Ellen
Blaabjerg, Frede
Blay, Jean-Yves
Bogers, Marcel
Bolton, Declan J.
Boyer, Cyrille
Brocca, Luca
Bruix, Jordi
Buhalis, Dimitrios
Burdick, Jason A.
Byrd, John C.
Cabeza, Luisa F.
Cabrerizo-Lorite, Francisco Javier
Cai, Jianchao
Calhoun, Vince D.
Cantu, Robert C.
Cerqueira, Miguel
Chang, Jo-Shu
Chau, Kwok-wing
Chemat, Farid
Chen, Jianmin
Chen, Jun
Chen, Min
Chen, Shaowei
Chen, Wei
Chen, Wei-Hsin
Chen, Xiaofeng
Chen, Yangkang
Chen, Zhi-Gang
Chiclana, Francisco
Corella, Dolores
Cortes, Javier
Cortes, Jorge
Cummings, Kenneth Michael
Dai, Shifeng
Decker, Eric A.
DePinho, Ronald A.
Dimopoulos, Meletios-Athanasios
Dincer, Ibrahim
Du, Yihong
Dupont, Didier
Edwards, David
Ellahi, Rahmat
Ellis, Erle C.
ElMasry, Gamal
Esteller, Manel
Estruch, Ramón
Fang, Chuanglin
Fasano, Alessio
Fernandez-Lafuente, Roberto
Ferreira, Isabel
Fortino, Giancarlo
Galluzzi, Lorenzo
Galvano, Fabio
Gandomi, Amir H.
Gandomi, Amir H.
Gao, Bin
Gao, Feng
Gao, Wei
Garbe, Claus
García, Hermenegildo
Geschwind, Daniel H.
Giampieri, Francesca
Giralt, Sergio A.
Glanz, Karen
Goldewijk, Kees Klein
Gössling, Stefan
Govindan, Kannan
Granato, Daniel
Grosso, Giuseppe
Grosso, Giuseppe
Guerrero, Josep M.
Haase, Dagmar
Hagger, Martin S.
Hamblin, Michael R.
Han, Heesup
Jankovic, Joseph
Janotti, Anderson

Jiang, Hai-Long
Kalaji, Hazem M.
Kalantar-Zadeh, Kourosh
Kaner, Richard B.
Karimi, Hamid Reza
Kataoka, Kazunori
Keesstra, Saskia
Kepp, Oliver
Kerminen, Veli-Matti
Keyzers, Robert A.
Khademhosseini, Ali
Khan, Nafees A.
Kim, Ki-Hyun
Klemeš, Jiří Jaromír
Klenk, Hans-Peter
Konopleva, Marina Y.
Krammer, Florian
Krebs, Frederik C.
Kroemer, Guido
Kudo, Masatoshi
Kurths, Juergen
Kurzrock, Razelle
Kuznetsov, Nikolay V.
Kyrpides, Nikos C.
La Vecchia, Carlo
Lai, Yuekun
Lam, James
Lancellotti, Patrizio
Lee, Sangmoon
Leung, Victor C. M.
Li, Jinghong
Li, Yurui
Lindahl, José M. Merigó
Lip, Gregory Y. H.
Loh, Xian Jun
Long, Hualou
Lund, Henrik
Luo, Jingshan
Luque, Rafael
Lyons, Timothy W.
Ma, Jun
Ma, Wen-Xiu
Ma, Yanming
Maeda, Keisuke
Makarova, Kira
Mantovani, Alberto
Martín-Belloso, Olga
Martinoia, Enrico
Marzband, Mousa
Masclaux-Daubresse, Celine
Masson, Patrick
Mateos, María Victoria
Mathiesen, Brian Vad
Matyjaszewski, Krzysztof
McArthur, Grant A.
McCauley, Darren
Medlock, Jolyon M.
Melero, Ignacio
Mezzetti, Bruno
Miroshnichenko, Andrey E.
Moran, Daniel
Mueller, Lukas A.
Mueller-Roeber, Bernd
Naushad, Mu
Nemeroff, Charles B.
Nieto, Juan J.
O'Donnell, Colm
Ogino, Shuji
Olabi, Abdul-Ghani
O'Regan, Donal
Orsini, Nicola
Oswald, Isabelle P.
Ozcan, Aydogan
Pahl-Wostl, Claudia
Pang, Huan
Payne, James E.
Peng, Shushi
Perc, Matjaz
Perez-Alvarez, Jose Angel
Piquero, Alex R.
Ploss, Alexander
Postolache, Mihai
Pradhan, Biswajeet
Prinsep, Michele R.
Qian, Dong
Qu, Xiaogang
Reiter, Russel J.
Riahi, Keywan
Richter, Andreas
Rignot, Eric
Robert, Caroline
Ros, Emilio
Rosell, Rafael

Rosen, Marc A.
Rossolini, Gian Maria
Saad, Fred
Saad, Walid
Sadorsky, Perry
Sakthivel, Rathinasamy
Schwab, Matthias
Scolyer, Richard A.
Serra-Majem, Lluis
Sethi, Gautam
Seto, Karen C.
Settele, Josef
Seymour, John F.
Shi, Peng
Siano, Pierluigi
Sillanpää, Mika
Simal-Gandara, Jesus
Smagghe, Guy
Srivastava, Hari M.
Stadler, Peter F.
Sun, Fengchun
Sunderland, Elsie M.
Suzuki, Nobuhiro
Svenning, Jens-Christian
Tan, Weihong
Teixeira, José António
Thakur, Vijay Kumar
Tong, Shilu
Tornabene, Francesco
Tsao, Rong
Tukker, Arnold
Turskis, Zenonas
Uversky, Vladimir N.
van Wesemael, Bas
Van Zwieten, Lukas
Vangronsveld, Jaco
Varma, Rajender S.
Varshney, Rajeev K.
Vasquez, Juan C.
Velicogna, Isabella
Vieta, Eduard
Wade, Timothy J.
Wagner, Wolfgang
Wamba, Samuel Fosso
Wang, Chunsheng
Wang, Guoxiu
Wang, Joseph
Wang, Qi
Wang, Tao
Wang, Yuan
Wiens, John J.
Wu, Hao Bin
Wu, Hui
Wu, Tom
Wu, Zhongbiao
Xia, Xinhui
Xiao, Wenjiao
Xin, Sen
Xiong, Rui
Xu, Bin
Xu, Zeshui
Yan, Huaicheng
Yang, Bing
Yang, Hongxing
Yang, Jie
Yang, Xiao-Jun
Yin, Shen
Ying, Guang-Guo
Young, Allan H.
Yu, Guihua
Zarco-Tejada, Pablo J.
Zavadskas, EdmundasKazimieras
Zeadally, Sherali
Zhang, Fan
Zhang, Liangpei
Zhang, Qichun
Zhang, Xian-Ming
Zhang, Yue-Jun
Zhao, Guochun
Zhao, Li-Dong
Zhu, Zhe
Zhuang, Xiaodong
Zou, Quan

The full list of 2020 Highly Cited Researchers  can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/

--- Highly Cited Researchers (HCR) is a Clarivate product.

10 July 2020
Meet Us at the Society for Neurosciences’ 50th Annual Meeting (Neuroscience 2020), Washington, USA, 24–28 October 2020


MDPI will be attending the conference Neuroscience 2020, which will be hosted in Washington, USA, 24–28 October 2020.

SfN’s 50th annual meeting is the premier venue for the presentation of emerging science in the field of neurosciences, where one can learn from experts, forge collaborations with peers, explore new tools and technologies, and advance their career.

The following MDPI journals will be represented:

If you are attending this conference, please feel free to stop by our booth (Booth #208). Our delegates look forward to meeting you in person, to answer any questions you may have. For more information about the conference, please visit:

https://www.sfn.org/meetings/neuroscience-2020

9 July 2020
Open Access Agreement Between Jisc Collections and MDPI

We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.

All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.

Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.

Jisc logo

About Jisc

Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection.  Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.

For more information, contact [email protected].

About MDPI

MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).

For any questions about this agreement, please contact the MDPI IOAP team at [email protected].

2 July 2020
EBMs of JPM recognized as Highly Cited Researchers for 2019

Professor Dr. Grant McArthu and Professor Dr. Ewout W. Steyerberg, Editorial Board Members of JPM, have recently been recognized as Clarivate Analytics Highly Cited Researchers for 2019. This corresponds to the top 1% of the most cited researchers in the field of clinical medicine for that publication year.

Professor Dr. Grant McArthu

Professor Dr. Ewout W. Steyerberg

29 June 2020
Updated Impact Factors Released in the Journal Citation Reports (Clarivate)

The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.

  • Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
  • 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
  • Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).

First Impact Factors

Journal Impact Factor Rank Category Details
Actuators 1.957 31/64 (Q2) • Instruments & Instrumentation Link
Agriculture 2.072 25/91 (Q2) • Agronomy Link
Biology 3.796 19/93 (Q1) • Biology Link
Biomedicines  4.717 30/138 (Q1)
36/270 (Q1)
• Medicine, Research & Experimental
• Pharmacology & Pharmacy
Link
Biosensors 3.240 24/86 (Q2) • Chemistry, Analytical Link
Chemosensors 3.108 16/64 (Q1)
27/86 (Q2)
13/27 (Q2)
• Instruments & Instrumentation
• Chemistry, Analytical
• Electrochemistry
Link
Children 2.078 50/128 (Q2) • Pediatrics Link
Healthcare 1.916 62/102 (Q3)
45/87 (Q3)
• Health Care Sciences & Services (SCIE)
• Health Policy & Services (SSCI)
Link
Journal of Fungi 4.621 5/29 (Q1)
31/135 (Q1)
• Mycology
• Microbiology
Link
Journal of Personalized Medicine 4.433 24/165 (Q1)
10/102 (Q1)
• Medicine, General & Internal
• Health Care Sciences & Services
Link
Land 2.429 58/123 (Q2) • Environmental Studies (SSCI) Link
Life 2.991 26/93 (Q2)
109/267 (Q2)
• Biology
• Microbiology
Link
Magnetochemistry 1.947 22/45 (Q2)
109/159 (Q3)
201/314 (Q3)
• Chemistry, Inorganic & Nuclear
• Chemistry, Physical
• Materials Science, Multidisciplinary
Link
Membranes 3.094 53/143 (Q2)
129/314 (Q2)
23/89 (Q2)
• Engineering, Chemical
• Materials Science, Multidisciplinary
• Polymer Science
Link
Pharmaceuticals 4.286 49/270 (Q1) • Pharmacology & Pharmacy Link
Photonics 2.140 48/97 (Q2) • Optics Link
Separations 1.900 53/86 (Q3) • Chemistry, Analytical Link
Toxics 3.271 32/92 (Q2)
92/265 (Q2)
• Toxicology
• Environmental Sciences
Link

Updated Impact Factors

Journal Impact Factor Rank Category Details
Agronomy 2.603 18/91 (Q1)
65/234 (Q2)
• Agronomy
• Plant Sciences
Link
Animals 2.323 10/63 (Q1)
14/142 (Q1)
• Agriculture, Dairy & Animal Science
• Veterinary Sciences
Link
Antibiotics 3.893 23/93 (Q1)
64/270 (Q1)
• Infectious Diseases
• Pharmacology & Pharmacy
Link
Antioxidants 5.014 10/139 (Q1)
56/297 (Q1)
7/61 (Q1)
• Food Science & Technology
• Biochemistry & Molecular Biology
• Chemistry, Medicinal
Link
Applied Sciences 2.474 161/314 (Q3)
32/91 (Q2)
88/177 (Q2)
62/154 (Q2)
• Materials Science, Multidisciplinary
• Engineering, Multidisciplinary
• Chemistry, Multidisciplinary
• Physics, Applied
Link
Atmosphere 2.397 48/93 (Q3) • Meteorology & Atmospheric Sciences Link
Biomolecules 4.082 98/297 (Q2) • Biochemistry & Molecular Biology Link
Brain Sciences 3.332 113/271 (Q2) • Neurosciences Link
Cancers 6.126 37/244 (Q1) • Oncology Link
Catalysts 3.520 65/159 (Q2) • Chemistry, Physical Link
Cells 4.366 70/195 (Q2) • Cell Biology Link
Coatings 2.436 10/21 (Q2) • Materials Science, Coatings & Films Link
Crystals 2.404 10/26 (Q2)
165/314 (Q3)
• Crystallography
• Materials Science, Multidisciplinary
Link
Diagnostics 3.110 39/165 (Q1) • Medicine, General & Internal Link
Diversity 1.402 119/168 (Q3) • Ecology Link
Electronics 2.412 125/266 (Q2) • Engineering, Electrical & Electronic Link
Energies 2.702 63/112 (Q3) • Energy & Fuels Link
Entropy 2.494 33/85 (Q2) • Physics, Multidisciplinary Link
Foods 4.092 27/139 (Q1) • Food Science & Technology Link
Forests 2.221 17/68 (Q1) • Forestry Link
Genes 3.759 53/177 (Q2) • Genetics & Heredity Link
Insects 2.220 18/101 (Q1) • Entomology Link
International Journal of Environmental Research and Public Health (IJERPH) 2.849 58/193 (Q2)

32/170 (Q1)

105/265 (Q2)
• Public, Environmental & Occupational Health (SCIE)
• Public, Environmental & Occupational Health (SSCI)
• Environmental Sciences (SCIE)
Link
International Journal of Molecular Sciences (IJMS) 4.556 74/297 (Q1)
48/177 (Q2)
• Biochemistry & Molecular Biology
• Chemistry, Multidisciplinary
Link
ISPRS International Journal of Geo-Information (IJGI) 2.239 31/50 (Q3)
18/30 (Q3)
• Geography, Physical
• Remote Sensing
Link
Journal of Clinical Medicine 3.303 36/165 (Q1) • Medicine, General & Internal Link
Journal of Marine Science and Engineering 2.033 31/66 (Q2) • Oceanography Link
Marine Drugs 4.073 16/61 (Q2) • Chemistry, Medicinal Link
Materials 3.057 132/314 (Q2) • Materials Science, Multidisciplinary Link
Mathematics 1.747 28/324 (Q1) • Mathematics Link
Medicina 1.205 107/165 (Q3) • Medicine, General & Internal Link
Metabolites 4.097 95/297 (Q2) • Biochemistry & Molecular Biology Link
Metals 2.117 18/79 (Q1)
185/314 (Q3)
• Metallurgy & Metallurgical Engineering
• Materials Science, Multidisciplinary
Link
Micromachines 2.523 56/92 (Q3)
23/64 (Q2)
• Nanoscience & Nanotechnology
• Instruments & Instrumentation
Link
Microorganisms 4.152 37/135 (Q2) • Microbiology Link
Minerals 2.380 6/21 (Q2)
11/30 (Q2)
• Mining & Mineral Processing
• Mineralogy
Link
Molecules 3.267 70/177 (Q2)
141/297 (Q2)
• Chemistry, Multidisciplinary
• Biochemistry & Molecular Biology
Link
Nanomaterials 4.324 89/314 (Q2)
42/103 (Q2)
• Materials Science, Multidisciplinary
• Nanoscience & Nanotechnology
Link
Nutrients 4.546 17/89 (Q1) • Nutrition & Dietetics Link
Pathogens 3.018 65/135 (Q2) • Microbiology Link
Pharmaceutics 4.421 44/270 (Q1) • Pharmacology & Pharmacy Link
Plants 2.762 58/234 (Q1) • Plant Sciences Link
Polymers 3.426 16/89 (Q1) • Polymer Science Link
Processes 2.753 59/143 (Q2) • Engineering, Chemical Link
Remote Sensing 4.509 9/30 (Q2) • Remote Sensing Link
Sensors 3.275 22/86 (Q2)
77/266 (Q2)
15/64 (Q1)
• Chemistry, Analytical
• Engineering, Electrical & Electronic
• Instruments & Instrumentation
Link
Sustainability 2.576 120/265 (Q2)
26/41 (Q3)

53/123 (Q2)
6/8 (Q3)
• Environmental Sciences (SCIE)
• Green & Sustainable Science & Technology (SCIE)
• Environmental Studies (SSCI)
• Green & Sustainable Science & Technology (SSCI)
Link
Symmetry 2.645 29/71 (Q2) • Multidisciplinary Sciences Link
Toxins 3.531 21/92 (Q1)
34/139 (Q1)
• Toxicology
• Food Science & Technology
Link
Universe 1.752 18/29 (Q3)
42/68 (Q3)
• Physics, Particles & Fields
• Astronomy & Astrophysics
Link
Vaccines 4.086 57/158 (Q2)
50/138 (Q2)
• Immunology
• Medicine, Research & Experimental
Link
Viruses 3.816 12/37 (Q2) • Virology Link
Water 2.544 31/94 (Q2) • Water Resources Link

Source: Clarivate 2020, InCites Journal Citation Reports®.

29 June 2020
Journal of Personalized Medicine Receives First Journal Impact Factor of 4.433

The editors are pleased to inform that Journal of Personalized Medicine has received a first Impact Factor of 4.433, as published in the 2019 Edition of the Journal Citation Reports® (Clarivate), released just now. Journal of Personalized Medicine ranks 24th out of 165 (Q1) titles in the 'Medicine, General & Internal', as well as 10th out of 102 (Q1) tiles in the 'Health Care Sciences & Services' category.

Thank you to the authors, editorial board members and reviewers for their contribution in achieving this milestone for Journal of Personalized Medicine.

13 May 2020
COVID-19 Academic Resources Center


Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.

The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.

COVID-19 Academic Resources Center contains a variety of information related to COVID-19 available from MDPI, including journal articles, special issues, and preprints, among others.

For more information, please visit: https://www.mdpi.com/covid-19

30 April 2020
Meet Us at the European Society of Cardiology Congress 2020(ESC Congress 2020) in Amsterdam, The Netherlands, 29 Aug–2 Sep 2020

MDPI will be attending the European Society of Cardiology Congress 2020(ESC Congress 2020) in Amsterdam, The Netherlands, 29 Aug–2 Sep 2020.

ESC Congress 2020 will build on the solid foundations of a congress which attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth N600). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit here.

9 April 2020
Free Open Platforms to Support Academics During the COVID-19 Pandemic

As a leading Open Access publisher, MDPI is committed to fostering open scientific exchange in all forms across all disciplines. Due to the outbreak of COVID-19, many researchers have to stay at home and many academic conferences have been cancelled or postponed. In light of these changes, MDPI has adopted numerous initiatives that may help accelerate scientific exchange and provide support to the academics during this period.

Scholarly Community—Encyclopedia

Encyclopedia is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

Comprehensive and Free Literature DatabaseScilit

Scilit is a comprehensive, free database for scientists that uses a new method to collate data and index scientific material. Our crawlers extract the latest data from CrossRef and PubMed on a daily basis. This means that newly published articles are immediately added to Scilit.

Display Academic AchievementsSciProfiles

SciProfiles is an innovative social network for researchers and scholars that is developed by MDPI. In line with our broad mission, the purpose of SciProfiles is to accelerate discovery and innovation by facilitating immediate access to research results and providing opportunities for academic networking.

Organize and Participate in Conferences OnlineSciforum

Sciforum is an event planning platform that supports open science by offering the opportunity to host and participate in academic conferences. It provides an environment for scholarly exchange, discussion of topics of current interest, building of networks, and establishing collaborations.

Post Early Versions of Research OutputsPreprints

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. We post original research articles and comprehensive reviews, and papers can be updated by authors at any time. Content on Preprints is not peer-reviewed, and feedback can be received from readers.

***

MDPI remains committed to open science and open data and has signed a statement, along with more than thirty scholarly publishers, showing our intention to facilitate sharing of new research findings as early on as possible. The initiative sees publishers collectively removing barriers to new research, in the face of a global healthcare crisis.

25 March 2020
MDPI Comment on the COVID-19 Virus

The world is currently suffering from a global pandemic of the corona virus COVID-19. MDPI expresses its sympathies for all of those affected by the virus and stands in solidarity with medical staff and researchers treating patients and searching for scientific solutions.

MDPI has previously published papers covering corona viruses in addition to new papers on the current outbreak, see all papers here. In particular, Viruses has published a number of Special Issues and papers on the topic (see here, here, and here) as well as a forthcoming Special Issue.

Alongside journal articles, MDPI has been a strong supporter of preprints, which are increasingly being used to rapidly disseminate the latest research, and we run the preprint server Preprints.org. Our database of research articles, Scilit, is free to use and covers all publishers including preprint servers. New papers are often in search results within hours of publication and users can set up alerts for new papers.

Our main priority during this period has been the health and safety of staff, and we continue to allow staff to work at home and closely monitor the situation in all locations in which we work. Despite the restrictions, we continue to provide a full publication service and, by close collaboration with our editorial boards and making use our in-house teams, ensure that there are no unnecessary delays in publishing vital research. Fast and open publication has always been at the core of MDPI values and is now more important than ever.

We hope that a solution to the current situation will emerge soon. In the meantime, we will do our best to continue communicating vital research in all fields.

20 March 2020
MDPI Backs Open Pharma Statement on Open Access

MDPI has endorsed Open Pharma’s Position Statement in support of open access publishing with the aim of advancing medical science and ultimately, improving patient care. Open pharma is a group of research funders, healthcare professionals, publishers, academics, and other healthcare stakeholders.

Since its inception in 1996, MDPI’s efforts have aligned with Open Pharma’s vision of more effective and transparent publishing, collaborating internationally with experts to deliver peer-reviewed online research journals to the scientific community and the general public. MDPI publishes 56 journals in the field of Medicine and Pharmacology and is planning to hold the World Pharma Forum in Basel in 2021.

Published under a Creative Commons License, MDPI’s articles can be freely shared and their content re-used, upon proper attribution. In support of the statement, MDPI will continue to uphold its open access policy and provide fast editorial services to ensure that new medical evidence can be read by everyone, without paywall restrictions.

18 March 2020
MDPI Co-Signed Position Statement on Transformative Agreements

The advantages of the open access model of scientific publishing are being increasingly recognized in the scientific community. It allows new scientific evidence to be accessed from the moment of publication for free by anyone around the globe, boosting the impact of new research. In response, many funders, libraries and universities have been adopting new principles to accelerate the transition to open access.

Recently, “transformative agreements” have been negotiated between traditional publishers and various institutions. While increasing the number of open access papers, these agreements lack binding commitments to a full transition to open access, their conditions vary across different regions, and access is still limited for many users.

MDPI is a co-signatory of the recent position statement raising concerns about potential downsides of transformative agreements and how they may delay a full transition to open access. The statement highlights that these models “risk perpetuating current limitations on access, transparency and market competitiveness, while simultaneously facilitating excessive charges on the public purse”.

As a pioneering open access journal publisher, MDPI is the first to promote the importance of science being made available to everyone. Our peer-reviewed journals, covering diverse academic disciplines, are fully accessible to the public free of charge under a Creative Commons Attribution License (CC BY). This is why, along with other open access publishers, MDPI is a proud signatory of the position paper and is committed to contributing to the replacement of weak transitional agreements with “agreements with publishers that are already fully committed to open science and who offer full, immediate and transparent Open Access”.

Read the position paper here

17 March 2020
Catching Up with Journal of Personalized Medicine Editors at PMWC 2020

The Precision Medicine World Conference 2020 was held in Silicon Valley, CA, USA during 21-24 Jan 2020. As an exhibitor, we had the chance to meet Editorial Board Member Professor Dr. Kathryn A. Phillips, Guest Editor Professor Dr. Sergey Suchkov and many other experts in the filed. We appreciate their inputs for developing the journal.

16 March 2020
Encyclopedia Outstanding Contributor Awards 2020 - Open for Application

We are pleased to announce that Encyclopedia will be awarding five Outstanding Contributor Awards for researchers in 2020. The nominations and applications will be assessed by an Evaluation Committee consisting of senior scholars from the Encyclopedia Editorial Board.

Prize for Winners

  1. An official certificate;
  2. A cash award of 500 CHF or an MDPI discount voucher of 800 CHF.


Application Deadline

31 December, 2020 (Please send your application email with a list of all entries you contributed to our office before the deadline: [email protected])

Candidate Requirements

  1. Have a Ph.D. degree;
  2. Have more than three qualified entries published in Encyclopedia in 2020.

Evaluation Standards

  1. Number of entries published in Encyclopedia in 2020;
  2. Quality of entries online (including length, figure quality, and novelty);
  3. Impact of entries (including the number of likes, discussion contents, views, and downloads).

If you are a researcher and have not yet contribute entries to Encyclopedia, please do not miss this chance to highlight your research results.

19 February 2020
Meet Us at American Thoracic Society (ATS) 2020 Congress in Philadelphia, PA, USA, 15–20 May 2020


MDPI will be attending the American Thoracic Society (ATS) 2020 Congress in Philadelphia, PA, USA, 15–20 May 2020.

The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.

This international conference is also multidisciplinary. Clinicians and researchers in many other fields attend the conference, thereby enriching conversations that lead to insights that ultimately improve patient care.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth 1101). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://conference.thoracic.org.

11 December 2019
Meet Us at Precision Medicine World Conference 2020 in Silicon Valley, CA, USA, 21-24 January, 2020


MDPI will be attending Precision Medicine World Conference 2020 in Silicon Valley, CA, USA, 21-24 January, 2020.

PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth C1823). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.pmwcintl.com/

11 October 2019
Introducing SciProfiles, an Academic Social Network

MDPI is pleased to announce the release of SciProfiles, its social network platform for researchers and scholars.

The purpose of SciProfiles is aligned with MDPI’s broad mission to accelerate discovery and innovation by facilitating immediate access to research results and to serve scholars and communities by providing opportunities for academic networking.

SciProfiles also ambitions to serve as a sustainable, transparent and community-driven research evaluation system aligned with the DORA principles (https://sfdora.org/). Through their scientific profiles, academics can highlight their contribution to research communities, and measure their impact on their field, beyond publication numbers and impact factors. SciProfiles is currently a beta version and will enrich to give researchers the possibility to highlight all of their contributions to science and their scientific communities as authors, reviewers, editors, conference organizers, conference panelists, conference keynote speakers, or even as lecturers or student mentors at their University.

The classic components of popular community social networks, including follower/following, classical metrics, endorsements and recommendations (https://www.mdpi.com/about/announcements/1690), comments (https://www.mdpi.com/about/announcements/1397) are or will be very soon highlighted in SciProfiles as open science contributions.

To help increase the impact and visibility of articles and their authors to an appropriate audience, the platform offers a NewsFeed that includes recommendations of relevant content based on interests, publication history, saved searches or colleagues’ recommendations.

SciProfiles’ avatars are now being integrated on several MDPI platforms, meaning that you will directly access researchers’ profiles from any of the MDPI platforms:

MDPI's journal publishing website: www.mdpi.com
MDPI's conference hosting and management website: www.sciforum.net
MDPI's pre-print website : www.preprints.org
MDPI's knowledge sharing website : www.encyclopedia.pub
MDPI's books store: www.mdpi.com/books
MDPI's literature database : www.scilit.net

SciProfiles aims to serve scientific communities at large. It can be embedded into third-party websites and also welcomes integration of data from third-parties.

Dr. Shu-Kun Lin: https://sciprofiles.com/profile/2
Dr. Franck Vazquez: https://sciprofiles.com/profile/FranckVazquez
Dr. Martyn Rittman: https://sciprofiles.com/profile/martynrittman

2 October 2019
Winners of the 2019 MDPI Writing Prize

We are delighted to announce the winners of the 2019 MDPI Writing Prize. Entrants were asked to write on the theme "Judging research: How should research and researchers be evaluated and rewarded?" We received a large number of excellent essays from PhD students and postdocs, and the process of shortlisting and choosing winners was not an easy one. The winners demonstrated excellent writing skills alongside interesting and thought-provoking ideas.

As last year, we will begin the process of collating all entries into a book that will be available in open access format. Alongside promoting good writing skills, we see the prize as a way to promote the voices of early career researchers within broader debates and policy discussions.

Congratulations to all of the participants and especially the winners. The winners are:

1st Prize (500 CHF):
Albin Nilsson (National Centre for Nuclear Research, Warsaw, Poland)
[Read here]

2nd Prize (250 CHF):
Qi Zhang (Shandong University, Jinan, China)
[Read here]
Igor Ogashawara (Indiana University, Indianapolis, US)
[Read here]

3rd Prize (100 CHF):
Margaret Sivapragasam (Universiti Teknologi Petronas, Perak, Malaysia)
[Read here]
Arvind Sharma (The University of Queensland, Gatton, Australia)
[Read here]
Jose Flores-Guerrero (University Medical Center Groningen, Groningen, The Netherlands)
[Read here]

The MDPI Writing Prize is an annual award supported by MDPI Author Services, which provides services including language editing, reformatting, plagiarism checks, and image editing.

20 September 2019
MDPI Now Gives Scholars the Possibility to Endorse and Recommend Articles

MDPI is pleased to announce the release of a new functionality giving the possibility for researchers and scholars to endorse, and formally recommend articles to their colleagues.

MDPI was an early signatory of the San Francisco Declaration on Research Assessment (https://sfdora.org/read/) which calls for improvement in how quality and impact of scholarly research outputs are evaluated, especially in moving beyond journal-based citation metrics (journal Impact Factor, Scopus Citescore, etc.).

MDPI supports the establishment of article-level impact metrics, including citations, views, downloads, and Altmetric scores. These measures serve as an impact indicator for research articles on a case–by-case basis, assessing paper on its own merit. However, these metrics are also subjective and can give a biased picture of the article impact: they do not directly reflect the quality or the intrinsic scientific value of the article.

In our view, community engagement with publications based on community-driven metrics can help to overcome this limitation. We have therefore launched an option for scholars to endorse articles, indicating their own assessment of its content and making a recommendation to their community. This follows our implementation of the open source Hypothesis commenting tool, which has been available for all articles published by MDPI for over a year (https://www.mdpi.com/about/announcements/1397). Both endorsement and commenting are available for all previously published and forthcoming MDPI articles.

In addition to potentially serving as a sustainable solution to article assessment, endorsements will help scientific communities to identify the most relevant articles, independently of the journal in which it was published.

The code for the endorsing functionality, which relies on DOIs and ORCIDs, will be made available on GitHub with an open source license.

Dr. Shu-Kun Lin, President and Founder
Dr. Franck Vazquez, Chief Scientific Officer
Dr. Martyn Rittman, Publishing Director

11 September 2019

Create an Entry in Encyclopedia to Get a 100 CHF Voucher in Publishing in MDPI Journals

Encyclopedia is pleased to announce that certain well-prepared entries are eligible for a 100 CHF voucher, which can be used for paper publication in any journals in MDPI. We believe that your contribution would be a great help in keeping up with scientific developments. Do not miss the chance to publish with us. Please clink here to find the detailed guideline.

Encyclopedia is a free online reference created and curated by active scholars. It aims to highlight the latest research results as well as provide a comprehensive record of scientific development. If you have any suggestions or questions, please feel free to contact us via [email protected].

22 August 2019
Journal of Fungi, Journal of Personalized Medicine and Separations Accepted into the SCIE in the Web of Science

We are happy to announce the inclusion of three more journals into the Science Citation Index Expanded (SCIE) in the Web of ScienceTM. Journal of Fungi (JoF), Journal of Personalized Medicine (JPM) and Separations are due to receive 2019 journal metrics in the 2020 release of the Journal Citation ReportsTM (Clarivate Analytics).

Thank you to all authors, reviewers and editors who contributed to the journals and enabled these achievements!

Journal

Current Volume

Scope

Journal of Fungi Logo

Vol. 5 (2019) | articles
Twitter | Scopus

pathogenic and parasitic fungi; medical mycology; fungal biology | more | submit article

JPM Logo

Vol. 9 (2019) | articles Twitter | Scopus

pharmacogenomics/proteomics; genetic-based therapeutics; biomarker identification and application | more | submit article

Separations Logo

Vol. 6 (2019) | articles

chromatography; separation methods and technology | more | submit article

6 August 2019
Preprints Reaches 10,000 Posted Articles Milestone

We are pleased to announce that Preprints has passed the milestone of 10,000 posted preprints. We are delighted to have reached this after just over three years of operation. Our congratulations and thanks go to our authors and advisory board who have supported growth of the platform and been crucial to its operation.

You can find further details at https://www.preprints.org/announcement/show/37.

2 August 2019
DeepGreen Partnering with Publishers and Universities in Distributing Open Access Content to Institutional Repositories

Last week, the DeepGreen initiative in Germany started into an advanced test phase with the publishing partners S. Karger AG, SAGE Publishing, MDPI, Frontiers and De Gruyter, as well as 27 universities from all over Germany, from Hamburg University of Applied Sciences to University of Konstanz.

DeepGreen aims at lowering the barriers for open access publishing by automatically delivering metadata and full text publications from participating publishers to authorized repositories at German universities.

In preparation for a later live operation, the advanced test phase serves to gain experience with extensive data deliveries from publishers and also handling different repository software (including OPUS4, DSpace, EPrints, MyCoRe). DeepGreen thereby acts as a sophisticated platform, receiving articles published by authors affiliated with German universities and depositing these articles to respective university repositories, based on the affiliation metadata. For more information about DeepGreen: https://deepgreen.kobv.de

Karger AG has been a close cooperation partner of the DeepGreen consortium since 2016. S. Karger has more than 80 subscription-based and around 20 open access journals covering a wide spectrum in health science. DeepGreen will assign S. Karger articles to authorized institutions on the legal basis of German alliance and national licenses.

SAGE Publishing  was founded by Sara Miller McCune in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE publishes more than 1,000 journals and over 600 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington DC and Melbourne. SAGE Publishing has been a close cooperation partner of DeepGreen since 2016.

MDPI  is a scientific open access publisher and has been a partner of DeepGreen since 2017. MDPI comprises 205 peer-reviewed journals of various disciplines. All articles are published under a CC-BY license and are freely available without embargo period.

Frontiers  is a scientific open access publisher with 61 journals of over 600 academic disciplines. All articles are peer-reviewed and published freely available under CC-BY license.

De Gruyter  is an academic publisher with more than 700 subscription-based and open access journals of 29 disciplines. Articles provided by De Gruyter will be assigned to institutions with German alliance and national licenses.

There is promising communication with other publishers.

DeepGreen is funded by the German Research Foundation (DFG) and the consortium comprises six institutions: the Cooperative Library Network Berlin-Brandenburg, Bavarian State Library, Bavarian Library Network, University Library of the Technische Universität Berlin, University Library of Erlangen-Nuremberg and the Helmholtz Open Science Coordination Office at the GFZ German Research Centre for Geosciences.

If you would like to know in more detail which institutions take part in the advanced test phase of DeepGreen, you can find more information here.

30 July 2019
Meet Us at the 2019 APHA Annual Meeting and Expo


We will be attending the 2019 APHA Annual Meeting and Expo in Philadelphia, PA, USA from 2–6 November 2019. APHA's Annual Meeting and Expo is the largest and most influential annual gathering of public health professionals. Nearly 13,000 attendees join the conference each year to present, learn, and find inspiration. This year, the theme of the conference is “Creating the Healthiest Nation: For science. For action. For health”. Representatives of the following open access journals will attend:

IJERPH

Cancers

JCM

Healthcare

Vaccines

Microorganisms

Toxics

Sports

JPM

If you are also attending this conference, please feel free to stop by our booth (Booth #1144). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit https://www.apha.org/events-and-meetings/annual.

25 July 2019
Meet Us at the 12th European Public Health Conference

We will be attending the 12th European Public Health Conference. From 20–23 November 2019, Marseille is hosting the 12th European Public Health (EPH) Conference, where you can reach over 1500 international delegates attending a fully packed programme over four days. Marseille 2019 offers you exceptional opportunities to network, raise your profile in the public health community, and gain valuable access to influential opinion-leaders, policy-makers, and researchers. The theme of the Congress is: Building bridges for solidarity and public health. Representatives of the following open access journals will attend:

IJERPH
Cancers
Toxics
Healthcare
JPM

If you are also attending this conference, please feel free to stop by our booth (Booth #9). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://ephconference.eu/.

17 July 2019
First Basel Sustainable Publishing Forum

The University of Basel and the MDPI Sustainability Foundation are organizing the First Basel Sustainable Publishing Forum on 9th September 2019.

The aim of this event is to provide background and perspectives on Plan S to Learned Societies, which have to make well-informed decisions to transition their journals to Open Access (OA).

The BSPF will bring together several representatives of Learned societies, Plan S architects as well as representatives from various publishers and publishing platforms. After getting the big picture from cOAlition S, panel discussions will allow to better understand the diverse challenges that Learned societies are facing to transition their journals to OA as well as to identify sustainable, implementable and scalable solutions for successful Open Access transition.

For program details and registration, please follow the link below:
https://sciforum.net/conference/SustainableSolutionsToOpenAccess

19 June 2019
Meet Us at Neuroscience 2019 in Chicago, IL, USA, 19–23 October 2019


MDPI will be attending Neuroscience 2019, to be held at McCormick Place in Chicago, IL, USA, 19–23 October 2019.

Join 30,000 colleagues from more than 70 countries at the world’s largest marketplace of ideas and tools for global neuroscience.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth #405). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://www.sfn.org/Meetings/Neuroscience-2019.

6 June 2019
Meet Us at European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019

MDPI will be attending the European Society of Cardiology Congress 2019 in Paris, France, 31 August – 4 September 2019.

The ESC Congress is the world’s largest conference in cardiovascular medicine. ESC Congress 2019 will take place in one of the world’s most alluring cities, Paris, and will be organised in conjunction with the World Heart Federation emphasizing the global reach of the event.

ESC Congress 2019 will build on the solid foundations of a congress that attracts worldwide cardiology leaders to present and exchange on their knowledge and most important research results. It will focus on the best and latest science but will also emphasize the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth C590). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit the following link: http://www.escexhibition.org/ESC2019/default.aspx.

20 May 2019
Meet Us at the European Human Genetics Conference in Gothenburg, Sweden, 15–18 June 2019


MDPI will be attending the ESHG 2019, to be held in Gothenburg, Sweden, 15th-18th June 2019.

ESHG 2019 - The 53rd European Human Genetics Conference is everything you need in human genetics, whatever your professional background. The Scientific Program Committee (SPC) has worked hard to invite the best speakers from various sectors of human genetics, and to select the best abstracts for platform presentations.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth (Booth #492). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.eshg.org/

8 May 2019
Meet Us at the ESMO Congress 2019

Barcelona, Spain
27 September–1 October 2019

We will be attending the ESMO Congress 2019 in Barcelona, Spain from 27 September to 1 October 2019. The European Society for Medical Oncology (ESMO) is the leading European professional organization for medical oncology. Comprised of 17,000 oncology professionals from over 130 countries, they are the society of reference for oncology education and information. The annual ESMO Congress, which is held every year, is attended by 25,000 participants. The Congress presents the latest scientific developments in basic, translational and clinical cancer research and contextualizes new findings for practical implementation in everyday patient care. Representatives of the following MDPI open access journals will attend:

Cancers (https://www.mdpi.com/journal/cancers)

Diagnostics (https://www.mdpi.com/journal/diagnostics)

Genes (https://www.mdpi.com/journal/genes)

Healthcare (https://www.mdpi.com/journal/healthcare)

IJERPH (https://www.mdpi.com/journal/ijerph)

Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)

Journal of Personalized Medicine (https://www.mdpi.com/journal/jpm)

Medicina (https://www.mdpi.com/journal/medicina)

Medicines (https://www.mdpi.com/journal/medicines)

Vaccines (https://www.mdpi.com/journal/vaccines)

If you will attend this conference, please stop by our booth (Booth # P433). Our delegates look forward to meeting you in person and to answering any questions you may have concerning open access publishing and our journals.

For more information about the conference, please visit
https://www.esmo.org/Conferences/ESMO-Congress-2019

11 April 2019
Meet Us at the 46th Controlled Release Society Annual Meeting & Exposition

We will be attending the 46th Controlled Release Society Annual Meeting & Exposition. It is one of the biggest events in pharmaceutical field. Representatives of the following open access journals will attend:

Pharmaceutics
JCM
Biomolecules
Materials
IJMS
Molecules
Nanomaterials
Pharmaceuticals
Scientia Pharmaceutica
Vaccines
JPM
Genes
JFB
IJERPH
Biomedicines
Healthcare

If you are also attending this conference, please feel free to stop by our booth (Booth #303). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit: https://2019.controlledreleasesociety.org/

20 March 2019
Fostering Open Access Publishing Worldwide: New IOAP Participants in February and March 2019

We are pleased to welcome more universities from Poland, Italy, Germany, Brazil and other parts of the world to MDPI's Institutional Open Access Program (IOAP). A warm welcome to the institutions listed below, who have joined the Program in February and March this year.


James Madison University (JMU), Harrisonburg USA
Loughborough University UK
Lublin University of Technology Poland
Marquette University, Milwaukee USA
Massey University, Palmerston North New Zealand
Medical College of Wisconsin USA
Nicolaus Copernicus University, Toruń Poland
Poznań University of Life Sciences Poland
Robert Koch-Institut, Berlin Germany
Rothamsted Research, Harpenden UK
Santa Clara University (SCU)  USA
Technical University of Applied Sciences Wildau Germany
University of Aveiro Portugal
University of Brasília Brazil
University of Duisburg-Essen Germany
University of Greifswald Germany
University of Molise Italy
University of Naples Parthenope Italy
University of São Paulo (USP) - São Carlos Institute of Physics Brazil
University of Szczecin Poland
University of Warmia and Mazury, Olsztyn Poland
University West, Trollhättan Sweden
UTP University of Science and Technology, Bydgoszcz Poland
VTT - Technical Research Centre of Finland Finland


Authors affiliated with these institutions can now enjoy a discount on the APC for papers accepted for publication in any MDPI journal. If you would like to learn more about our program, please visit: https://www.mdpi.com/about/ioap or email us at [email protected].

5 March 2019
MDPI Joins Jisc’s Publications Router Service

We are delighted to announce our participation in Jisc’s Publication Router project, as of March 2019.

Publications Router is a Jisc service that automatically sends notifications about research articles to institutions' systems such as their repositories or CRISs, since May 2015. Through this agreement, MDPI will provide Jisc with daily feeds and information regarding published articles, which will be gathered by their system and delivered to institutions also registered to this service. Nearly all of our articles are published within 15 days of acceptance, so institutions will receive them quite promptly.

The feed will include the full text of the published version of record, with no embargo, so the articles can be exposed immediately for public view. They are accompanied by rich metadata, including confirmation of the immediate CC BY licence, minimising the need for any manual intervention or checking.

For more information about Publications Router, you may contact Jisc’s central helpdesk at [email protected]. For any queries about MDPI’s institutional agreements and collaborations, you may get in touch with MDPI’s Institutional Engagement team at [email protected], which would be very happy to hear from further UK institutions.

1 February 2019
2018 MDPI Top Reviewer AwardWinners Announced


Rigorous peer-review is the cornerstone of high quality academic publishing. Over 97,000 scholars served as reviewers for MDPI journals in 2018. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list all reviewers’ names to express our gratitude. In addition, this year the “MDPI Top Reviewer Awards” are announced, to recognize the very best reviewers for their expertise, dedication, high quality, and timely review reports. We are pleased to announce the following winners of the 2018 MDPI Top Reviewer Awards:

  • Ali Behnood
  • Andrea Pezzuolo
  • Angela Gorgoglione
  • Anna D'Auria
  • Antonio D'Andrea
  • Azhar Abbas
  • Bogdan Zagajewski
  • Chunhui Chen
  • Dominika Głąbska
  • Dominika Guzek
  • Dragan Pamucar
  • Francisco J. G. Silva
  • Frank Li
  • Gianluca Serafini
  • Gyorgy Szekely
  • Haozhi Pan
  • Helvi Heinonen-Tanski
  • José Manuel Gómez-Soberón
  • Kathy Lewis
  • Klara Kosova
  • Luis N. López De Lacalle
  • M. Z. Naser
  • Malwina Tytła
  • Masoume Amirkhani
  • Matteo Ghidelli
  • Moretti Laura
  • Petra Schneider
  • Roberto Cerchione
  • Spyros Papaefthymiou
  • Ştefan Cristian Gherghina

24 January 2019
JAMS Journals: A Low-Cost Publishing Platform


Since 2010, MDPI has run its own online submission system. More recently, we have made the software, with accompanying publishing services, available to other publishers as JAMS (Journal and Article Management System). We are now delighted to announce the launch of JAMS Journals, a standardized platform for operating open access journals at low cost.

JAMS Journals provides a comprehensive service, including a shared submission website, journal websites hosted at a URL provided by the publisher, and a full production service. There is a small setup fee and the cost for each published paper is just a few hundred Swiss francs.

The platform demonstrates that running an open access journal can be straightforward and affordable. The JAMS Journals platform is suitable for

  • small publishers or groups of scholars looking to launch their own journal;
  • existing publishers or societies seeking to explore open access options;
  • publishers looking to convert an existing subscription journal to open access.

JAMS journals launches with two journals from Canadian-based publisher Etcetera Publications:

Dr AJ Al-Rajab (President of Etcetera Publications) comments:

“In the past few months, we were working on our project to launch new open access scientific journals in the field of agricultural and environmental sciences. We decided to go with JAMS for this venture because of the high quality of their services, reasonable prices, professionalism and easy communication. Our portfolio is expected to grow rapidly during 2019 to include more titles covering different areas in agriculture and environment. MDPI earned already our complete satisfaction and we are looking for a long term cooperation.”

Alongside the new platform, we continue to provide flexible, tailored journal management solutions for existing publishers. For any questions or to request a quotation, contact Dr. Constanze Schelhorn ([email protected]).

24 January 2019
Popularity of Preprints Continues to Grow

2018 was a great year for preprints, with increasing numbers of authors looking to make their papers available online before peer review. Along with other preprint servers, our platform Preprints.org  saw an increase in the uptake from authors, and more than double the number of announced papers compared to 2017. In fact, we recently passed two important milestones: 8000 preprints online and 30,000 authors. 

We believe that the whole research community has the opportunity to benefit from work being available online as early as possible. We thank and congratulate our authors for supporting us to make this goal a reality.

In 2019, we will be looking carefully at how to provide better value for authors, maintain efficiency while growing in size, and make sure we remain well-connected with the research community. 

If you want to participate, you can consider screening preprints or joining our advisory board. And, of course, posting your own work.

9 January 2019
Open Access Agreement between the Austrian Academic Library Consortium (KEMÖ), the Austrian Science Fund (FWF), and MDPI

We are delighted to announce the establishment of our national Open Access agreement with the Austrian Academic Library Consortium (KEMÖ) and the Austrian Science Fund (FWF). Through this national agreement, the Austrian institutions listed below as well as FWF will cover the Article Processing Charges (APC) of manuscripts published by eligible corresponding or funded authors in MDPI journals as long as central funds are available.

All participating institutions have gained access to the MDPI online submission system where they can find full article metadata and pricing information as well as Funder and Grant ID details for easy identification and additional transparency. At the same time eligible authors are benefited from an APC discount which comes at no cost for the institutions.

Eligible corresponding authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email address. To claim their discount, FWF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript. The institutions will then crosscheck the information and confirm the APC funding.

Eligible authors that have their APC covered by their institution or funder are advised to include the following sentence in their acknowledgments: "Open Access Funding by the [name of the institution/funder]".

The full text of the agreement is openly available online at: http://doi.org/10.5281/zenodo.2536007

For any questions about the agreement, please contact the KEMÖ Consortium at [email protected], FWF at [email protected], or the MDPI IOAP team at [email protected].

The Austrian institutions participating in this agreement are:

  • Austrian Science Fund (FWF)
  • University for Continuing Education Krems
  • University of Applied Sciences BFI Vienna
  • University of Applied Sciences Upper Austria
  • University of Applied Sciences Technikum Wien
  • Vorarlberg University of Applied Sciences
  • International Institute for Applied Systems Analysis (IIASA)
  • Institute of Science and Technology Austria
  • MCI Management Center Innsbruck
  • University of Graz
  • University of Linz
  • University of Salzburg
  • Graz University of Technology
  • TU Wien
  • University of Veterinary Medicine Vienna
  • University of Vienna

This is our first collective agreement with a national library consortium, while the individual institutions around the world participating in our IOAP are now more than 500 - see details here: https://www.mdpi.com/about/ioap. We would be mostly interested in discussing about possible collaborations with other consortia, funders, and institutions in our mutual efforts to accelerate Open Access.

2 January 2019
Encyclopedia—the Scholarly Community Encyclopedia

We are pleased to announce the new platform Encyclopedia, which is an online reference created and curated by active scholars. It aims to highlight the latest research results as well as providing benchmark information for researchers and the general public interested in accurate and advanced knowledge on specific topics.

We encourage authors of review articles to quote and adapt the content of their published papers to create Encyclopedia entries. You can create completely new entries on topics in which you have knowledge and expertise. There is no limit on the topics or research fields. All of science and the humanities are included. Each entry will be published directly after submission.

We also have prepared a DOI application function in Encyclopedia. Once a DOI application is approved, the entry website will announce the DOI number and a pdf version with DOI information will be automatically created.

We look forward to your contributions and hope you will make use of this service. Find more about the service at: https://encyclopedia.pub/

30 October 2018
Institutional Open Access Agreement between Bill and Melinda Gates Foundation and MDPI


We are delighted to announce that the Bill and Melinda Gates Foundation (BMGF) is now a participant of our Institutional Open Access Program (IOAP). Authors funded by the BMGF can enjoy discounts on the APC, while the funder covers the costs of eligible articles centrally. BMGF also has access to the MDPI online submission system where they can find full article metadata and pricing information as well as Grant ID details for easy identification and additional transparency.

We hope that funded authors find the programme beneficial and we are happy to offer our IOAP to other funders that need a streamlined workflow of compliance checking and APC coverage. 

To claim their discount, BMGF funded authors should choose the particular funder and add their Grant ID upon online submission of their manuscript.

For any questions about the BMGF agreement, please contact the funder at [email protected] or the MDPI IOAP team at [email protected].

11 October 2018
Meet Us at the NanoBio&Med2018 conference in Barcelona, Spain, 20–22 November 2018

MDPI will be attending NanoBio&Med2018, to be held in Barcelona, Spain, 20–22 November 2018.

This conference presents the most recent international developments in the field of Nanobiotechnology and Nanomedicine. Emerging and future trends of the converging fields of Nanotechnology, Biotechnology and Medicine will be discussed among industry, academic, governmental and non-governmental institutions and the conference will provide a platform for multidisciplinary communication.

The following MDPI journals will be represented:

If you are also attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any question you may have. For more information about the conference, please visit: http://www.nanobiomedconf.com/NBM18/index.php

2 October 2018
MDPI Welcomes Plan S

Recently, it was announced that a group of European funders supported 10 principles that will help to expand open access, known as Plan S. MDPI warmly welcomes this move as a step towards achieving more open and accessible communication of research across all disciplines. Some aspects remain to be clarified, however the details given so far match the aims and values that MDPI has held over the past two decades.

We believe that open access publishers should be active participants in discussions around Plan S, particularly regarding potential new business models and practical aspects of implementation. MDPI supports APCs as a transparent unit of payment for article publishing, however we are committed to exploring other measures and recently signed the Jussieu Call. Sustainability is a key value for MDPI, and future funding models should have at their heart the sustainability of knowledge and research dissemination. Plan S provides an opportunity for funders and publishers to directly discuss funding of open access journals in ways that are beneficial to all parties involved.

30 August 2018
MDPI establishes Open Access agreement with Qatar National Library

We are happy to announce the establishment of an Open Access (OA) agreement with Qatar National Library (QNL). QNL is committed to supporting and helping Qatar authors publish OA at no cost. Through this national agreement, QNL will cover the Article Processing Charges (APC) of manuscripts published by Qatar-based corresponding authors in MDPI journals.

Eligible corresponding authors affiliated with Qatar research centers and universities are prompted to choose QNL as part of our Institutional Open Access Program (IOAP) when they submit an article via our online submission system. The program will be selected automatically if authors submit their papers using their institutional email and/or a computer registered with the institution’s IP range. QNL will then crosscheck the information and confirm the APC funding.

Qatar authors that have their APC covered by QNL are advised to include the following sentence in their acknowledgments: "The publication of this article was funded by Qatar National Library".

For more information, please visit Open Access at QNL or email the QNL Open Access team at [email protected].

3 July 2018
Meet Us at the ESMO 2018 Congress (19–23 October 2018) in Munich, Germany


We will be attending the ESMO 2018 Congress in Munich, Germany from 19th to 23rd October 2018. The European Society for Medical Oncology (ESMO) is the leading European professional organization for medical oncology. Comprising 18,000 oncology professionals from over 150 countries, they are the society of reference for oncology education and information. The ESMO 2018 Congress will provide a scientific and educational program able to directly impact the daily clinical practice of oncologists. This year, the program also features a dedicated nursing track through a collaboration with the European Oncology Nursing Society (EONS). Representatives of the following MDPI open access journals will attend:

Cancers (https://www.mdpi.com/journal/cancers)
Antibodies (https://www.mdpi.com/journal/antibodies)
Epigenomes (https://www.mdpi.com/journal/epigenomes)
Healthcare (https://www.mdpi.com/journal/healthcare)
High-Throughput (https://www.mdpi.com/journal/high-throughput)
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm)
Journal of Personalized Medicine (https://www.mdpi.com/journal/jpm)
Medical Sciences (https://www.mdpi.com/journal/medsci)
Medicina (https://www.mdpi.com/journal/medicina)
Medicines (https://www.mdpi.com/journal/medicines)
Vaccines (https://www.mdpi.com/journal/vaccines)

If you are attending this conference, please stop by our booth (Booth # P106). Our delegates look forward to meeting you in person and answering any questions you may have concerning open access publishing and our journals.

For more information about the conference, please visit:
http://www.esmo.org/Conferences/ESMO-2018-Congress

1 June 2018
Journal of Personalized Medicine 2017 CiteScore™ Announced - 2.61

We are pleased to report the Journal of Personalized Medicine (JPM) received a CiteScore of 2.61 for 2017. The metric reflects citation activity in 2017 in Scopus for papers published in the period 2014‒2016.

For the full details in the current CiteScore release, please see the journal's Source profile. To check the full list of MDPI journals receiving CiteScores, please see here.

31 May 2018
2017 CiteScore™ Metrics Released

The 2017 CiteScore™ data is available now, based on citation data in the Scopus® database. The current CiteScore reflects citation activity in 2017 for articles published in 2014‒2016. Please note that the list below includes journals assigned a CiteScore in this year’s release. For a full list of journals indexed in Scopus, please see our journal list.

Thirteen of our journals received a CiteScore which is in the top 10% of the distribution in at least one of the categories (marked with * in the table below), while a further 32 journals exhibit scores that are in the first quartile of the respective categories.

To access the full data for MDPI journals, please see here. More data can also be found in SJR Scimago Journal & Country Rank.

Unlike CiteScores and the widely used Journal Impact Factors, the Source Normalized Impact per Paper (SNIP) metrics are normalized in order to correct for differences in citation practices between scientific fields. Therefore, the SNIP allows direct comparison between journals specialized in different fields.

According to 2017 data, MDPI publishes six journals with an average citation impact, or SNIP, in excess of 1.500. These journals are Biomolecules, Cancers, Journal of Clinical Medicine (JCM), Marine Drugs, Remote Sensing and Sensors (see the last column in the table below).

CiteScore Data for MDPI Journals

Journal Rank (Quartile)
Category Link CiteScore 2017
2016

2015
SNIP 2017
Aerospace 43/116 (Q2) • Aerospace Engineering Link 1.23 - -  1.152
Agriculture 69/309 (Q1)

91/398 (Q1)
78/255 (Q2)
• Agronomy and Crop Science
• Plant Science
• Food Science
Link 1.93 - -  1.133
Agronomy 46/309 (Q1) • Agronomy and Crop Science Link 2.38 - -  1.115
Algorithms 22/46 (Q2)
61/125 (Q2)

60/107 (Q3)

64/114 (Q3)
• Numerical Analysis
• Computational Mathematics
• Computational Theory and Mathematics
• Theoretical Computer Science
Link 1.03 1.15 1.07  0.749
Animals 12/154 (Q1) *
48/367 (Q1)
• General Veterinary
• Animal Science and Zoology
Link 2.02 1.46 1.66  1.099
Antibiotics 6/68 (Q1) *


62/263 (Q1)
55/230 (Q1)
31/108 (Q2)
47/134 (Q2)
139/398 (Q2)
• General Pharmacology, Toxicology and Pharmaceutics
• Infectious Diseases
• Pharmacology (medical)
• Microbiology (medical)
• Microbiology
• Biochemistry
Link 2.85 1.65 -  0.975
Antibodies 43/143 (Q2)
61/164 (Q2)
85/189 (Q2)
• Drug Discovery
• Immunology and Allergy
• Immunology
Link 2.85 - -  0.844
Antioxidants 23/119 (Q1)
35/169 (Q2)
100/398 (Q2)
119/367 (Q2)
102/264 (Q2)
• Clinical Biochemistry
• Physiology
• Biochemistry
• Molecular Biology
• Cell Biology
Link 3.42 - -  1.361
Applied Sciences 48/270 (Q1)
15/66 (Q1)

31/116 (Q2)
18/53 (Q2)

151/434 (Q2)

186/535 (Q2)
• General Engineering
• Fluid Flow and Transfer Processes
• Instrumentation
• Process Chemistry and Technology
• General Materials Science
• Computer Science Applications
Link 1.90 - -  0.801
Biology 12/177 (Q1)*

32/186 (Q1)


10/40 (Q1)
• General Agricultural and Biological Sciences
• General Biochemistry, Genetics and Molecular Biology
• General Immunology and Microbiology
Link 3.48 3.02 2.78  0.961
Biomolecules 31/398 (Q1) *
41/367 (Q1)
• Biochemistry
• Molecular Biology
Link 5.72 1.67 3.08  1.542
Biosensors 20/119 (Q1) • Clinical Biochemistry Link 3.59 2.83 2.37  1.122
Brain Sciences 47/111 (Q2) • General Neuroscience Link 2.56 - -  0.695
Cancers 26/323 (Q1) *
23/191 (Q1)
• Oncology
• Cancer Research
Link 5.82 5.02 4.07  1.567
Catalysts 32/151 (Q1)

21/46 (Q2)
• Physical and Theoretical Chemistry
• Catalysis
Link 3.23 3.44 3.45  0.954
Crystals 76/272 (Q2)

140/434 (Q2)

127/398 (Q2)

26/64 (Q2)
• General Chemical Engineering
• General Materials Science
• Condensed Matter Physics
• Inorganic Chemistry
Link 1.97 1.89 1.47  0.745
Diagnostics 49/119 (Q2) • Clinical Biochemistry Link 2.43 - -  0.788
Diversity 30/124 (Q1)

14/52 (Q2)


83/306 (Q2)
11/29 (Q2)
• Nature and Landscape Conservation
• Agricultural and Biological Sciences (miscellaneous)
• Ecology
• Ecological Modelling
Link 2.15 2.03 1.96  1.300
Electronics 109/644 (Q1)

26/148 (Q1)

42/224 (Q1)

50/259 (Q1)

23/96 (Q1)
• Electrical and Electronic Engineering
• Hardware and
Architecture
• Control and Systems Engineering
• Computer Networks and Communications
• Signal Processing
Link 2.97 - -  1.227
Energies 6/73 (Q1) *
31/192 (Q1)

103/644 (Q1)

4/16 (Q1)
47/140 (Q2)
• Control and Optimization
• Energy Engineering and Power Technology
• Electrical and Electronic Engineering
• Energy (miscellaneous)
• Renewable Energy, Sustainability and the Environment
Link 3.11 2.50 2.87  1.340
Entropy 35/202 (Q1) • General Physics and Astronomy Link 2.41 1.87 1.99  1.189
Forests 17/129 (Q1) • Forestry Link 2.31 2.06 1.76  0.990
Future Internet 132/259 (Q3) • Computer Networks and Communications Link 1.25 - - -
Games 132/187 (Q3)
78/110 (Q3)

305/418 (Q3)
• Statistics and Probability
• Statistics, Probability and Uncertainty
• Applied Mathematics
Link 0.61 0.87 0.57  1.038
Genes 21/91 (Q1)
74/311 (Q1)
• Genetics (clinical)
• Genetics
Link 3.49 3.62 3.18  0.374
Geosciences 32/182 (Q1)

• General Earth and Planetary Sciences Link 1.97 1.67 1.29  0.856
Information 143/251 (Q3) • Information Systems Link 1.16 0.78 0.94  1.146
Insects 27/135 (Q1) • Insect Science Link 1.85 1.81 1.38  0.719
International Journal of Environmental Research and Public Health (IJERPH) 80/478 (Q1)


34/106 (Q2)
• Public Health, Environmental and Occupational Health
• Health, Toxicology and Mutagenesis
Link 2.41 2.38 2.42  0.931
International Journal of Molecular Sciences (IJMS) 7/69 (Q1) *
61/535 (Q1)

20/163 (Q1)
9/64 (Q1)
26/151 (Q1)

89/367 (Q2)
17/46 (Q2)
• Spectroscopy
• Computer Science Applications
• Organic Chemistry
• Inorganic Chemistry
• Physical and Theoretical Chemistry
• Molecular Biology
• Catalysis
Link 3.86 3.73 3.37  0.998
ISPRS International Journal of Geo-Information (IJGI) 79/605 (Q1)

22/82 (Q2)

13/36 (Q2)
• Geography, Planning and Development
• Earth and Planetary Sciences (miscellaneous)
• Computers in Earth Sciences
Link 2.10 1.62 1.52  1.062
Journal of Clinical Medicine (JCM) 10/841 (Q1) * • General Medicine Link 7.07 - -  1.535
Journal of Functional Biomaterials (JFB) 43/199 (Q1)
23/77 (Q2)
• Biomedical Engineering
• Biomaterials
Link 3.47 - -  1.344
Journal of Low Po-
wer Electronics and Applications (JLPEA)
301/644 (Q2) • Electrical and Electronic Engineering Link 1.12 0.98 0.83  0.367
Journal of Personalized Medicine (JPM) 54/189 (Q2) • Medicine (miscellaneous) Link 2.61 - -  0.944
Land 50/124 (Q2)

129/306 (Q2)
36/65 (Q3)
• Nature and Landscape Conservation
• Ecology
• Global and Planetary Change
Link 1.44 - -  0.658
Life 4/94 (Q1) *
70/561 (Q1)

40/186 (Q1)


20/80 (Q2)
• Palaeontology
• Ecology, Evolution, Behavior and Systematics
• General Biochemistry, Genetics and Molecular Biology
• Space and Planetary Science
Link 3.16 2.95 1.68  0.935
Marine Drugs 17/146 (Q1) • Drug Discovery Link 4.58 3.83 3.66  1.537
Materials 83/434 (Q1) • General Materials Science Link 3.02 3.26 3.11  1.285
Membranes 5/18 (Q2)

15/53 (Q2)

4/10 (Q2)
• Chemical Engineering (miscellaneous)
• Process Chemistry and Technology
• Filtration and Separation
Link 2.69 2.19 2.95  0.880
Metabolites 47/209 (Q1)

103/398 (Q2)
127/367 (Q2)
• Endocrinology, Diabetes and Metabolism
• Biochemistry
• Molecular Biology
Link 3.35 - -  0.925
Metals 155/434 (Q2) • General Materials Science Link 1.87 - -  0.955
Micromachines 105/554 (Q1)
154/644 (Q1)

64/224 (Q2)
• Mechanical Engineering
• Electrical and Electronic Engineering
• Control and Systems Engineering
Link 2.31 1.83 1.78  0.987
Minerals 33/175 (Q1)


45/208 (Q1)
• Geotechnical Engineering and Engineering Geology
• Geology
Link 2.21 2.13 1.77  1.149
Molecules 4/25 (Q1)

25/172 (Q1)
18/104 (Q1)
31/163 (Q1)
30/151 (Q1)

31/146 (Q1)
55/160 (Q2)
• Chemistry (miscellaneous)
• Pharmaceutical Science
• Analytical Chemistry
• Organic Chemistry
• Physical and Theoretical Chemistry
• Drug Discovery
• Molecular Medicine
Link 3.27 3.09 2.65  1.146
Nutrients 11/255 (Q1) *
9/112 (Q1) *
• Food Science
• Nutrition and Dietetics
Link 4.35 4.29 4.07  1.403
Pathogens 38/263 (Q1)
20/108 (Q1)
9/40 (Q1)

40/164 (Q1)
110/367 (Q2)
• Infectious Diseases
• Microbiology (medical)
• General Immunology and Microbiology
• Immunology and Allergy
• Molecular Biology
Link 3.52 - -  1.166
Pharmaceuticals 14/172 (Q1) *
33/160 (Q1)
• Pharmaceutical Science
• Molecular Medicine
Link 4.12 4.90 3.64  1.370
Pharmaceutics 21/172 (Q1) • Pharmaceutical Science Link 3.68 3.83 2.68  1.092
Photonics 30/116 (Q1)
80/270 (Q2)

53/160 (Q2)
• Instrumentation
• Radiology Nuclear Medicine and Imaging
• Atomic and Molecular Physics, and Optics
Link 1.96 - -  0.817
Plants 73/561 (Q1)

48/389 (Q1)
44/306 (Q1)
• Ecology, Evolution, Behavior and Systematics
• Plant Science
• Ecology
Link 3.13 - -  0.969
Polymers 17/142 (Q1)
63/359 (Q1)
• Polymers and Plastics
• General Chemistry
Link 3.30 3.74 3.37  1.213
Religions 26/389 (Q1) * • Religious Studies Link 0.56 - -  0.676
Remote Sensing 13/182 (Q1) * • General Earth and Planetary Sciences Link 4.03 3.56 3.76  1.559
Resources 19/142 (Q1)

39/261 (Q1)
• Nature and Landscape Conservation
• Management, Monitoring, Policy and Law
Link 2.69 - -  1.387
Scientia Pharmaceutica 92/172 (Q3) • Pharmaceutical Science Link 0.86 - -  0.513
Sensors 9/116 (Q1) *
25/160 (Q1)

100/644 (Q1)

19/104 (Q1)
113/398 (Q2)
• Instrumentation
• Atomic and Molecular Physics, and Optics
• Electrical and Electronic Engineering
• Analytical Chemistry
• Biochemistry
Link 3.23 2.78 2.21  1.550
Social Sciences 81/213 (Q2) • General Social Sciences Link 0.60 - -  0.445
Sustainability 61/605 (Q1) *

55/261 (Q1)

60/140 (Q2)
• Geography, Planning and Development
• Management, Monitoring, Policy and Law
• Renewable Energy, Sustainability and the Environment
Link 2.37 1.96 1.78  1.030
Symmetry 44/327 (Q1)
17/45 (Q2)

16/40 (Q2)

14/25 (Q2)
• General Mathematics
• Computer Science (miscellaneous)
• Physics and Astronomy (miscellaneous)
• Chemistry (miscellaneous)
Link 1.32 1.12 0.95  0.802
Toxins 18/106 (Q1)

21/111 (Q1)
• Health, Toxicology and Mutagenesis
• Toxicology
Link 3.32 3.34 3.76  1.136
Vaccines 5/230 (Q1) *
13/263 (Q1) *
18/302 (Q1) *
11/146 (Q1) *
32/189 (Q1)
• Pharmacology (medical)
• Infectious Diseases
• Pharmacology
• Drug Discovery
• Immunology
Link 4.88 1.23 3.76  1.255
Viruses 29/263 (Q1)
16/68 (Q1)
• Virology
• Infectious Diseases
Link 3.88 3.60 3.74  1.130
Water 66/605 (Q1)

37/191 (Q1)

43/199 (Q1)
193/398 (Q2)
• Geography, Planning and Development
• Water Science and Technology
• Aquatic Science
• Biochemistry
Link 2.29 2.05 1.96  1.007

30 April 2018
Winners of the First MDPI Writing Prize

We are pleased to announce the results of the first MDPI Writing Prize. We received a large number of entries from across the globe on the theme of “The Global Benefits of Open Research”. It was a pleasure to read so many original, well-researched and well-presented ideas, and the final choice was not an easy one. We are pleased to announce that the winners are as follows:

1st prize (500 CHF, Swiss knife and certificate)

Edmond Sanganyado, Shantou University, China

2nd prizes (250 CHF, Swiss knife and certificate)

Kamala T. Rajahgopal, Asia e University, Malaysia
Yin Zhixuan, Qingdao University of Technology, China

3rd prizes (100 CHF, Swiss knife and certificate)

Alexandra Ticea, Carol Davila University of Medicine and Pharmacy, Romania
Ankur Sarker, University of Virginia, USA
Daniel Attoye, United Arab Emirates University, UAE

Congratulations to all of them! The winning entries can be downloaded by clicking on the names above. A compilation of all entries will soon be available as an open access book.

The writing prize is sponsored by the MDPI English editing service.

23 March 2018
Check for Updates: A New Function in the Article PDF Version

At MDPI, we always want to keep you up to date. Even for already published articles, some corrections or minor changes may occur. To prevent you from missing any updates, from now on you will be able to access the latest version of any manuscript by clicking on the “check for updates” logo that you can find in the PDF file, even if you have saved the file on your computer.

13 March 2018
MDPI Becoming a Member of UKSG

We are proud to announce that MDPI is now a member of UKSG, the UK´s largest scholarly communications community. Through UKSG, different stakeholders share their knowledge and experience in order to improve the knowledge and information environment for researchers. UKSG´s members include universities, publishers, content providers, intermediaries, and other similar organisations. Members participate in discussions and events on issues around scholarly communications.

The UKSG Annual Conference and Exhibition is a flagship initiative from the UKSG and one of the most stimulating events in the scholarly communications calendar. It is held annually and attracts a large number of delegates. More information is available at https://www.uksg.org/events/annualconference

MDPI is delighted to be a part of this active community and we look forward to making our own contribution. We will continue to support organisations and initiatives that boost collaboration and vision within scholarly communication.

More information about UKSG can be found at https://www.uksg.org/. The full membership list is available at: https://www.uksg.org/members.

1 February 2018
MDPI Signed the San Francisco Declaration on Research Assessment (DORA)

The DORA initiative addresses the need for advanced approaches in the evaluation and measurement of the quality of scientific research outputs. It is a worldwide initiative covering all scholarly disciplines. MDPI proudly joins a list of more than 400 organizations around the world which support DORA’s recommendations for improving the way the quality of research results is evaluated.

More info can be found at http://www.ascb.org/dora/

21 December 2017
Meet Us at the AACR Annual Meeting 2018 in Chicago, IL, USA


We will be attending the AACR Annual Meeting 2018, to be held in Chicago, IL, USA, 14-18 April 2018. The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. The AACR gives the opportunity to gain visibility for your organization among more than 21,000 scientists and other cancer professionals who are projected to attend from around the world. Representatives of the following MDPI open access journals will attend:

Antibodies (https://www.mdpi.com/journal/antibodies)
Biomedicines (https://www.mdpi.com/journal/biomedicines)
Cancers (https://www.mdpi.com/journal/cancers)
Cells (https://www.mdpi.com/journal/cells)
Children (https://www.mdpi.com/journal/children)
Diagnostics (https://www.mdpi.com/journal/diagnostics)
Epigenomes (https://www.mdpi.com/journal/epigenomes)
Genes (https://www.mdpi.com/journal/genes)
Healthcare (https://www.mdpi.com/journal/healthcare)
High-Throughput (https://www.mdpi.com/journal/high-throughput)
IJERPH (https://www.mdpi.com/journal/ijerph)
JCM (https://www.mdpi.com/journal/jcm)
IJMS (https://www.mdpi.com/journal/ijms)
JPM (https://www.mdpi.com/journal/jpm)
Medical Sciences (https://www.mdpi.com/journal/medsci)
Medicines (https://www.mdpi.com/journal/medicines)
Metabolites (https://www.mdpi.com/journal/metabolites)
ncRNA (https://www.mdpi.com/journal/ncrna)
Pharmaceuticals (https://www.mdpi.com/journal/pharmaceuticals)
Pharmaceutics (https://www.mdpi.com/journal/pharmaceutics)
Scientia Pharmaceutica (https://www.mdpi.com/journal/scipharm)
Vaccines (https://www.mdpi.com/journal/vaccines)

Please come along to our stand, No.1339, to have a chat with our delegates about the journals, and information on online publishing as well as our editorial procedures. You may also learn more about the various awards offered by the journals, including the Best Paper Awards, the Young Investigator Awards, Travel Awards, etc. Some useful handouts are also available. We look forward to meeting you in person to answer any questions you may have.

Conference address:
AACR Annual Meeting 2018
McCormick Place North/South
Chicago, IL, USA

Conference date:
14-18 April 2018

For more information on the conference, please visit:
http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=136

19 December 2017
Announcing the MDPI English Writing Prize

 

The competition is still open until end of March! Please check out the banner for more details: https://mdpi-res.com/data/english-prize.pdf

15 December 2017
UCL Press Adopts the MDPI Editorial Platform JAMS

We are delighted to announce that UCL Press has adopted MDPI's Journal Article & Management System, JAMS, including production services. JAMS is a modular, integrated editorial platform for academic publishers. It offers flexibility, ease-of-use, and is a fully integrated solution for the end-to-end management of scholarly journals. JAMS is based on the software used to publish MDPI’s portfolio of journals. 

Ian Caswell, UCL Press Journals Manager, says he is "excited to see UCL Press and MDPI partner together to implement the JAMS submission system for all UCL Press journals. The system offered a flexible, efficient and straightforward solution for our processes from author submission to ready for publication. I am grateful for the valuable experience and support MDPI have offered and look forward to developing our programme with an effective submission system in place.” Dr Martyn Rittman, MDPI’s Publishing Services Manager, adds, “We are proud to support one of the UK’s premier university presses in their publishing operation. This is an excellent way for us at MDPI to share our experience and knowledge, and benefit the research community beyond our own journals.”

JAMS combines services that are kept separate for many publishers. The entire editorial process, production and invoicing (e.g. for open access article processing charges) are fully integrated into a single platform. This allows for efficient, fast manuscript processing. For further information about JAMS, see https://www.mdpi.com/publishing_services

23 November 2017
New Participants in the Institutional Open Access Program (IOAP)

We are pleased to welcome new participants to MDPI's Institutional Open Access Program (IOAP), designed to help institutions manage the transition to the Open Access publishing model. Researchers affiliated with participating universites benefit from a 10% discount on the Article Processing Charges (APC) for any paper published in an MDPI journal, while the participating library or university incurs no basic fee for participating in the program.

The IOAP set of free services, provided by MDPI to institutions that sign up, include:
  • No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
  • Authors affiliated with the university will receive a 10% discount on the APC.
  • The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
  • By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
  • Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.

More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap

Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form

The following North American universities have signed up to the IOAP program recently:

Connecticut College, USA
Emory University, USA
Florida International University, USA
Johns Hopkins University, USA
Mississippi State University, USA
Northeastern University, USA
Rice University, USA
University of Ontario Institute of Technology, Canada
University of Rhode Island, USA
University of Texas Southwestern Medical Center, USA
University of Toronto, Canada
University of Windsor, Canada
University of Wisconsin–Madison, USA
Wellesley College, USA
West Virginia University, USA

Many prestigious institutions from Europe and Asia have joined as well:

Asia Pacific University of Technology & Innovation, Malaysia
Czech Technical University in Prague, Czech Republic
Gdansk University of Technology, Poland
Martin-Luther-Universität Halle-Wittenberg, Germany
National Chung Hsing University, Taiwan
Newcastle University, UK
Northumbria University, UK
Southwest University, China
Technical University of Crete, Greece
University Malaya, Malaysia
University of Antwerp, Belgium
University of Cyprus, Cyprus
University of Manchester, UK
University of Reading, UK
University of Sussex, UK
University of Warwick, UK
West Pomeranian University of Technology Szczecin, Poland

We offer a warm welcome to the new participants!

10 November 2017
Available Journal Awards at MDPI

In order to reward the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields, for example, Young Investigator Awards, Travel Awards, Best Paper Awards, and Best Poster Awards, etc. The awardees range from PhD students to junior scientists.

Currently, the following 44 awards given by MDPI journals are accepting applications. Please click on the award title below to check whether you are eligible for it and start the application process.

Subject

Journal

Award

Intended Awardee

Biology & Life Sciences

Animals

Travel Award 2018

PhD students or postdoctoral researchers

Antioxidants

Travel Awards 2018

Postdoctoral researchers or PhD students

Biology

Travel Award 2018

PhD or postdoctoral fellows

Forests

2019 Travel award

Postdocs or PhD students

International Journal of Molecular Sciences (IJMS)

Outstanding Contribution Awards 2018

Ground-breaking contribution in the fields of Molecular Biology, and Molecular Pathology

Journal of Fungi (JoF)

Travel Awards 2018

PhD graduate students, and postdoctoral fellows

Life

Travel Award 2018

PhD students or postdoctoral fellows

Metabolites

Travel Award 2018

PhD students

Pharmaceuticals

Travel Award 2018

PhD students

Toxins

Travel Award 2018

Postdoctoral fellows

Viruses

Best Oral Presentation Award 2018

Viruses 2018 participants

Viruses

Best Poster Award 2018

Viruses 2018 participants

Water

2018 Young Investigator Award

Young investigators

Chemistry & Materials Science

Biomimetics

 

Travel Award 2018

Graduate Student or Postdoctoral Trainee / Research Associate

Catalysts

Travel Award 2018

PhD students

Chemosensors

Travel Award 2018

PhD or postdoctoral fellows

Entropy

Young Investigator Award 2018

Young investigators

Fibers

2018 Travel award

Postdocs or PhD students

Magnetochemistry

Travel Award 2018

Postdocs

Materials

Travel Award 2018

PhD or postdoctoral fellows

Metals

Travel Award 2018

PhD or postdoctoral fellows

Minerals

Travel Awards 2018

PhD or postdoctoral fellows

Sensors

Travel Award 2018

PhD or postdoctoral fellows

Sensors

Outstanding Reviewer Awards 2017

Sensors' reviewers in 2017

Sensors

Young Investigator Award 2018

Young investigators

Technologies

Travel Award 2018

PhD students

Computer Science & Mathematics

Multimodal Technologies and Interaction (MTI)

Travel Awards 2018

Postdoctoral researchers or PhD students

ISPRS International Journal of Geo-Information(IJGI)

2018 Travel Award

Postdocs

Journal of Sensor and Actuator Networks (JSAN)

Travel Award 2018

Postdoctoral fellows and PhD students

Journal of Imaging

Travel Award 2018

Postdoctoral fellows and PhD students

Engineering

Actuators

Travel Award 2018

PhD or postdoctoral fellows

Remote Sensing

Best Paper Awards 2019

Authors

Machines

Travel Award 2018

PhD or postdoctoral fellows

Micromachines

Travel Awards 2018

PhD or postdoctoral fellows

Fluids

Travel Award 2018

Postdoctoral fellows and PhD students

ChemEngineering

Travel Award 2018

Postdoctoral researchers and PhD students

Environmental & Earth Sciences

Diversity

Travel Awards 2018

Postdoctoral fellows

International Journal of Environmental Research and Public Health (IJERPH)

Best Paper Award 2018

Authors who submit from 1 Nov 2017 to 31 Oct 2018

Resources

Travel Award 2018

Postdocs or PhD students

Geosciences

Travel Award 2018

Postdoctoral fellows and PhD students

Physical Sciences & Astronomy

Galaxies

Travel Award 2018

Ph.D. students, postdoctoral fellows, or lecturers in cosmology or galaxies physics

Applied Science

Travel Award 2018

Postdocs

Medicine & Pharmacology; Public Health & Healthcare

Journal of Clinical Medicine (JCM)

2018 Travel Award

PhD or postdoctoral fellows

Medicines

Travel Award 2018

Postdocs

7 November 2017
MDPI has signed the Jussieu Call for Open Science and Bibliodiversity

The Jussieu Call aims to develop and implement alternative models to meet the aims of open science while promoting bibliodiversity. In particular it wishes to promote new business models for funding open access publication. It was drafted on the Jussieu campus in Paris by a group of French researchers and scientific publishing professionals.

MDPI supports scholarly communities and initiatives that innovate and further promote Open Access publishing. There is a need to explore different frameworks to fund open access in ways that ensure that excessive funds are not diverted from research towards publishing. Many fair funding models already exist, and they can be further developed and extended. These include institutional support, library contributions or subsidies, premium services, participatory funding, etc. For this reason, MDPI has signed up to the Jussieu call and welcomes its aims.

More information can be found at http://jussieucall.org/ (archived here)

 

6 October 2017
Dr. Franck Vazquez, MDPI CEO, Interviewed by Scholarly Kitchen

The Society for Scholarly Publishing’s popular blog about topics in academic publishing, Scholarly Kitchen, recently interviewed MDPI’s CEO, Dr. Franck Vazquez. He shared some thoughts and information on the past and future of MDPI and open access publishing in general:

“In the long run, we aim to anchor MDPI in research communities. We recently developed and launched the preprint platform Preprints, revamped our free-to-use conference hosting platform Sciforum, and are working on other projects, such as Scilit, our bibliographic database.”

Read the full interview here.

2 October 2017
Meet Us at the ASHG 2017 Conference in Orlando

We will attend the American Society of Human Genetics (ASHG 2017) Conference that will be held in Orlando, FL, USA 17–21 October 2017, representing our open access journals at the interface of nanotechnology, medicine and biology:

Biomolecules
Genes
Journal of Personalized Medicine
High-Throughput

Please stop by booth 534 to chat with our delegates about the journals. They will answer any questions about open access publishing and our journals. We look forward to meeting you in Orlando!

For more information on the conference, please visit:
http://www.ashg.org/2017meeting/

25 September 2017
Meet Us at the ICONAN 2017 Conference in Barcelona

We will attend the International Conference On Nanomedicine And Nanobiotechnology (ICONAN 2017) that will be held in Barcelona, Spain, 25–27 September 2017, representing our open access journals at the interface of nanotechnology, medicine and biology:

Bioengineering
Biomedicines
Biomimetics
Biomolecules
Journal of Functional Biomaterials
Journal of Personalized Medicine
High-Throughput
Medical Sciences
Scientia Pharmaceutica

Please stop by our booth to chat with our delegates about our journals. They will answer any questions about open access publishing and our journals. We look forward to meeting you in Barcelona!

For more information on the conference, please visit:
http://premc.org/conferences/iconan-nanomedicine-nanobiotechnology/

19 September 2017
A Warm Welcome to the New IOAP Participants

We are delighted to have welcomed 24 new participants to our Institutional Open Access Programme (IOAP) since the beginning of September this year. These are University libraries and Research Institutions located around the world; from the USA and Canada to the UK, and from Norway and Spain to Greece. Well respected Universities, such as the University of Denver, the University of Colorado Boulder, and the University of Arizona in the US, have signed up, while their researchers can now benefit from a 10% discount on the Article Processing Charges (APC) for any papers they publish in MDPI journals, at no cost for the library or the University.

We are more than happy to see the Open Access movement growing stronger and wider every day and we appreciate the vital role which librarians, repository managers, and other scholarly communications professionals play in the field. Our communication with and service to this community is, therefore, one of our principal priorities. The IOAP is our way to support academic and scientific Institutions as well as their scholars in managing, administrating, and publishing research in an Open Access world.

The IOAP set of free services, provided by MDPI to institutions that sign up, include:

  • No fee for participants and no obligation to prolong after the initial 12 months. The participants may withdraw from the programme at any time, and we will also keep it free for the library for as long as they continue in the programme.
  • Authors affiliated with the university will receive a discount on the article processing charge (APC).
  • The institution is granted free access to the MDPI submission system and can receive free alerts of new submissions to our journals.
  • By default, authors from the institution will continue to be invoiced directly unless the institution opts for central billing.
  • Auto-archiving of papers into the institutions´ repository as long as it supports SWORD 1.3.

More details about the programme and a list of our current participant institutions can be found at: https://www.mdpi.com/about/ioap

Institutions which are interested to participate may do so online at: https://www.mdpi.com/ioap-form

 The full list of the Institutions that signed up in September is as follows:

  1. University of Denver, USA
  2. University of Colorado Boulder, USA
  3. University of Arizona, USA
  4. Institute of Metrology of Bosnia and Herzegovina, Bosnia and Herzegovina
  5. Middlebury College, USA
  6. Touro College, USA
  7. University of New Orleans, USA
  8. University of Leicester, UK
  9. Indiana University-Purdue University Indianapolis, USA
  10. University of Strathclyde, UK
  11. Cranfield University, UK
  12. Hope College, USA
  13. Oregon State University, USA
  14. Drew University, USA
  15. Swansea University, UK
  16. University of South Florida, USA
  17. University of Georgia, USA
  18. Arizona State University, USA
  19. University of Southern Mississippi, USA
  20. Université du Québec à Chicoutimi, Canada
  21. Grinnell College, USA
  22. Norwegian University of Science and Technology, Norway
  23. University of Patras, Greece
  24. Public University of Navarre, Spain

23 June 2017

Congratulations for Publishing the 100,000th Peer-Reviewed Article

Congratulations to the authors Javier Monroy and Javier Gonzalez-Jimenez from Universidad de Malaga, Spain, Victor Hernandez-Bennets, Han Fan and Achim Lilienthal from Örebro University, Sweden for publishing the 100,000th peer-reviewed article.

The article is published in the Chemical Sensors section of Sensors.

GADEN: A 3D Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments

Evermore pressing environmental concerns have led global actors and decision-makers to search for stricter emission monitoring approaches. As part of novel monitoring systems, robots with gas and environmental sensors are a promising solution. However, validation of such robotic inspectors is expensive, time consuming, and plagued by repeatability issues. In this article, we present GADEN (the short form for Gas Dispersion Simulator for Mobile Robot Olfaction in Realistic Environments), which combines gas dispersion and robotics simulation in a common framework. Developed under the widely used Robot Operating System (ROS), GADEN enables validation of sensing strategies with gas dispersion being simulated using computational fluid dynamics and filament dispersion theory. GADEN allows simulating complex, realistic, 3D environments for reproducible testing of robotic gas sensing algorithms. Through qualitative and quantitative evaluations, we show that GADEN is a versatile and user-friendly evaluation tool and emphasize its enormous potential for the mobile robot olfaction community.

 

Read the full article here: https://www.mdpi.com/1424-8220/17/7/1479/htm

6 June 2017
CiteScore™ Metrics Released for Scopus Journals

The CiteScore, the new citation metric for journals covered in the Scopus® database, was released on 1 June 2017, reflecting the citation activity in 2016 for articles published during the three previous years. Please note that the list below does not contain all MDPI journals covered in Scopus. For the CiteScore to serve as a reliable metric at least three volumes of articles need to be indexed in Scopus; journals which have not met this criterion have been omitted here.

Ten MDPI journals received a CiteScore which is in the Top 10% of scores in at least one of the categories, while a further 21 journals exhibit scores that are in the first quartile of the respective categories.

CiteScore Data for MDPI Journals

Journal Rank Category Link CiteScore 2016
2015

2014
Algorithms 44/112 (Q2)
49/111 (Q2)
19/42 (Q2)

52/113 (Q2)
• Numerical Analysis
• Computational Mathematics
• Computational Theory and Mathematics
• Theoretical Computer Science
Link 1.15 1.07 1.06
Animals 69/343 (Q1)
21/146 (Q1)
• Animal Science and Zoology
• General Veterinary
Link 1.46 1.66 0.74
Biology 13/92 (Q1)

34/81 (Q1)

10/75 (Q1)

• General Agricultural and Biological Sciences
• General Biochemistry, Gene-
tics and Molecular Biology
• General Immunology and Microbiology
Link 3.02 2.78 1.74
Biomolecules 234/382 (Q3)
260/353 (Q3)
• Biochemistry
• Molecular Biology
Link 1.67 3.08 1.00
Biosensors 36/118 (Q2)
209/2156 (Q1)
• Clinical Biochemistry
• General Medicine
Link 2.83 2.37 2.04
Cancers 29/196 (Q1)
27/321 (Q1)
• Cancer Research
• Oncology
Link 5.02 4.07 2.31
Catalysts 18/44 (Q2)
27/144 (Q1)
• Catalysis
• Physical and Theoretical Chemistry
Link 3.44 3.45 2.17
Crystals 70/270 (Q2)

25/64 (Q2)
118/398 (Q2)
131/424 (Q2)
• General Chemical Engineering
• Inorganic Chemistry
• Condensed Matter Physics
• General Materials Science
Link 1.89 1.47 1.03
Diversity 10/41 (Q1)

9/25 (Q2)
76/291 (Q2)
24/109 (Q1)
• Agricultural and Biological Sciences (miscellaneous)
• Ecological Modelling
• Ecology
• Nature and Landscape Conservation
Link 2.03 1.96 1.82
Energies - - Link 2.50 2.87 2.66
Entropy 51/198 (Q2) • General Physics and Astronomy Link 1.87 1.99 1.69
Forests 17/127 (Q1) • Forestry Link 2.06 1.76 1.84
Games 204/398 (Q3)
83/181 (Q2)
48/105 (Q2)
• Applied Mathematics
• Statistics and Probability
• Statistics, Probability and Uncertainty
Link 0.87 0.57 0.64
Genes 62/300 (Q1)
18/90 (Q1)
• Genetics
• Genetics (clinical)
Link 3.62 3.18 1.33
Geosciences 36/169 (Q1)

• General Earth and Planetary Sciences Link 1.67 1.29 1.13
Information 156/237 (Q3) • Information Systems Link 0.78 0.94 0.74
Insects 28/131 (Q1) • Insect Science Link 1.81 1.38 1.23
International Journal of Environmental Research and Public Health (IJERPH) 67/446 (Q1)

31/102 (Q2)
• Public Health, Environmental and Occupational Health
• Health, Toxicology and Mutagenesis
Link 2.38 2.42 2.47
International Journal of Molecular Sciences (IJMS) 23/157 (Q1)
8/64 (Q1)
90/353 (Q1)
22/144 (Q1)

16/44 (Q1)
8/62 (Q1)
• Organic Chemistry
• Inorganic Chemistry
• Molecular Biology
• Physical and Theoretical Chemistry
• Catalysis
• Spectroscopy
Link 3.73 3.37 3.06
ISPRS International Journal of Geo-Information 12/29 (Q2)
28/79 (Q2)

96/587 (Q1)
• Computers in Earth Sciences
• Earth and Planetary Sciences (miscellaneous)
• Geography, Planning and Development
Link 1.62 1.52 -
Journal of Low Power Electronic Applications (JLPEA) 301/645 (Q2) • Electrical and Electronic Engineering Link 0.98 0.83 0.83
Life 65/525 (Q1)

36/186 (Q1)

5/92 (Q1)
20/80 (Q2)
• Ecology, Evolution, Behavior and Systematics
• General Biochemistry, Gene-
tics and Molecular Biology
• Palaeontology
• Space and Planetary Science
Link 2.95 1.68 1.20
Marine Drugs 18/145 (Q1) • Drug Discovery Link 3.83 3.66 3.59
Materials 63/424 (Q1) • General Materials Science Link 3.26 3.11 2.69
Membranes 103/424 (Q1) • Materials Science Link 2.19 2.95 2.42
Micromachines 173/645 (Q2)

69/211 (Q2)

113/526 (Q1)
• Electrical and Electronic Engineering
• Control and Systems Engineering
• Mechanical Engineering
Link 1.83 1.78 2.10
Minerals 45/206 (Q1)
29/167 (Q1)
• Geology
• Geotechnical Engineering and Engineering Geology
Link 2.13 1.77 -
Molecules 32/157 (Q1) • Organic Chemistry Link 3.09 2.65 2.62
Nutrients 12/247 (Q1) • Food Science Link 4.29 4.07 3.78
Pharmaceuticals 8/168 (Q1)
21/158 (Q1)
• Pharmaceutical Science
• Molecular Medicine
Link 4.90 3.64 1.92
Pharmaceutics 19/168 (Q1) • Pharmaceutical Science Link 3.83 2.68 2.46
Polymers 13/138 (Q1)
44/354 (Q1)
• Polymers and Plastics
• General Chemistry
Link 3.74 3.37 4.10
Remote Sensing 13/169 (Q1) • General Earth and Planetary Sciences Link 3.56 3.76 3.23
Sensors 25/96 (Q2)
25/159 (Q1)

124/382 (Q2)
103/645 (Q1)
• Analytical Chemistry
• Atomic and Molecular Physics, and Optics
• Biochemistry
• Electrical and Electronic Engineering
Link 2.78 2.21 2.40
Sustainability 49/129 (Q2)

68/587 (Q1)

56/236 (Q1)
• Renewable Energy, Sustai-nability and the Environment
• Geography, Planning and Development
• Management, Monitoring, Policy and Law
Link 1.96 1.78 1.52
Symmetry 17/42 (Q2)
49/111 (Q2)
• Numerical Analysis
• Computational Mathematics
Link 1.12 0.95 1.02
Toxins 16/102 (Q1)

16/108 (Q1)
• Health, Toxicology and Mutagenesis
• Toxicology
Link 3.34 3.76 2.85
Vaccines 146/184 (Q4)
151/250 (Q3)
93/145 (Q3)
186/299 (Q3)
130/232 (Q3)
• Immunology
• Infectious Diseases
• Drug Discovery
• Pharmacology
• Pharmacology (medical)
Link 1.23 3.76 2.85
Viruses 15/68 (Q1)
34/250 (Q1)
• Virology
• Infectious Diseases
Link 3.60 3.74 3.80
Water 33/184 (Q1)

48/195 (Q1)
62/587 (Q1)

198/382 (Q3)
• Water Science and Technology
• Aquatic Science
• Geography, Planning and Development
• Biochemistry
Link 2.05 1.96 1.45

24 May 2017
Stanford Researchers Study the Reliability of Smart Watches in JPM Article

Measuring heart rate and energy expenditure using wrist-worn devices has recently become very popular, but do they really work? Professor Euan A. Ashley and his colleagues from Stanford University have tested seven different models to see how they perform in different activities. The paper, which was published in the Journal of Personalized Medicine, represents an important study in the use of personal activity monitoring, and the authors call for the establishment of better benchmarking for such devices.

17 May 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the Goethe University of Frankfurt, the Technical University of Hamburg (TU Hamburg-Harburg), as well as the Humboldt University of Berlin, in Germany, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

          

 

4 May 2017
MDPI Supports the Initiative for Open Citations (I4OC)

As an open access publisher, we are keen to support openness and transparency in the research process. Citation data is very important for assessing the value of individual papers and the contribution of researchers. As such, we support the recently launched Initiative for Open Citations (I4OC). The initiative recognizes that citations should be freely available and machine-readable. By doing so, authors gain the maximum benefit from having their work cited.

MDPI now uploads citation data with metadata uploaded to Crossref when registering digital object identifiers (DOIs) for published papers. We are delighted to take this step to support a truly open research environment.

2 May 2017
Publons Peer Review Academy Goes Live

Getting high quality review reports is critical for any journal’s editorial process. At MDPI we have put in place several measures to motivate reviewers and reward them for their work. We are proud of the quality of reviewer reports we receive and grateful for the hours put in by active researchers from across the globe.

Reviewers of MDPI’s largest journals can get recognition via Publons, a website dedicated to rewarding peer reviewers. They have now taken this one step further and launched the Publons Reviewer Academy to help train reviewers to provide useful feedback. Through the academy, researchers can be trained and tutored in various aspects of how to provide structured feedback that will be of genuine help to editors and authors. We support this initiative and recommend it to potential MDPI reviewers, especially early career researchers. See the Publons announcement for further information.

More information on reviewing for MDPI, including how to volunteer as a reviewer, can be found here.

24 April 2017
Two New Institutional Memberships Established

Inst Member

We are pleased to announce that the following universities have joined MDPI's institutional membership program: Trinity University, San Antonio, Texas, USA and the University of New South Wales (UNSW), Sydney, Australia. Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 Trinity    UNSW

 

30 March 2017
Credit for Preprints Comments via Publons

Preprints.org is a platform run by MDPI that allows authors to make early versions of manuscripts available before peer review has been completed.

One of the major benefits of putting a preprint online is to get feedback before journal submission. Until now, however, the feedback has been on a voluntary basis. Preprints is delighted to be the first preprint server to collaborate with Publons to acknowledge substantial comments as reviews and give commentators the opportunity to receive credit for their efforts. 

When you add a comment to any article, there is a check box to click for it to appear on Publons. If you have already linked your account it will be passed on automatically. If you don't already have a Publons account, you will be contacted soon afterwards with instructions on how to create one.

We appreciate the enthusiasm and cooperation of Publons in this project and expect it to be of great benefit to authors and commenters alike.

20 March 2017
MDPI 2016 Annual Report Released

We are pleased to announce that our annual report for the year 2016 has now been published. 

It contains information regarding company and journal performance, conferences and other publishing services that we provided throughout 2016. 

To read the report in full or download a copy, please click here.

15 March 2017
Our 100,000th Article Could be Yours!

After the 20th anniversary of MDPI in 2016, we will reach another milestone this year and will publish the 100,000th peer-reviewed article in one of our 170+ open access journals.

100,000th

We would like you to be part of this great achievement and so are offering to publish the 100,000th accepted paper free of charge.

To be in with a chance, select a journal in one of our 10 scientific subject areas and submit your paper.

Access the live tracker on published articles here.

100000tracker

 

 

3 March 2017
1000 Preprints Online

We are delighted that Preprints now has 1000 papers online since its launch on 3 May 2016.

For more information, see the editorial here.

 

9 February 2017
Minister and State Secretaries Visit MDPI Office at STP, Belgrade, Serbia

Earlier this week the Science Technology Park in Belgrade, Serbia was visited by Swiss Secretary of State Dr. Mauro Dell’Ambrogio, as well as Serbian Minister of Public Administration and Local Self-Government Ana Brnabic, State Secretary Dr. Vladimir Popovic and Mayor of Belgrade Mr. Siniša Mali.

During the visit to the STP they had a short presentation from MDPI’s CEO Dr. Franck Vazquez and IT Manager Mr. Miloš Čučulović, and further discussed important issues such as Open Access and Open education. Dr. Dell'Ambrogio said he was impressed with the potential for development and ideas for business.

For more information please see:

http://bit.ly/2kpIu7k and http://bit.ly/2kpUQfz

   

7 February 2017
The 6th World Sustainability Forum: Final Press Release

Basel, 29 January 2017

The 6th World Sustainability Forum #WSF2017SA: African universities critical to achieving the Sustainable Development Goals

Jeffrey and Sonia Sachs win first World Sustainability Award.

Universities need to take the lead in solving the greatest challenges the world faces today, particularly in Africa. They need to do this not only through education – teaching the next generation to think critically and creatively to find sustainable solutions – but also through research that cuts across a range of disciplines. To ensure these solutions are implemented, they need to partner with the private sector and with government.

This was the key message from the 6th World Sustainability Forum (WSF2017), which took place in Cape Town on 27 and 28 January 2017. Sponsored by MDPI and the journal Sustainability under the patronage of the Universities of the Western Cape (UWC), Cape Town (UCT), University of Basel and the National Research Foundation (NRF) of South Africa, the conference was attended by key national and international speakers, including world-leading economist Professor Jeffrey D. Sachs, senior United Nations (UN) advisor and director of the Earth Institute at Columbia University.

The WSF is an annual sustainability conference which addresses research in a range of areas related to sustainable development and sustainability globally. This was the first WSF to take place on the African continent. Discussions at the 2017 conference were driven by the 17 sustainable development goals (SDGs) adopted as part of the 2030 Agenda for Sustainable Development by the UN in September 2015.

Achieving the SDGs “is the moonshot for our generation,” said Sachs. “Like the moonshot [moon landing] of the 1960s, these are tough, bold and achievable objectives.”

This is a nasty, tough world we live in, and our world agrees on very little. So when 193 governments agree on something, that is important. And when they agree on something as important as sustainable development, that is really something for us to grab hold of – that is a lifeline.”

There was agreement at the WSF that the SDGs are particularly important for Africa, and that African universities in particular have a role to play in achieving them.

Said Professor Tyrone Pretorius, vice-chancellor of UWC: “The quest for sustainable development can only be met through education. Universities today are the oil that fuels the knowledge economy.”

As part of the drive to develop academic capacity to provide the knowledge needed to meet the SDGs, WSF2017 was preceded by the 1st Postgraduate Forum on Sustainability. “A series of workshops for postgraduate education linked to WSF are important, in order to equip postgraduates with the skills necessary to promote sustainability,” said Professor Thandi Mgwebi, director for research at UWC. A second postgraduate forum will take place alongside the WSF2018 in Beijing.

This capacity development is particularly critical to Africa. Said Sachs: “African universities need to do research to find solutions to Africa’s development challenges, because no other university will.”

The UN set a target of achieving the SDGs by 2030: “I regard this as the breakthrough period to end extreme poverty on the continent,” said Sachs, “and for Africa to become one of the most dynamic centres of the world economy.”

It is a critical time for South African universities, said Professor Mamokgethi Phakeng, deputy vice-chancellor for research and internationalisation at UCT: “Higher education is at a crossroads, and there is much polarisation. We need to think carefully about how this sustainable development agenda is owned by all so that it is inclusionary.”

There was also strong emphasis on public–private partnerships – for universities, business and government to work together to achieve the goals.

Said Professor Francis Petersen, deputy vice-chancellor at UCT and vice-chancellor designate at the University of the Free State: “Business sustainability has become critical, because there is increasing demand and complexity of demand on business from the natural, social and economic environment. Sustainability cannot be a standalone issue, divorced from business as usual. Sustainability needs to be embedded into business.”

Environmental crises and climate change was also high on the WSF agenda. In his keynote address, Sachs noted the irreversibility of the climate- and environmental-related challenges.

If we don’t get our act together, we lose the chance of safety,” he said.

Said Professor Mark New, pro vice-chancellor and director of the African Climate and Development Initiative at UCT: “We have a fundamental challenge in responding to climate change, and we must go further than just putting a plaster on a wound. We need to address the deep structural issues, to move from our current model of development into climate-compatible development.”

This requires researchers to find the evidence for the correct development pathways to take, and then support the ability of policymakers at all levels to enable the shift to climate-compatible development planning.”

Said Dr. Aldo Stroebel, executive director of international relations and cooperation at the NRF, in closing: “We have seen over the past two days an urgency towards the next step of thinking, that critical type of framework that we all must engage with, not only from an academic perspective, but further up into the policy environment and into rural-based environments where one can clearly see the links and effectiveness of the work.”

World Sustainability Awards

The first World Sustainability Award and the first Emerging Sustainability Leader Awards were presented by Prof. Thandi Mgwebi, Director of Research at UWC, and Dr. Franck Vazquez, CEO of MDPI, during the ceremony on 27 January 2017 as part of the gala dinner of the 6th World Sustainability Forum in South Africa.after day one of proceedings of the 2017 World Sustainability Forum South Africa.

Professor Jeffrey D. Sachs and Dr. Sonia Ehrlich Sachs are the joint recipients of the first World Sustainability Award. Jeffrey Sachs is a world-renowned economist and senior United Nations (UN) advisor and director of the Earth Institute at Columbia University. Sonia Sachs is a paediatrician and public health specialist, and director of the Health Centre at the Centre for Sustainable Development, also at Columbia University.

The joint recipients of the first Emerging Sustainability Leader Award are Dr. Esther Ngumbi and Dr. Xiaosong Hu. Esther Ngumbi is a postdoctoral researcher at Auburn University in Alabama USA and serves as a 2015 Clinton Global University Mentor for agriculture. Xiaosong Hu is a professor at the Chongqing University in China and specialises in automotive control systems and mechanical engineering.

The World Sustainability Award and the Emerging Sustainability Leader Awards are funded to encourage new initiatives and developments in sustainability with the ultimate aim of fostering the transition to sustainable practices and societies.

The World Sustainability Award is funded by the MDPI Sustainability Foundation, and included a monetary prize of USD 100,000 to Jeffrey and Sonia Sachs. The Emerging Sustainability Leader Award is funded by the journal Sustainability, awarded to researchers under 40, and included a monetary prize of USD10,000.

Issued jointly by: UCT Global Strategy and Visibility, Research Office, UWC Communications & Media and MDPI AG

Conference photos are free available at: https://sciforum.net/conference/wsf-6/page/175 Photo credit: Matthias Burkhalter

Carla Bernardo
Tel: (021) 650 1277
Cell: 071 407 6105
E-mail: [email protected]
University of Cape Town

Luthando Tyhalibongo
Tel: (021) 959 2625
Cell: 082 472 69 61
079 880 4655
E-mail: [email protected]
University of the Western Cape

Matthias Burkhalter
Conferences Manager
MDPI AG - www.mdpi.com
St. Alban-Anlage 66, 4052 Basel,
Switzerland
Tel. +41 61 683 77 34
Email: [email protected]

Banner

31 January 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the Chalmers University of Technology, Sweden, the University of Manitoba, Canada and the Technical University of Cartagena, Spain, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

Tex      HIT    

 

Darmstadt  

27 January 2017
6th World Sustainability Forum under way in South Africa

The 6th World Sustainability Forum is currently being held at the Cape Sun Hotel until 28 January 2017. 

The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100,000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10,000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI.

Here are some pictures from the forum so far:

To see the full WSF2017 program and schedule, please see here: https://sciforum.net/conference/wsf-6/page/schedule

19 January 2017
Cape Town to Host the 6th World Sustainability Forum

Banner

Cape Town will host the 6th World Sustainability Forum at the Cape Sun Hotel on 27 and 28 January 2017. This prominent event, held for the first time in Africa, will include many illustrious South African and international experts, such as Her Excellency Graça Machel (Sustainable Development Advocate for the United Nations, Mozambique), Joyene Isaacs (HoD Agriculture Western Cape Government), Jeffrey Sachs (Columbia University, USA), Max Bergman (SRaM, University of Basel), Mark New (Pro Vice-Chancellor, University of Cape Town), Frans Swanepoel (FutureAfrica, University of Pretoria) and Francis Petersen (Vice-Chancellor-designate, University of the Free State). The Forum will provide a stage for national and international debates on sustainability in South Africa, the African continent, and about international perspectives on sustainability. It brings together researchers and representatives from government and the business sector to discuss a wide-ranging set of issues associated with sustainability, including food security, water and energy scarcity, mining, poverty reduction, climate change, and urbanisation.

The next few decades will be marked by profound changes in the relationships between global economics, national societies, and the environment. We have entered what some call the Anthropocene, an age in which human activity dominates the climate and the environment. These changes will have numerous consequences on societies around the globe. South Africa and Africa will play a central role, for better or worse, in creating opportunities and risks during these changing times as Africa is profoundly influencing and being influenced by global developments.

The adoption of the 17 United Nations Sustainable Development Goals and the 2030 Agenda for Sustainable Development in September 2015 was accompanied by what insiders considered an optimism they have not experienced in relation to UN resolutions before. The relative efficiency in the drafting, the lack of trenches between East and West, or between North and South, and the unanimity of support of the 193 countries speak volumes. In stark contrast, sustainability seems to go against a changing economic and political tide, where waves of nationalism and protectionism from some of the most powerful countries risk the wellbeing of the rest of the world. The 6th World Sustainability Forum will enable fruitful exchanges, which sensitise South African and international communities to the global urgency and specifics of sustainability.

The Forum will showcase the work of internationally renowned researchers and include more than 150 presentations. During the conference dinner, the World Sustainability Award, associated with a US$ 100 000 prize, will be announced, as well as the Emerging Sustainability Leader Award, associated with a US$ 10 000 prize. The prizes are sponsored by the MDPI Sustainability Foundation and Sustainability, an academic open access journal by MDPI. The World Sustainability Forum is preceded by the Postgraduate Forum on Sustainability, which will introduce more than 100 young scholars from South Africa and the African continent to sustainability research. Both events are organized and sponsored by the University of Cape Town, the University of the Western Cape, the University of Basel, MDPI, and by the National Research Foundation of South Africa.

Contacts:

Scientific Matters: Prof Manfred Max Bergman, Social Research and Methodology Group (SRaM), University of Basel, Switzerland; Email:  [email protected]

Press Accreditation and General Enquiries: Mr Matthias Burkhalter, MDPI AG, Basel, Switzerland; Email: [email protected]; Tel. +41 61 683 77 34 

Follow us on Twitter

twitter logo

#WSF2017SA

 

6 January 2017
MDPI Supports the OA2020 Initiative

MDPI is now a proud supporter of the OA2020 Initiative.

Open Access 2020 is an international initiative that aims to induce the swift, smooth and scholarly-oriented transformation of today’s scholarly journals from subscription to open access publishing.

MDPI is participating in the upcoming Berlin13 conference in March 2017, where we are contributing to the initiative by aiding in the design of the roadmap which will make OA the default publishing model.

For more information please see here.

 

5 January 2017
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the University of Texas at Arlington, USA, the Harbin Institute of Technology, China and TU Darmstadt, Germany, have joined MDPI's institutional membership program: Primary authors from these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Tex      HIT    Darmstadt  

22 December 2016
Happy Festive Season!

Season's greetings from everyone at MDPI!

22 December 2016
Two New Institutional Memberships Established

Inst Member

We are pleased to announce that the Otto-von-Guericke-Universität Magdeburg, Germany and the University of California, Berkeley, USA, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

  

19 December 2016
MDPI and Wellcome Trust Compliance

The Wellcome Trust has, for a number of years, required that the results of its funded projects are published in open access format. Recently it announced criteria that publishers must fulfil for publication fees to be paid by the Trust. MDPI is pleased to have been added to the list of compliant publishers.

Only publishers who have confirmed their compliance by 16 December 2016 will be eligible to receive payment of APCs by the Wellcome Trust as of 1 April 2017. For more information on the criteria and a full list of publishers that meet them, see here.

13 December 2016
Meet MDPI at the 2016 AGU Fall Meeting

MDPI is currently attending the 2016 AGU Fall Meeting (12–16 December, 2016)

If you are also attending the conference, please feel free to stop by our booth (Booth #1147) and meet the representative editors.

Conference details:

2016 AGU Fall Meeting
12–16 December 2016
Moscone Center
747 Howard St
San Francisco, CA 94103, USA

 

8 December 2016
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that Purdue University, USA, the Universitat Politécnica de Valencia, Spain and the Queensland University of Technology, Australia, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UNM            UPM             ShanghaiJT  

16 November 2016
World Sustainability Award - Final Extension

The deadline for the World Sustainability Award has been extended for one last time! You now have one more month to nominate an individual researcher, group or project! The final deadline for nominations will be December 15, 2016. 

For full details, please visit here.

11 November 2016
Three New Institutional Memberships Established

Inst Member

We are pleased to announce that the University of Minnesota, USA, the Universidad Politécnica de Madrid, Spain and Shanghai Jiao Tong University, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UNM            UPM             ShanghaiJT  

4 November 2016
MDPI Joins the United Nations Global Compact

MDPI has become a member of the United Nations Global Compact to support corporate sustainability and have committed ourselves to the ten principles associated with the Compact.

Sustainability has always been at the core of MDPI’s values, starting with the collection and preservation of rare chemical samples that started in 1996 and led to the first journal, Molecules. Sustainability has become one of our flagship journals and we have supported and organized several conferences and events based on Sustainability, including the upcoming 6th World Sustainability Forum. As a global enterprise, we see it as our duty to promote responsible practices that will ensure a bright future for our planet. Given this, the choice to join the Global Compact was an easy one and we will do our utmost to fully implement it.

 

3 November 2016
MDPI Now a Member of SPARC Europe

We are delighted to announce that MDPI has become a member of SPARC Europe, an organization that works for open scholarship in Europe, including support of open access publication.

As one of the few publishers to join SPARC Europe to date, MDPI looks forward to making a contribution that puts open scholarship on a positive and sustainable path. We fully support the goals of open scholarship that allow the largest number of people possible to benefit from work of researchers in all disciplines. We hope that our membership will enable us to work with other stakeholders to find the best possible solution.

2 November 2016
World Sustainability Award Deadline Extension

The deadline for the World Sustainability Award has been extended! You now have until November 15, 2016 to nominate an individual researcher, group or project!

For full details, please visit here.

.

26 October 2016
Four New Institutional Memberships Established

Inst Member

We are pleased to announce that the Wuppertal Institut, Germany, the University of Girona, Spain and Central South University and Huazhong University of Science and Technology, China, have joined MDPI's institutional membership program: Primary authors from these instititions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

CSUCSU

CSU  CSU

24 October 2016
International Open Access Week 2016

Meet us during International Open Access Week 2016! We will be presenting at various locations in Europe and China. 

To get involved and for full details see the complete list of events organised by MDPI here.

 

18 October 2016
Institutional Membership established with Universitat Pompeu Fabra, Spain and Aalto University, Finland

Inst Member

We are pleased to announce that the Universitat Pompeu Fabra, Spain and Aalto University, Finland, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Pompeu   Aalto

12 October 2016
Institutional Membership Established with Iowa State University and the University of North Texas, USA

Inst Member

We are pleased to announce that the Iowa State University and the University of North Texas, USA, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Iowa  UNT

7 October 2016
MDPI at Open Access Days in Munich, 10-11 October 2016

Meet MDPI during the Open Access Days held from 10-11 October 2016 at Ludwig Maximilian University of Munich, Germany. 

The two-day event will feature experts from the open access sector, scientists from all disciplines, publishing representatives and supporters of scientific research and communication from libraries as well as research institutes and funding institutions. Join us!

For more information about the event and to see the program, visit the event webpage.

OATageMunich

7 October 2016
Institutional Membership Established with the University of Sevilla and the University of Alicante, Spain

Inst Member

We are pleased to announce that the University of Sevilla and the University of Alicante, Spain have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Sevilla  Alicante

29 September 2016
Institutional Membership Established with the University of Delaware

Inst Member

We are pleased to announce that the University of Delaware, USA, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

Delaware

19 September 2016
Peer Review Week 2016

As an open access publisher indebted to the work of our peer reviewers, we are proud to support Peer Review Week 2016. As part of the week's activities and to celebrate this year's theme "Recognition for Review", MDPI will host two webinars that anyone can join.

These webinars will explore the role and value of reviewers and the recognition they receive from a publishers perspective, with examples from MDPI's experience in publishing nearly 80,000 peer reviewed papers, along with evidence from reviewer surveys. It will also touch upon potential changes in how review is carried out and tips for early career researchers who want to be involved in the review process.

Details and links to join can be found below:

Wednesday September 21, 08:00 (CEST)

Friday September 23, 16:00 (CEST)

For more information about all the activites taking place, please visit the Peer Review Week website.

 

6 September 2016
Institutional Membership established with Kansas State University and Northwestern University, USA

Inst Member

We are pleased to announce that Kansas State University and Northwestern Universty, USE, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

KState  NWest

5 September 2016
Institutional Membership Established with University College Cork

Inst Member

We are pleased to announce that University College Cork, Ireland, has joined MDPI's institutional membership program: Primary authors from this university will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

UCC

22 August 2016
MDPI New Office Location

We are pleased to announce that MDPI has now moved to a new permanent address:

MDPI AG
St. Alban Anlage 66
CH-4052 Basel
Postfach, CH-4020 Basel
Switzerland

Telephone and fax numbers remain unchanged.

10 August 2016
Institutional Membership established with the University of Texas at Austin, USA, the Wroclaw University of Science and Technology, Poland and the University of Granada and the Compultense University of Madrid, Spain

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in August 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

            

18 July 2016
Institutional Membership established with Louisiana State University and Florida State University, USA, Royal College of Surgeons, Ireland, University of Rostock, Germany, AGH University of Science and Technology, Poland and Southeast University, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in July 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

                    

12 July 2016
MDPI Moving to New Office Location in Basel (Switzerland) in August 2016

As of 20 August 2016, MDPI's new address in Basel will be:

MDPI AG
St. Alban-Anlage 66
CH-4052 Basel
Switzerland

Telephone and fax numbers remain unchanged.

St. Alban-Anlage 66 was built from 1947 to 1948 and initially the home of the "Bühler AG", a book printing business. 

 


For more information about this building, see: https://www.mdpi.com/about/headquarters

21 June 2016
"Behind the Scenes of Academic Publishing—A Publisher's Perspective" - MDPI's Lecture at the University of Basel

From the 15-16 September, 2016, MDPI will run a course on Academic Publishing at the University of Basel.

In this two day workshop, MDPI will look in detail at the role performed by academic journal publishers and how they interact with academics. Ethical dimensions, what happens when problems occur and how the publisher coordinates all aspects of the submission process will also be covered. 

For more detailed information about the program, trainers and registration please visit the course webpage.

 

 

14 June 2016
2015 Impact Factors Released

We are pleased to report the 2015 Journal Impact Factors in the latest Journal Citation Reports® Science Edition, published by Thomson Reuters in June 2016. Twenty out of 25 journals have seen an increase in their Impact Factor and two journals (Crystals and IJGI) received a first Impact Factor. Coatings was recently added to SCIE and will receive its first Impact Factor in next year’s JCR.

Updated Impact Factors for Journals in the Science Citation Index Expanded (SCIE)

Journal 2015 Impact Factor Details Category Rank
Applied Sciences 1.726 Link 83/163 (Q3) in ‘Chemistry, Multidisciplinary’;
129/271 (Q2) in ‘Materials Science, Multidisciplinary’;
64/145 (Q2) in ‘Physics, Applied’
Atmosphere 1.221 Link 66/84 (Q4) in ‘Meteorology & Atmospheric Sciences’
Catalysts 2.964 Link 53/144 (Q2) in ‘Chemistry, Physical’
Energies 2.077 Link 43/88 (Q2) in ‘Energy & Fuels’
Entropy 1.743 Link 25/79 (Q2) in ‘Physics, Multidisciplinary’
Forests 1.583 Link 19/66 (Q2) in ‘Forestry’
Genes 3.242 Link 60/165 (Q2) in ‘Genetics & Heredity’
International Journal of Environmental Research and Public Health (IJERPH) 2.035 Link 101/225 (Q2) in ‘Environmental Sciences’
International Journal of Molecular Sciences (IJMS) 3.257 Link 110/289 (Q2) in ‘Biochemistry & Molecular Biology’;
51/163 (Q2) in ‘Chemistry, Multidisciplinary’
Marine Drugs 3.345 Link 13/59 (Q1) in ‘Chemistry, Medicinal’
Materials 2.728 Link 63/271 (Q1) in ‘Materials Science, Multidisciplinary’
Metals 1.574 Link 18/73 (Q1) in ‘Metallurgy & Metallurgical Engineering’;
145/271 (Q3) in ‘Materials Science, Multidisciplinary’
Micromachines 1.295 Link 30/56 (Q3) in ‘Instruments & Instrumentation’
63/83 (Q4) in ‘Nanoscience & Nanotechnology’
Minerals 1.468 Link 9/21 (Q2) in ‘Mining & Mineral Processing;
14/29 (Q2) in ‘Mineralogy’
Molecules 2.465 Link 24/59 (Q2) in ‘Chemistry, Organic’
Nanomaterials 2.690 Link 64/271 (Q1) in ‘Materials Science, Multidisciplinary’;
36/83 (Q2) in ‘Nanoscience & Nanotechnology’
Nutrients 3.759 Link 16/78 (Q1) in ‘Nutrition & Dietetics’
Polymers 2.944 Link 20/85 (Q1) in ‘Polymer Science’
Remote Sensing 3.036 Link 5/28 (Q1) in ‘Remote Sensing’
Sensors 2.033 Link 36/75 (Q2) in ‘Chemistry, Analytical’;
16/27 (Q3) in ‘Electrochemistry’;
12/56 (Q1) in ‘Instruments & Instrumentation’
Sustainability 1.343 Link 146/225 (Q3) in ‘Environmental Sciences’;
22/29 (Q4) in ‘Green & Sustainable Science & Technology’
Symmetry 0.841 Link 31/63 (Q2) in ‘Multidisciplinary Sciences’
Toxins 3.571 Link 16/89 (Q1) in ‘Toxicology’
Viruses 3.042 Link 14/33 (Q2) in ‘Virology’
Water 1.687 Link 33/85 (Q2) in ‘Water Resources’

Journals with First Impact Factors

Journal 2015 Impact Factor Details Category Rank
Crystals 2.075 Link 13/26 (Q2) in ‘Crystallography’
ISPRS International Journal of Geo-Information 0.651 Link 45/49 (Q4) in ‘Geography, Physical’;
26/28 (Q4) in ‘Remote Sensing’.

 

26 May 2016
Institutional Membership established with University of Bremen, Germany, Koç University, Turkey, IIASA, Austria and Jilin University and Kunming Institute of Botany, CAS, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in May 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

                

23 May 2016
Institutional Membership Established with the KTH Royal Institute of Technology, Sweden and the South China University of Technology, Beijing University of Technology and Southern Medical University, China

We are pleased to announce that the following institutions have joined MDPI's institutional membership program in April and May 2016:

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

            

26 April 2016
New Section on www.mdpi.com - Latest Books

You may have noticed a new section that is now visible on our home page. This section is called "Latest Books" and showcases recent publications from MDPI Books, our book publishing service.

Books Section

By clicking on the hyperlink "More Books" you will be taken to the MDPI Books Home Page. There you will find more information about the service, as well as the "Recent Publications" list. 

Clicking on any of the book images in this list will take you to detailed information about that book (shown below). Here you can also download a PDF version of the book, or order a hardcover printed copy.

For further information about the MDPI Books service, please visit the webpage or contact [email protected].

 Individual Book Page

 

31 March 2016
Axioms, Behavioral Sciences, Photonics, Separations and Toxics added to the Emerging Sources Citation Index in Web of Science

We are pleased to announce that the journals Axioms, Behavioral Sciences, Photonics, Separations and Toxics were recently accepted for inclusion in the newly launched Emerging Sources Citation Index (ESCI) in Web of Science.

ESCI serves to highlight promising journals which are still under consideration for the Science Citation Index Expanded (SCIE) or the Social Sciences Citation Index (SSCI).

 

The Emerging Sources Citation Index (ESCI), Science Citation Index Expanded (SCIE), Social Sciences Citation Index
(SSCI), and Web of Science™ (WoS) are Thomson Reuters products.

Thomson Reuters Logo

 

 

 

30 March 2016
Institutional Membership established with the University of Winchester, UK, Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China

Inst Member

We are pleased to announce that the University of Winchester, UK, the Silesian University of Technology, Poland and Beijing Jiaotong University and Zhejiang University, China, have joined our Institutional Membership program. Primary authors from these universities will benefit from a 10% discount on article processing charges.

Additional details can be found on our institutional membership page.

Winchester Silesian Beijing Jiaotong Zhejiang

24 March 2016
New Editorial Office in Barcelona, Spain

We are excited to announce the opening of our new editorial office in Barcelona, Spain. The launch team is led by a Senior Editor and comprises further staff holding doctoral degrees with several years of research experience. The new editorial team will help us to get closer to European research communities and progress Sciforum, the platform to support the scientific community via conference hosting and other functions. They will also help spread the word about Open Access and meet academics at scientific events.

We are in the process of hiring more doctoral and masters graduates to join the editorial team and welcome applications via [email protected]. For contact details about the office, see our contact page.

22 February 2016
Membership Established with the Max Planck Society

We are pleased to announce that the Max Planck Digital Library (MPDL) has signed an agreement with MDPI to support authors associated with the Max Planck Society (Max-Planck-Gesellschaft). As of 22 February 2016, corresponding authors will receive full funding from the MPDL for articles published in MDPI journals, with a 10% discount applied to the Article Processing Charges. Additional details can be found at our institutional membership page.

Founded in 1948, The Max Planck Society is one of Germany’s leading research organizations, and is currently made up of 83 institutes conducting basic research in natural sciences, life sciences, social sciences and humanities. 18 Nobel laureates have emerged from its ranks of scientists and the society has more than 15,000 publications in scientific journals each year.

 

5 February 2016
Institutional Membership Extension: Wageningen University, CSIC, University of Zürich, ETH Zürich, University of Tübingen and Osnabrück University

We are pleased to announce that Wageningen University, the Netherlands, the Spanish National Research Council (CSIC), Spain, the University of Zürich and ETH Zürich, Switzerland, and the University of Tübingen and Osnabrück University, Germany, have not only renewed their institutional memberships with MDPI after two years of successful cooperation, but have also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.

Additional details can be found on our institutional membership page.

WageningenCISCZurich ETHZurichTuebingen Osnabrück 

5 February 2016
Institutional Membership established with Brock University, Canada and the University of Pisa, Italy

Inst Member

We are pleased to announce that Brock University, Cananda, and the University of Pisa, Italy, have joined MDPI's institutional membership program: Primary authors from these universities will benefit from a 10% discount on the article processing charges as of 01 February 2016. 

Additional details can be found on our institutional membership page.

Brock Pisa

25 January 2016
MDPI Sponsors diss:kurs with the University of Basel

 

MDPI is pleased to announce its newly established sponsorship of diss:kurs, an event coordinated by the University of Basel to support their doctorate program. For more information about the event and how to register, please visit the diss:kurs webpage.

 

7 January 2016
New Institutional Memberships Established with Tsinghua University, the Chinese Society of Micro-Nano Technology, Ruhr University Bochum and the University of Ulm

We are pleased to announce that the following institutions have joined MDPI's institutional membership program as of 1 January 2016:

  • Tsinghua University, China
  • Chinese Society of Micro-Nano Technology (CSMNT)
  • Ruhr University Bochum, Germany
  • University of Ulm, Germany

Authors affiliated with these institutions will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

 

 

5 January 2016
Safety, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae Released Their First Issue in December 2015

We are pleased to announce that MDPI's open access journals Safety, Journal of Imaging, Fermentation, C-Journal of Carbon Research, Magnetochemistry, Batteries and Horticulturae released their first issue at the end of December 2015.

  

23 December 2015
Happy Festive Season!

Season's greetings from everyone at MDPI!

style="width:304px;height:228px;"

17 December 2015
Institutional Membership Extension: University of Bern, Switzerland

We are pleased to announce that the University of Bern, Switzerland has not only renewed their institutional membership with MDPI after two years of successful cooperation, but also increased the reduction of the article processing charges (APCs) for affiliated authors to 25%.

 

17 December 2015
Institutional Membership with the University of Ulm and Helmholtz Zentrum Munich

We are pleased to announce that University of Ulm, Germany and Helmholtz Zentrum Munich, Germany has joined MDPI's institutional membership program:

Primary authors from the University of Ulm and Helmholtz Zentrum Munich will benefit from a 10% discount on the article processing charges as of 1 January 2016. Additional details can be found on our institutional membership page.

 

style="width:150px;height:228px;"         style="width:304px;height:228px;"

9 December 2015
Membership Established with the Virginia Polytechnic Institute and State University (Virginia Tech)

We are pleased to announce that Virginia Tech has joined MDPI's institutional membership program. Authors from Virginia Tech will benefit from a 10% discount on the article processing charges as of 1 December 2015. Additional details can be found on our institutional membership page.

1 December 2015
Membership Established with the Technical University of Denmark and the University of North Florida

We are pleased to announce that the following universities have joined MDPI's institutional membership program:

  • Technical University of Denmark (as of 1 November 2015)
  • University of North Florida, USA (as of 15 November 2015)

Primary authors from the Technical University of Denmark and the University of North Florida will benefit from a 10% discount on the article processing charges.

Additional details can be found on our institutional membership page.

2 October 2015
Membership Established with the University of Freiburg and the University of Regensburg

We are pleased to announce that the following universities have joined MDPI's institutional membership program:

University of Freiburg, Germany
University of Regensburg, Germany

Primary authors from the University of Freiburg and the University of Regensburg will benefit from a 10% discount on the article processing charges as of 1 October 2015 and 1 November 2015.

Additional details can be found on our institutional membership page.

Back to TopTop